 
# GREAT version 3.0.0	Species assembly: hg19	Association rule: Basal+extension: 5000 bp upstream, 1000 bp downstream, 1000000 bp max extension, curated regulatory domains included
# Ontology summary statistics are provided in the footer.
#
# Ontology	ID	Desc	BinomRank	BinomP	BinomBonfP	BinomFdrQ	RegionFoldEnrich	ExpRegions	ObsRegions	GenomeFrac	SetCov	HyperRank	HyperP	HyperBonfP	HyperFdrQ	GeneFoldEnrich	ExpGenes	ObsGenes	TotalGenes	GeneSetCov	TermCov	Regions	Genes
GO Molecular Function	GO:0047783	corticosterone 18-monooxygenase activity	1	4.497249e-5	1.658585e-1	1.658585e-1	2.223582e+4	4.497249e-5	1	4.497249e-5	1.000000e+0	1	1.108586e-4	4.088465e-1	4.088465e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CYP11B2
GO Molecular Function	GO:0004507	steroid 11-beta-monooxygenase activity	2	6.211336e-5	2.290741e-1	1.145370e-1	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	2	2.217111e-4	8.176705e-1	4.088353e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
GO Molecular Function	GO:0016713	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen	3	3.197202e-4	1.000000e+0	3.930427e-1	3.127735e+3	3.197202e-4	1	3.197202e-4	1.000000e+0	3	7.758812e-4	1.000000e+0	9.538166e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	CYP11B2
GO Molecular Function	GO:0008395	steroid hydroxylase activity	4	1.044359e-3	1.000000e+0	9.628990e-1	9.575247e+2	1.044359e-3	1	1.044359e-3	1.000000e+0	4	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
GO Molecular Function	GO:0004497	monooxygenase activity	5	7.515851e-3	1.000000e+0	1.000000e+0	1.330521e+2	7.515851e-3	1	7.515851e-3	1.000000e+0	5	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	CYP11B2
GO Molecular Function	GO:0020037	heme binding	6	8.778443e-3	1.000000e+0	1.000000e+0	1.139154e+2	8.778443e-3	1	8.778443e-3	1.000000e+0	6	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	CYP11B2
GO Molecular Function	GO:0046906	tetrapyrrole binding	7	9.836374e-3	1.000000e+0	1.000000e+0	1.016635e+2	9.836374e-3	1	9.836374e-3	1.000000e+0	7	1.524040e-2	1.000000e+0	1.000000e+0	6.536594e+1	1.529849e-2	1	138	5.000000e-1	7.246377e-3	unnamed	CYP11B2
GO Molecular Function	GO:0005506	iron ion binding	8	1.254896e-2	1.000000e+0	1.000000e+0	7.968786e+1	1.254896e-2	1	1.254896e-2	1.000000e+0	9	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	CYP11B2
GO Molecular Function	GO:0016705	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen	9	1.379212e-2	1.000000e+0	1.000000e+0	7.250518e+1	1.379212e-2	1	1.379212e-2	1.000000e+0	8	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	CYP11B2
GO Molecular Function	GO:0016491	oxidoreductase activity	10	6.045513e-2	1.000000e+0	1.000000e+0	1.654119e+1	6.045513e-2	1	6.045513e-2	1.000000e+0	10	7.769532e-2	1.000000e+0	1.000000e+0	1.261608e+1	7.926390e-2	1	715	5.000000e-1	1.398601e-3	unnamed	CYP11B2
GO Molecular Function	GO:0046914	transition metal ion binding	11	1.321251e-1	1.000000e+0	1.000000e+0	7.568583e+0	1.321251e-1	1	1.321251e-1	1.000000e+0	11	1.516365e-1	1.000000e+0	1.000000e+0	6.334621e+0	1.578626e-1	1	1424	5.000000e-1	7.022472e-4	unnamed	CYP11B2
GO Molecular Function	GO:0046872	metal ion binding	12	3.527991e-1	1.000000e+0	1.000000e+0	2.834474e+0	3.527991e-1	1	3.527991e-1	1.000000e+0	12	3.911753e-1	1.000000e+0	1.000000e+0	2.275605e+0	4.394435e-1	1	3964	5.000000e-1	2.522704e-4	unnamed	CYP11B2
GO Molecular Function	GO:0043169	cation binding	13	3.606111e-1	1.000000e+0	1.000000e+0	2.773071e+0	3.606111e-1	1	3.606111e-1	1.000000e+0	13	3.968711e-1	1.000000e+0	1.000000e+0	2.238337e+0	4.467602e-1	1	4030	5.000000e-1	2.481390e-4	unnamed	CYP11B2
GO Molecular Function	GO:1901363	heterocyclic compound binding	14	4.273925e-1	1.000000e+0	1.000000e+0	2.339769e+0	4.273925e-1	1	4.273925e-1	1.000000e+0	14	5.012582e-1	1.000000e+0	1.000000e+0	1.701981e+0	5.875506e-1	1	5300	5.000000e-1	1.886792e-4	unnamed	CYP11B2
GO Molecular Function	GO:0097159	organic cyclic compound binding	15	4.323803e-1	1.000000e+0	1.000000e+0	2.312779e+0	4.323803e-1	1	4.323803e-1	1.000000e+0	15	5.069571e-1	1.000000e+0	1.000000e+0	1.678857e+0	5.956433e-1	1	5373	5.000000e-1	1.861158e-4	unnamed	CYP11B2
GO Molecular Function	GO:0003824	catalytic activity	16	4.361959e-1	1.000000e+0	1.000000e+0	2.292548e+0	4.361959e-1	1	4.361959e-1	1.000000e+0	16	5.163312e-1	1.000000e+0	1.000000e+0	1.641882e+0	6.090571e-1	1	5494	5.000000e-1	1.820167e-4	unnamed	CYP11B2
GO Molecular Function	GO:0043167	ion binding	17	5.095070e-1	1.000000e+0	1.000000e+0	1.962682e+0	5.095070e-1	1	5.095070e-1	1.000000e+0	17	5.570694e-1	1.000000e+0	1.000000e+0	1.494945e+0	6.689208e-1	1	6034	5.000000e-1	1.657275e-4	unnamed	CYP11B2
GO Molecular Function	GO:0005488	binding	18	8.171102e-1	1.000000e+0	1.000000e+0	1.223825e+0	8.171102e-1	1	8.171102e-1	1.000000e+0	18	8.942547e-1	1.000000e+0	1.000000e+0	7.409644e-1	1.349593e+0	1	12174	5.000000e-1	8.214227e-5	unnamed	CYP11B2
GO Biological Process	GO:0002017	regulation of blood volume by renal aldosterone	1	6.550931e-5	6.839172e-1	6.839172e-1	1.526501e+4	6.550931e-5	1	6.550931e-5	1.000000e+0	3	2.217111e-4	1.000000e+0	7.715546e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
GO Biological Process	GO:0048242	epinephrine secretion	2	8.278228e-5	8.642470e-1	4.321235e-1	1.207988e+4	8.278228e-5	1	8.278228e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LY6E
GO Biological Process	GO:0032342	aldosterone biosynthetic process	3	1.051046e-4	1.000000e+0	3.657640e-1	9.514330e+3	1.051046e-4	1	1.051046e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	6.943799e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	CYP11B2
GO Biological Process	GO:0034651	cortisol biosynthetic process	3	1.051046e-4	1.000000e+0	3.657640e-1	9.514330e+3	1.051046e-4	1	1.051046e-4	1.000000e+0	5	3.325574e-4	1.000000e+0	6.943799e-1	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	CYP11B2
GO Biological Process	GO:0048241	epinephrine transport	5	1.834054e-4	1.000000e+0	3.829505e-1	5.452401e+3	1.834054e-4	1	1.834054e-4	1.000000e+0	3	2.217111e-4	1.000000e+0	7.715546e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	LY6E
GO Biological Process	GO:0006705	mineralocorticoid biosynthetic process	6	2.018897e-4	1.000000e+0	3.512881e-1	4.953199e+3	2.018897e-4	1	2.018897e-4	1.000000e+0	9	5.542315e-4	1.000000e+0	6.429085e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP11B2
GO Biological Process	GO:0035865	cellular response to potassium ion	7	2.801381e-4	1.000000e+0	4.178060e-1	3.569668e+3	2.801381e-4	1	2.801381e-4	1.000000e+0	9	5.542315e-4	1.000000e+0	6.429085e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP11B2
GO Biological Process	GO:0006704	glucocorticoid biosynthetic process	8	3.946376e-4	1.000000e+0	5.150021e-1	2.533970e+3	3.946376e-4	1	3.946376e-4	1.000000e+0	12	9.975062e-4	1.000000e+0	8.678304e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP11B2
GO Biological Process	GO:0050432	catecholamine secretion	9	4.492891e-4	1.000000e+0	5.211754e-1	2.225738e+3	4.492891e-4	1	4.492891e-4	1.000000e+0	7	4.433975e-4	1.000000e+0	6.612957e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	LY6E
GO Biological Process	GO:0006700	C21-steroid hormone biosynthetic process	10	6.038319e-4	1.000000e+0	6.304005e-1	1.656090e+3	6.038319e-4	1	6.038319e-4	1.000000e+0	16	1.440682e-3	1.000000e+0	9.400450e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CYP11B2
GO Biological Process	GO:0001977	renal system process involved in regulation of blood volume	11	7.671717e-4	1.000000e+0	7.281157e-1	1.303489e+3	7.671717e-4	1	7.671717e-4	1.000000e+0	19	1.551461e-3	1.000000e+0	8.524870e-1	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	CYP11B2
GO Biological Process	GO:0008211	glucocorticoid metabolic process	12	1.137490e-3	1.000000e+0	9.896163e-1	8.791284e+2	1.137490e-3	1	1.137490e-3	1.000000e+0	20	1.662234e-3	1.000000e+0	8.676861e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	CYP11B2
GO Biological Process	GO:0042415	norepinephrine metabolic process	13	1.218917e-3	1.000000e+0	9.788841e-1	8.204002e+2	1.218917e-3	1	1.218917e-3	1.000000e+0	11	7.758812e-4	1.000000e+0	7.363818e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	LY6E
GO Biological Process	GO:0008207	C21-steroid hormone metabolic process	14	1.222222e-3	1.000000e+0	9.114284e-1	8.181819e+2	1.222222e-3	1	1.222222e-3	1.000000e+0	24	2.437470e-3	1.000000e+0	1.000000e+0	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	CYP11B2
GO Biological Process	GO:0003084	positive regulation of systemic arterial blood pressure	15	1.356561e-3	1.000000e+0	9.441665e-1	7.371579e+2	1.356561e-3	1	1.356561e-3	1.000000e+0	16	1.440682e-3	1.000000e+0	9.400450e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CYP11B2
GO Biological Process	GO:0042181	ketone biosynthetic process	16	1.506641e-3	1.000000e+0	9.830833e-1	6.637283e+2	1.506641e-3	1	1.506641e-3	1.000000e+0	26	2.880326e-3	1.000000e+0	1.000000e+0	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	CYP11B2
GO Biological Process	GO:0051937	catecholamine transport	17	1.559386e-3	1.000000e+0	9.576465e-1	6.412780e+2	1.559386e-3	1	1.559386e-3	1.000000e+0	14	1.219107e-3	1.000000e+0	9.091055e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	LY6E
GO Biological Process	GO:0003091	renal water homeostasis	18	1.619686e-3	1.000000e+0	9.394179e-1	6.174036e+2	1.619686e-3	1	1.619686e-3	1.000000e+0	16	1.440682e-3	1.000000e+0	9.400450e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CYP11B2
GO Biological Process	GO:0055075	potassium ion homeostasis	19	1.635863e-3	1.000000e+0	8.988637e-1	6.112980e+2	1.635863e-3	1	1.635863e-3	1.000000e+0	12	9.975062e-4	1.000000e+0	8.678304e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP11B2
GO Biological Process	GO:0055078	sodium ion homeostasis	20	1.886558e-3	1.000000e+0	9.847833e-1	5.300659e+2	1.886558e-3	1	1.886558e-3	1.000000e+0	15	1.329898e-3	1.000000e+0	9.256090e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	CYP11B2
GO Biological Process	GO:0003071	renal system process involved in regulation of systemic arterial blood pressure	21	1.949603e-3	1.000000e+0	9.692312e-1	5.129250e+2	1.949603e-3	1	1.949603e-3	1.000000e+0	21	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP11B2
GO Biological Process	GO:0050891	multicellular organismal water homeostasis	22	2.018309e-3	1.000000e+0	9.577794e-1	4.954643e+2	2.018309e-3	1	2.018309e-3	1.000000e+0	21	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP11B2
GO Biological Process	GO:0015844	monoamine transport	23	2.255801e-3	1.000000e+0	1.000000e+0	4.433016e+2	2.255801e-3	1	2.255801e-3	1.000000e+0	21	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	LY6E
GO Biological Process	GO:0030104	water homeostasis	24	3.321795e-3	1.000000e+0	1.000000e+0	3.010421e+2	3.321795e-3	1	3.321795e-3	1.000000e+0	27	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	CYP11B2
GO Biological Process	GO:0042180	cellular ketone metabolic process	25	3.770613e-3	1.000000e+0	1.000000e+0	2.652089e+2	3.770613e-3	1	3.770613e-3	1.000000e+0	38	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CYP11B2
GO Biological Process	GO:0001990	regulation of systemic arterial blood pressure by hormone	26	4.160689e-3	1.000000e+0	1.000000e+0	2.403448e+2	4.160689e-3	1	4.160689e-3	1.000000e+0	28	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CYP11B2
GO Biological Process	GO:0042446	hormone biosynthetic process	27	4.321627e-3	1.000000e+0	1.000000e+0	2.313943e+2	4.321627e-3	1	4.321627e-3	1.000000e+0	34	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	CYP11B2
GO Biological Process	GO:0045777	positive regulation of blood pressure	28	4.644542e-3	1.000000e+0	1.000000e+0	2.153065e+2	4.644542e-3	1	4.644542e-3	1.000000e+0	28	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CYP11B2
GO Biological Process	GO:0030325	adrenal gland development	29	4.678207e-3	1.000000e+0	1.000000e+0	2.137571e+2	4.678207e-3	1	4.678207e-3	1.000000e+0	25	2.658910e-3	1.000000e+0	1.000000e+0	3.758542e+2	2.660606e-3	1	24	5.000000e-1	4.166667e-2	unnamed	LY6E
GO Biological Process	GO:0006584	catecholamine metabolic process	30	5.411360e-3	1.000000e+0	1.000000e+0	1.847964e+2	5.411360e-3	1	5.411360e-3	1.000000e+0	30	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	LY6E
GO Biological Process	GO:0050886	endocrine process	31	5.915240e-3	1.000000e+0	1.000000e+0	1.690549e+2	5.915240e-3	1	5.915240e-3	1.000000e+0	33	4.650770e-3	1.000000e+0	1.000000e+0	2.147738e+2	4.656061e-3	1	42	5.000000e-1	2.380952e-2	unnamed	CYP11B2
GO Biological Process	GO:0003044	regulation of systemic arterial blood pressure mediated by a chemical signal	32	6.113111e-3	1.000000e+0	1.000000e+0	1.635828e+2	6.113111e-3	1	6.113111e-3	1.000000e+0	34	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	CYP11B2
GO Biological Process	GO:0055010	ventricular cardiac muscle tissue morphogenesis	33	6.528715e-3	1.000000e+0	1.000000e+0	1.531695e+2	6.528715e-3	1	6.528715e-3	1.000000e+0	32	4.429551e-3	1.000000e+0	1.000000e+0	2.255125e+2	4.434344e-3	1	40	5.000000e-1	2.500000e-2	unnamed	LY6E
GO Biological Process	GO:0015850	organic hydroxy compound transport	34	7.016786e-3	1.000000e+0	1.000000e+0	1.425154e+2	7.016786e-3	1	7.016786e-3	1.000000e+0	50	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	LY6E
GO Biological Process	GO:0003229	ventricular cardiac muscle tissue development	35	7.072373e-3	1.000000e+0	1.000000e+0	1.413953e+2	7.072373e-3	1	7.072373e-3	1.000000e+0	36	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	LY6E
GO Biological Process	GO:0071248	cellular response to metal ion	36	7.115213e-3	1.000000e+0	1.000000e+0	1.405439e+2	7.115213e-3	1	7.115213e-3	1.000000e+0	48	9.180352e-3	1.000000e+0	1.000000e+0	1.086807e+2	9.201264e-3	1	83	5.000000e-1	1.204819e-2	unnamed	CYP11B2
GO Biological Process	GO:0035265	organ growth	37	7.196438e-3	1.000000e+0	1.000000e+0	1.389576e+2	7.196438e-3	1	7.196438e-3	1.000000e+0	31	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	LY6E
GO Biological Process	GO:0034754	cellular hormone metabolic process	38	7.502043e-3	1.000000e+0	1.000000e+0	1.332970e+2	7.502043e-3	1	7.502043e-3	1.000000e+0	50	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	CYP11B2
GO Biological Process	GO:0055067	monovalent inorganic cation homeostasis	39	7.523661e-3	1.000000e+0	1.000000e+0	1.329140e+2	7.523661e-3	1	7.523661e-3	1.000000e+0	42	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	CYP11B2
GO Biological Process	GO:0046879	hormone secretion	40	8.068314e-3	1.000000e+0	1.000000e+0	1.239416e+2	8.068314e-3	1	8.068314e-3	1.000000e+0	41	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	LY6E
GO Biological Process	GO:0071241	cellular response to inorganic substance	41	8.138409e-3	1.000000e+0	1.000000e+0	1.228741e+2	8.138409e-3	1	8.138409e-3	1.000000e+0	49	9.842351e-3	1.000000e+0	1.000000e+0	1.013539e+2	9.866415e-3	1	89	5.000000e-1	1.123596e-2	unnamed	CYP11B2
GO Biological Process	GO:0009914	hormone transport	42	8.335601e-3	1.000000e+0	1.000000e+0	1.199674e+2	8.335601e-3	1	8.335601e-3	1.000000e+0	42	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	LY6E
GO Biological Process	GO:0046165	alcohol biosynthetic process	43	8.603659e-3	1.000000e+0	1.000000e+0	1.162296e+2	8.603659e-3	1	8.603659e-3	1.000000e+0	54	1.127592e-2	1.000000e+0	1.000000e+0	8.843627e+1	1.130758e-2	1	102	5.000000e-1	9.803922e-3	unnamed	CYP11B2
GO Biological Process	GO:0016125	sterol metabolic process	44	9.229781e-3	1.000000e+0	1.000000e+0	1.083449e+2	9.229781e-3	1	9.229781e-3	1.000000e+0	56	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	CYP11B2
GO Biological Process	GO:0003014	renal system process	45	9.421661e-3	1.000000e+0	1.000000e+0	1.061384e+2	9.421661e-3	1	9.421661e-3	1.000000e+0	45	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	CYP11B2
GO Biological Process	GO:0055008	cardiac muscle tissue morphogenesis	46	9.507190e-3	1.000000e+0	1.000000e+0	1.051836e+2	9.507190e-3	1	9.507190e-3	1.000000e+0	37	5.977571e-3	1.000000e+0	1.000000e+0	1.670463e+2	5.986364e-3	1	54	5.000000e-1	1.851852e-2	unnamed	LY6E
GO Biological Process	GO:0006694	steroid biosynthetic process	47	9.527568e-3	1.000000e+0	1.000000e+0	1.049586e+2	9.527568e-3	1	9.527568e-3	1.000000e+0	55	1.215761e-2	1.000000e+0	1.000000e+0	8.200455e+1	1.219445e-2	1	110	5.000000e-1	9.090909e-3	unnamed	CYP11B2
GO Biological Process	GO:0018958	phenol-containing compound metabolic process	48	1.014252e-2	1.000000e+0	1.000000e+0	9.859485e+1	1.014252e-2	1	1.014252e-2	1.000000e+0	45	7.855690e-3	1.000000e+0	1.000000e+0	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	LY6E
GO Biological Process	GO:0003073	regulation of systemic arterial blood pressure	49	1.015904e-2	1.000000e+0	1.000000e+0	9.843452e+1	1.015904e-2	1	1.015904e-2	1.000000e+0	47	8.407740e-3	1.000000e+0	1.000000e+0	1.186908e+2	8.425254e-3	1	76	5.000000e-1	1.315789e-2	unnamed	CYP11B2
GO Biological Process	GO:0060415	muscle tissue morphogenesis	50	1.019621e-2	1.000000e+0	1.000000e+0	9.807562e+1	1.019621e-2	1	1.019621e-2	1.000000e+0	39	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	LY6E
GO Biological Process	GO:0006805	xenobiotic metabolic process	51	1.071330e-2	1.000000e+0	1.000000e+0	9.334193e+1	1.071330e-2	1	1.071330e-2	1.000000e+0	63	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP11B2
GO Biological Process	GO:0071466	cellular response to xenobiotic stimulus	52	1.074828e-2	1.000000e+0	1.000000e+0	9.303814e+1	1.074828e-2	1	1.074828e-2	1.000000e+0	65	1.721965e-2	1.000000e+0	1.000000e+0	5.782372e+1	1.729394e-2	1	156	5.000000e-1	6.410256e-3	unnamed	CYP11B2
GO Biological Process	GO:0048644	muscle organ morphogenesis	53	1.085339e-2	1.000000e+0	1.000000e+0	9.213711e+1	1.085339e-2	1	1.085339e-2	1.000000e+0	42	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	LY6E
GO Biological Process	GO:0009410	response to xenobiotic stimulus	54	1.166921e-2	1.000000e+0	1.000000e+0	8.569563e+1	1.166921e-2	1	1.166921e-2	1.000000e+0	66	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	CYP11B2
GO Biological Process	GO:0003208	cardiac ventricle morphogenesis	55	1.190350e-2	1.000000e+0	1.000000e+0	8.400890e+1	1.190350e-2	1	1.190350e-2	1.000000e+0	40	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	LY6E
GO Biological Process	GO:1901617	organic hydroxy compound biosynthetic process	56	1.407648e-2	1.000000e+0	1.000000e+0	7.104051e+1	1.407648e-2	1	1.407648e-2	1.000000e+0	61	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	CYP11B2
GO Biological Process	GO:0042445	hormone metabolic process	57	1.528787e-2	1.000000e+0	1.000000e+0	6.541135e+1	1.528787e-2	1	1.528787e-2	1.000000e+0	63	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP11B2
GO Biological Process	GO:0023061	signal release	58	1.708648e-2	1.000000e+0	1.000000e+0	5.852579e+1	1.708648e-2	1	1.708648e-2	1.000000e+0	60	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	LY6E
GO Biological Process	GO:0003231	cardiac ventricle development	59	1.776830e-2	1.000000e+0	1.000000e+0	5.628001e+1	1.776830e-2	1	1.776830e-2	1.000000e+0	52	1.039385e-2	1.000000e+0	1.000000e+0	9.596277e+1	1.042071e-2	1	94	5.000000e-1	1.063830e-2	unnamed	LY6E
GO Biological Process	GO:0003206	cardiac chamber morphogenesis	60	1.806229e-2	1.000000e+0	1.000000e+0	5.536396e+1	1.806229e-2	1	1.806229e-2	1.000000e+0	53	1.116569e-2	1.000000e+0	1.000000e+0	8.931188e+1	1.119672e-2	1	101	5.000000e-1	9.900990e-3	unnamed	LY6E
GO Biological Process	GO:0008217	regulation of blood pressure	61	1.837522e-2	1.000000e+0	1.000000e+0	5.442112e+1	1.837522e-2	1	1.837522e-2	1.000000e+0	62	1.699983e-2	1.000000e+0	1.000000e+0	5.857468e+1	1.707222e-2	1	154	5.000000e-1	6.493506e-3	unnamed	CYP11B2
GO Biological Process	GO:0008202	steroid metabolic process	62	2.056033e-2	1.000000e+0	1.000000e+0	4.863735e+1	2.056033e-2	1	2.056033e-2	1.000000e+0	70	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	CYP11B2
GO Biological Process	GO:0003205	cardiac chamber development	63	2.129569e-2	1.000000e+0	1.000000e+0	4.695785e+1	2.129569e-2	1	2.129569e-2	1.000000e+0	56	1.314903e-2	1.000000e+0	1.000000e+0	7.580252e+1	1.319217e-2	1	119	5.000000e-1	8.403361e-3	unnamed	LY6E
GO Biological Process	GO:0048738	cardiac muscle tissue development	64	2.162079e-2	1.000000e+0	1.000000e+0	4.625178e+1	2.162079e-2	1	2.162079e-2	1.000000e+0	59	1.447015e-2	1.000000e+0	1.000000e+0	6.885878e+1	1.452248e-2	1	131	5.000000e-1	7.633588e-3	unnamed	LY6E
GO Biological Process	GO:0010038	response to metal ion	65	2.200656e-2	1.000000e+0	1.000000e+0	4.544100e+1	2.200656e-2	1	2.200656e-2	1.000000e+0	69	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	CYP11B2
GO Biological Process	GO:0035270	endocrine system development	66	2.325419e-2	1.000000e+0	1.000000e+0	4.300300e+1	2.325419e-2	1	2.325419e-2	1.000000e+0	58	1.413995e-2	1.000000e+0	1.000000e+0	7.047266e+1	1.418990e-2	1	128	5.000000e-1	7.812500e-3	unnamed	LY6E
GO Biological Process	GO:0010817	regulation of hormone levels	67	2.334828e-2	1.000000e+0	1.000000e+0	4.282970e+1	2.334828e-2	1	2.334828e-2	1.000000e+0	2	1.493887e-4	1.000000e+0	7.798090e-1	8.163348e+1	2.449975e-2	2	221	1.000000e+0	9.049774e-3	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0006066	alcohol metabolic process	68	2.594421e-2	1.000000e+0	1.000000e+0	3.854425e+1	2.594421e-2	1	2.594421e-2	1.000000e+0	77	3.472547e-2	1.000000e+0	1.000000e+0	2.854589e+1	3.503132e-2	1	316	5.000000e-1	3.164557e-3	unnamed	CYP11B2
GO Biological Process	GO:0010035	response to inorganic substance	69	3.091140e-2	1.000000e+0	1.000000e+0	3.235052e+1	3.091140e-2	1	3.091140e-2	1.000000e+0	78	3.581436e-2	1.000000e+0	1.000000e+0	2.767025e+1	3.613990e-2	1	326	5.000000e-1	3.067485e-3	unnamed	CYP11B2
GO Biological Process	GO:0003007	heart morphogenesis	70	3.155445e-2	1.000000e+0	1.000000e+0	3.169125e+1	3.155445e-2	1	3.155445e-2	1.000000e+0	67	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	LY6E
GO Biological Process	GO:0008015	blood circulation	71	3.353044e-2	1.000000e+0	1.000000e+0	2.982364e+1	3.353044e-2	1	3.353044e-2	1.000000e+0	75	3.058208e-2	1.000000e+0	1.000000e+0	3.244784e+1	3.081869e-2	1	278	5.000000e-1	3.597122e-3	unnamed	CYP11B2
GO Biological Process	GO:0003013	circulatory system process	72	3.378328e-2	1.000000e+0	1.000000e+0	2.960044e+1	3.378328e-2	1	3.378328e-2	1.000000e+0	76	3.080038e-2	1.000000e+0	1.000000e+0	3.221607e+1	3.104041e-2	1	280	5.000000e-1	3.571429e-3	unnamed	CYP11B2
GO Biological Process	GO:0044283	small molecule biosynthetic process	73	3.466661e-2	1.000000e+0	1.000000e+0	2.884620e+1	3.466661e-2	1	3.466661e-2	1.000000e+0	82	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	CYP11B2
GO Biological Process	GO:0007517	muscle organ development	74	3.489956e-2	1.000000e+0	1.000000e+0	2.865365e+1	3.489956e-2	1	3.489956e-2	1.000000e+0	73	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	LY6E
GO Biological Process	GO:0014706	striated muscle tissue development	75	3.543065e-2	1.000000e+0	1.000000e+0	2.822415e+1	3.543065e-2	1	3.543065e-2	1.000000e+0	71	2.653920e-2	1.000000e+0	1.000000e+0	3.742946e+1	2.671692e-2	1	241	5.000000e-1	4.149378e-3	unnamed	LY6E
GO Biological Process	GO:0044711	single-organism biosynthetic process	76	3.645402e-2	1.000000e+0	1.000000e+0	2.743181e+1	3.645402e-2	1	3.645402e-2	1.000000e+0	85	4.439500e-2	1.000000e+0	1.000000e+0	2.227284e+1	4.489773e-2	1	405	5.000000e-1	2.469136e-3	unnamed	CYP11B2
GO Biological Process	GO:0071705	nitrogen compound transport	77	3.671157e-2	1.000000e+0	1.000000e+0	2.723937e+1	3.671157e-2	1	3.671157e-2	1.000000e+0	88	4.666947e-2	1.000000e+0	1.000000e+0	2.117488e+1	4.722576e-2	1	426	5.000000e-1	2.347418e-3	unnamed	LY6E
GO Biological Process	GO:1901615	organic hydroxy compound metabolic process	78	3.732400e-2	1.000000e+0	1.000000e+0	2.679241e+1	3.732400e-2	1	3.732400e-2	1.000000e+0	8	5.102199e-4	1.000000e+0	6.658370e-1	4.421814e+1	4.523031e-2	2	408	1.000000e+0	4.901961e-3	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0060537	muscle tissue development	79	3.787799e-2	1.000000e+0	1.000000e+0	2.640055e+1	3.787799e-2	1	3.787799e-2	1.000000e+0	72	2.785133e-2	1.000000e+0	1.000000e+0	3.565415e+1	2.804723e-2	1	253	5.000000e-1	3.952569e-3	unnamed	LY6E
GO Biological Process	GO:0055065	metal ion homeostasis	80	3.963025e-2	1.000000e+0	1.000000e+0	2.523325e+1	3.963025e-2	1	3.963025e-2	1.000000e+0	81	4.168376e-2	1.000000e+0	1.000000e+0	2.373816e+1	4.212627e-2	1	380	5.000000e-1	2.631579e-3	unnamed	CYP11B2
GO Biological Process	GO:0055080	cation homeostasis	81	4.294640e-2	1.000000e+0	1.000000e+0	2.328484e+1	4.294640e-2	1	4.294640e-2	1.000000e+0	86	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	CYP11B2
GO Biological Process	GO:0032940	secretion by cell	82	4.352339e-2	1.000000e+0	1.000000e+0	2.297615e+1	4.352339e-2	1	4.352339e-2	1.000000e+0	84	4.428662e-2	1.000000e+0	1.000000e+0	2.232797e+1	4.478687e-2	1	404	5.000000e-1	2.475248e-3	unnamed	LY6E
GO Biological Process	GO:0008610	lipid biosynthetic process	83	4.482047e-2	1.000000e+0	1.000000e+0	2.231123e+1	4.482047e-2	1	4.482047e-2	1.000000e+0	92	5.390802e-2	1.000000e+0	1.000000e+0	1.829716e+1	5.465329e-2	1	493	5.000000e-1	2.028398e-3	unnamed	CYP11B2
GO Biological Process	GO:0001701	in utero embryonic development	84	4.511140e-2	1.000000e+0	1.000000e+0	2.216735e+1	4.511140e-2	1	4.511140e-2	1.000000e+0	79	3.864260e-2	1.000000e+0	1.000000e+0	2.562642e+1	3.902223e-2	1	352	5.000000e-1	2.840909e-3	unnamed	LY6E
GO Biological Process	GO:0048732	gland development	85	4.607135e-2	1.000000e+0	1.000000e+0	2.170546e+1	4.607135e-2	1	4.607135e-2	1.000000e+0	74	2.927180e-2	1.000000e+0	1.000000e+0	3.391165e+1	2.948839e-2	1	266	5.000000e-1	3.759398e-3	unnamed	LY6E
GO Biological Process	GO:0050801	ion homeostasis	86	4.634969e-2	1.000000e+0	1.000000e+0	2.157512e+1	4.634969e-2	1	4.634969e-2	1.000000e+0	90	5.045424e-2	1.000000e+0	1.000000e+0	1.956725e+1	5.110581e-2	1	461	5.000000e-1	2.169197e-3	unnamed	CYP11B2
GO Biological Process	GO:0032870	cellular response to hormone stimulus	87	4.853379e-2	1.000000e+0	1.000000e+0	2.060420e+1	4.853379e-2	1	4.853379e-2	1.000000e+0	89	4.721062e-2	1.000000e+0	1.000000e+0	2.092923e+1	4.778006e-2	1	431	5.000000e-1	2.320186e-3	unnamed	CYP11B2
GO Biological Process	GO:0040007	growth	88	5.170662e-2	1.000000e+0	1.000000e+0	1.933988e+1	5.170662e-2	1	5.170662e-2	1.000000e+0	80	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	LY6E
GO Biological Process	GO:0046903	secretion	89	5.307229e-2	1.000000e+0	1.000000e+0	1.884223e+1	5.307229e-2	1	5.307229e-2	1.000000e+0	93	5.444710e-2	1.000000e+0	1.000000e+0	1.811345e+1	5.520758e-2	1	498	5.000000e-1	2.008032e-3	unnamed	LY6E
GO Biological Process	GO:0050878	regulation of body fluid levels	90	5.804318e-2	1.000000e+0	1.000000e+0	1.722855e+1	5.804318e-2	1	5.804318e-2	1.000000e+0	96	6.573237e-2	1.000000e+0	1.000000e+0	1.495937e+1	6.684774e-2	1	603	5.000000e-1	1.658375e-3	unnamed	CYP11B2
GO Biological Process	GO:0061061	muscle structure development	91	5.824539e-2	1.000000e+0	1.000000e+0	1.716874e+1	5.824539e-2	1	5.824539e-2	1.000000e+0	86	4.601990e-2	1.000000e+0	1.000000e+0	2.147738e+1	4.656061e-2	1	420	5.000000e-1	2.380952e-3	unnamed	LY6E
GO Biological Process	GO:0007507	heart development	92	6.055164e-2	1.000000e+0	1.000000e+0	1.651483e+1	6.055164e-2	1	6.055164e-2	1.000000e+0	83	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	LY6E
GO Biological Process	GO:0048878	chemical homeostasis	93	6.670945e-2	1.000000e+0	1.000000e+0	1.499038e+1	6.670945e-2	1	6.670945e-2	1.000000e+0	97	7.172348e-2	1.000000e+0	1.000000e+0	1.368816e+1	7.305582e-2	1	659	5.000000e-1	1.517451e-3	unnamed	CYP11B2
GO Biological Process	GO:0048729	tissue morphogenesis	94	7.459408e-2	1.000000e+0	1.000000e+0	1.340589e+1	7.459408e-2	1	7.459408e-2	1.000000e+0	91	5.261359e-2	1.000000e+0	1.000000e+0	1.875364e+1	5.332299e-2	1	481	5.000000e-1	2.079002e-3	unnamed	LY6E
GO Biological Process	GO:0009725	response to hormone stimulus	95	7.546651e-2	1.000000e+0	1.000000e+0	1.325091e+1	7.546651e-2	1	7.546651e-2	1.000000e+0	99	7.673686e-2	1.000000e+0	1.000000e+0	1.277691e+1	7.826617e-2	1	706	5.000000e-1	1.416431e-3	unnamed	CYP11B2
GO Biological Process	GO:0043009	chordate embryonic development	96	7.717062e-2	1.000000e+0	1.000000e+0	1.295830e+1	7.717062e-2	1	7.717062e-2	1.000000e+0	94	6.230023e-2	1.000000e+0	1.000000e+0	1.579772e+1	6.330026e-2	1	571	5.000000e-1	1.751313e-3	unnamed	LY6E
GO Biological Process	GO:0009792	embryo development ending in birth or egg hatching	97	7.766421e-2	1.000000e+0	1.000000e+0	1.287594e+1	7.766421e-2	1	7.766421e-2	1.000000e+0	95	6.305155e-2	1.000000e+0	1.000000e+0	1.560640e+1	6.407627e-2	1	578	5.000000e-1	1.730104e-3	unnamed	LY6E
GO Biological Process	GO:0055114	oxidation-reduction process	98	7.921377e-2	1.000000e+0	1.000000e+0	1.262407e+1	7.921377e-2	1	7.921377e-2	1.000000e+0	106	9.970771e-2	1.000000e+0	1.000000e+0	9.773023e+0	1.023225e-1	1	923	5.000000e-1	1.083424e-3	unnamed	CYP11B2
GO Biological Process	GO:0006629	lipid metabolic process	99	9.193917e-2	1.000000e+0	1.000000e+0	1.087676e+1	9.193917e-2	1	9.193917e-2	1.000000e+0	110	1.144784e-1	1.000000e+0	1.000000e+0	8.477914e+0	1.179536e-1	1	1064	5.000000e-1	9.398496e-4	unnamed	CYP11B2
GO Biological Process	GO:0071495	cellular response to endogenous stimulus	100	9.410737e-2	1.000000e+0	1.000000e+0	1.062616e+1	9.410737e-2	1	9.410737e-2	1.000000e+0	102	8.523905e-2	1.000000e+0	1.000000e+0	1.147646e+1	8.713486e-2	1	786	5.000000e-1	1.272265e-3	unnamed	CYP11B2
GO Biological Process	GO:0042592	homeostatic process	101	1.047074e-1	1.000000e+0	1.000000e+0	9.550420e+0	1.047074e-1	1	1.047074e-1	1.000000e+0	109	1.125996e-1	1.000000e+0	1.000000e+0	8.623805e+0	1.159581e-1	1	1046	5.000000e-1	9.560229e-4	unnamed	CYP11B2
GO Biological Process	GO:0072358	cardiovascular system development	102	1.056924e-1	1.000000e+0	1.000000e+0	9.461416e+0	1.056924e-1	1	1.056924e-1	1.000000e+0	100	7.854686e-2	1.000000e+0	1.000000e+0	1.247649e+1	8.015077e-2	1	723	5.000000e-1	1.383126e-3	unnamed	LY6E
GO Biological Process	GO:0009887	organ morphogenesis	103	1.105874e-1	1.000000e+0	1.000000e+0	9.042623e+0	1.105874e-1	1	1.105874e-1	1.000000e+0	101	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	LY6E
GO Biological Process	GO:0007267	cell-cell signaling	104	1.200910e-1	1.000000e+0	1.000000e+0	8.327020e+0	1.200910e-1	1	1.200910e-1	1.000000e+0	104	9.823445e-2	1.000000e+0	1.000000e+0	9.923542e+0	1.007705e-1	1	909	5.000000e-1	1.100110e-3	unnamed	LY6E
GO Biological Process	GO:0009790	embryo development	105	1.260409e-1	1.000000e+0	1.000000e+0	7.933935e+0	1.260409e-1	1	1.260409e-1	1.000000e+0	107	1.021254e-1	1.000000e+0	1.000000e+0	9.535412e+0	1.048722e-1	1	946	5.000000e-1	1.057082e-3	unnamed	LY6E
GO Biological Process	GO:0009719	response to endogenous stimulus	106	1.264308e-1	1.000000e+0	1.000000e+0	7.909468e+0	1.264308e-1	1	1.264308e-1	1.000000e+0	111	1.223892e-1	1.000000e+0	1.000000e+0	7.912719e+0	1.263788e-1	1	1140	5.000000e-1	8.771930e-4	unnamed	CYP11B2
GO Biological Process	GO:0051649	establishment of localization in cell	107	1.284678e-1	1.000000e+0	1.000000e+0	7.784051e+0	1.284678e-1	1	1.284678e-1	1.000000e+0	114	1.571416e-1	1.000000e+0	1.000000e+0	6.103180e+0	1.638490e-1	1	1478	5.000000e-1	6.765900e-4	unnamed	LY6E
GO Biological Process	GO:1901564	organonitrogen compound metabolic process	108	1.379740e-1	1.000000e+0	1.000000e+0	7.247740e+0	1.379740e-1	1	1.379740e-1	1.000000e+0	116	1.637442e-1	1.000000e+0	1.000000e+0	5.846079e+0	1.710548e-1	1	1543	5.000000e-1	6.480881e-4	unnamed	LY6E
GO Biological Process	GO:0071702	organic substance transport	109	1.396970e-1	1.000000e+0	1.000000e+0	7.158351e+0	1.396970e-1	1	1.396970e-1	1.000000e+0	117	1.786811e-1	1.000000e+0	1.000000e+0	5.334418e+0	1.874619e-1	1	1691	5.000000e-1	5.913661e-4	unnamed	LY6E
GO Biological Process	GO:0071310	cellular response to organic substance	110	1.544577e-1	1.000000e+0	1.000000e+0	6.474265e+0	1.544577e-1	1	1.544577e-1	1.000000e+0	115	1.591759e-1	1.000000e+0	1.000000e+0	6.021696e+0	1.660662e-1	1	1498	5.000000e-1	6.675567e-4	unnamed	CYP11B2
GO Biological Process	GO:0051641	cellular localization	111	1.548748e-1	1.000000e+0	1.000000e+0	6.456828e+0	1.548748e-1	1	1.548748e-1	1.000000e+0	118	1.828954e-1	1.000000e+0	1.000000e+0	5.205136e+0	1.921180e-1	1	1733	5.000000e-1	5.770340e-4	unnamed	LY6E
GO Biological Process	GO:0009888	tissue development	112	1.692045e-1	1.000000e+0	1.000000e+0	5.910010e+0	1.692045e-1	1	1.692045e-1	1.000000e+0	112	1.422163e-1	1.000000e+0	1.000000e+0	6.772147e+0	1.476637e-1	1	1332	5.000000e-1	7.507508e-4	unnamed	LY6E
GO Biological Process	GO:0070887	cellular response to chemical stimulus	113	1.826020e-1	1.000000e+0	1.000000e+0	5.476391e+0	1.826020e-1	1	1.826020e-1	1.000000e+0	119	1.959705e-1	1.000000e+0	1.000000e+0	4.839324e+0	2.066404e-1	1	1864	5.000000e-1	5.364807e-4	unnamed	CYP11B2
GO Biological Process	GO:0003008	system process	114	1.967197e-1	1.000000e+0	1.000000e+0	5.083376e+0	1.967197e-1	1	1.967197e-1	1.000000e+0	121	2.046945e-1	1.000000e+0	1.000000e+0	4.621158e+0	2.163960e-1	1	1952	5.000000e-1	5.122951e-4	unnamed	CYP11B2
GO Biological Process	GO:0044281	small molecule metabolic process	115	2.001784e-1	1.000000e+0	1.000000e+0	4.995545e+0	2.001784e-1	1	2.001784e-1	1.000000e+0	126	2.509628e-1	1.000000e+0	1.000000e+0	3.716728e+0	2.690538e-1	1	2427	5.000000e-1	4.120313e-4	unnamed	CYP11B2
GO Biological Process	GO:0010033	response to organic substance	116	2.019131e-1	1.000000e+0	1.000000e+0	4.952626e+0	2.019131e-1	1	2.019131e-1	1.000000e+0	123	2.147469e-1	1.000000e+0	1.000000e+0	4.391675e+0	2.277036e-1	1	2054	5.000000e-1	4.868549e-4	unnamed	CYP11B2
GO Biological Process	GO:0044765	single-organism transport	117	2.288177e-1	1.000000e+0	1.000000e+0	4.370291e+0	2.288177e-1	1	2.288177e-1	1.000000e+0	128	2.680389e-1	1.000000e+0	1.000000e+0	3.461435e+0	2.888975e-1	1	2606	5.000000e-1	3.837299e-4	unnamed	LY6E
GO Biological Process	GO:0009653	anatomical structure morphogenesis	118	2.467616e-1	1.000000e+0	1.000000e+0	4.052494e+0	2.467616e-1	1	2.467616e-1	1.000000e+0	120	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	LY6E
GO Biological Process	GO:0044710	single-organism metabolic process	119	2.517961e-1	1.000000e+0	1.000000e+0	3.971468e+0	2.517961e-1	1	2.517961e-1	1.000000e+0	132	3.105584e-1	1.000000e+0	1.000000e+0	2.946913e+0	3.393382e-1	1	3061	5.000000e-1	3.266906e-4	unnamed	CYP11B2
GO Biological Process	GO:0007166	cell surface receptor signaling pathway	120	2.539087e-1	1.000000e+0	1.000000e+0	3.938424e+0	2.539087e-1	1	2.539087e-1	1.000000e+0	129	2.743799e-1	1.000000e+0	1.000000e+0	3.374673e+0	2.963250e-1	1	2673	5.000000e-1	3.741115e-4	unnamed	LY6E
GO Biological Process	GO:1901362	organic cyclic compound biosynthetic process	121	2.593182e-1	1.000000e+0	1.000000e+0	3.856266e+0	2.593182e-1	1	2.593182e-1	1.000000e+0	130	2.978897e-1	1.000000e+0	1.000000e+0	3.084986e+0	3.241505e-1	1	2924	5.000000e-1	3.419973e-4	unnamed	CYP11B2
GO Biological Process	GO:0065008	regulation of biological quality	122	2.713082e-1	1.000000e+0	1.000000e+0	3.685845e+0	2.713082e-1	1	2.713082e-1	1.000000e+0	68	2.452977e-2	1.000000e+0	1.000000e+0	6.383935e+0	3.132864e-1	2	2826	1.000000e+0	7.077141e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0006810	transport	123	2.770578e-1	1.000000e+0	1.000000e+0	3.609355e+0	2.770578e-1	1	2.770578e-1	1.000000e+0	134	3.291182e-1	1.000000e+0	1.000000e+0	2.763634e+0	3.618425e-1	1	3264	5.000000e-1	3.063725e-4	unnamed	LY6E
GO Biological Process	GO:0048513	organ development	124	2.824258e-1	1.000000e+0	1.000000e+0	3.540753e+0	2.824258e-1	1	2.824258e-1	1.000000e+0	125	2.446169e-1	1.000000e+0	1.000000e+0	3.820627e+0	2.617372e-1	1	2361	5.000000e-1	4.235493e-4	unnamed	LY6E
GO Biological Process	GO:0051234	establishment of localization	125	2.827781e-1	1.000000e+0	1.000000e+0	3.536342e+0	2.827781e-1	1	2.827781e-1	1.000000e+0	137	3.336507e-1	1.000000e+0	1.000000e+0	2.721937e+0	3.673854e-1	1	3314	5.000000e-1	3.017502e-4	unnamed	LY6E
GO Biological Process	GO:0042221	response to chemical stimulus	126	2.954524e-1	1.000000e+0	1.000000e+0	3.384640e+0	2.954524e-1	1	2.954524e-1	1.000000e+0	135	3.326549e-1	1.000000e+0	1.000000e+0	2.731002e+0	3.661660e-1	1	3303	5.000000e-1	3.027551e-4	unnamed	CYP11B2
GO Biological Process	GO:0044249	cellular biosynthetic process	127	3.470471e-1	1.000000e+0	1.000000e+0	2.881453e+0	3.470471e-1	1	3.470471e-1	1.000000e+0	143	4.041671e-1	1.000000e+0	1.000000e+0	2.192102e+0	4.561831e-1	1	4115	5.000000e-1	2.430134e-4	unnamed	CYP11B2
GO Biological Process	GO:1901576	organic substance biosynthetic process	128	3.536536e-1	1.000000e+0	1.000000e+0	2.827626e+0	3.536536e-1	1	3.536536e-1	1.000000e+0	144	4.118439e-1	1.000000e+0	1.000000e+0	2.145184e+0	4.661604e-1	1	4205	5.000000e-1	2.378121e-4	unnamed	CYP11B2
GO Biological Process	GO:0009058	biosynthetic process	129	3.586722e-1	1.000000e+0	1.000000e+0	2.788061e+0	3.586722e-1	1	3.586722e-1	1.000000e+0	145	4.178650e-1	1.000000e+0	1.000000e+0	2.109565e+0	4.740314e-1	1	4276	5.000000e-1	2.338634e-4	unnamed	CYP11B2
GO Biological Process	GO:0051179	localization	130	3.597525e-1	1.000000e+0	1.000000e+0	2.779689e+0	3.597525e-1	1	3.597525e-1	1.000000e+0	142	3.970433e-1	1.000000e+0	1.000000e+0	2.237227e+0	4.469819e-1	1	4032	5.000000e-1	2.480159e-4	unnamed	LY6E
GO Biological Process	GO:0006725	cellular aromatic compound metabolic process	131	3.683046e-1	1.000000e+0	1.000000e+0	2.715144e+0	3.683046e-1	1	3.683046e-1	1.000000e+0	148	4.506323e-1	1.000000e+0	1.000000e+0	1.931998e+0	5.175988e-1	1	4669	5.000000e-1	2.141786e-4	unnamed	LY6E
GO Biological Process	GO:0044767	single-organism developmental process	132	3.730678e-1	1.000000e+0	1.000000e+0	2.680478e+0	3.730678e-1	1	3.730678e-1	1.000000e+0	136	3.331076e-1	1.000000e+0	1.000000e+0	2.726874e+0	3.667202e-1	1	3308	5.000000e-1	3.022975e-4	unnamed	LY6E
GO Biological Process	GO:1901360	organic cyclic compound metabolic process	133	3.827617e-1	1.000000e+0	1.000000e+0	2.612592e+0	3.827617e-1	1	3.827617e-1	1.000000e+0	98	7.336665e-2	1.000000e+0	1.000000e+0	3.691631e+0	5.417660e-1	2	4887	1.000000e+0	4.092490e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0048731	system development	134	3.900631e-1	1.000000e+0	1.000000e+0	2.563688e+0	3.900631e-1	1	3.900631e-1	1.000000e+0	138	3.405107e-1	1.000000e+0	1.000000e+0	2.660914e+0	3.758107e-1	1	3390	5.000000e-1	2.949853e-4	unnamed	LY6E
GO Biological Process	GO:0007165	signal transduction	135	3.912589e-1	1.000000e+0	1.000000e+0	2.555852e+0	3.912589e-1	1	3.912589e-1	1.000000e+0	146	4.201465e-1	1.000000e+0	1.000000e+0	2.096328e+0	4.770246e-1	1	4303	5.000000e-1	2.323960e-4	unnamed	LY6E
GO Biological Process	GO:0006807	nitrogen compound metabolic process	136	4.138051e-1	1.000000e+0	1.000000e+0	2.416597e+0	4.138051e-1	1	4.138051e-1	1.000000e+0	151	4.994558e-1	1.000000e+0	1.000000e+0	1.709399e+0	5.850008e-1	1	5277	5.000000e-1	1.895016e-4	unnamed	LY6E
GO Biological Process	GO:0048856	anatomical structure development	137	4.234725e-1	1.000000e+0	1.000000e+0	2.361429e+0	4.234725e-1	1	4.234725e-1	1.000000e+0	140	3.845834e-1	1.000000e+0	1.000000e+0	2.320087e+0	4.310182e-1	1	3888	5.000000e-1	2.572016e-4	unnamed	LY6E
GO Biological Process	GO:0007275	multicellular organismal development	138	4.357034e-1	1.000000e+0	1.000000e+0	2.295139e+0	4.357034e-1	1	4.357034e-1	1.000000e+0	141	3.919536e-1	1.000000e+0	1.000000e+0	2.270451e+0	4.404412e-1	1	3973	5.000000e-1	2.516990e-4	unnamed	LY6E
GO Biological Process	GO:0044700	single organism signaling	139	4.371810e-1	1.000000e+0	1.000000e+0	2.287382e+0	4.371810e-1	1	4.371810e-1	1.000000e+0	149	4.576762e-1	1.000000e+0	1.000000e+0	1.897056e+0	5.271326e-1	1	4755	5.000000e-1	2.103049e-4	unnamed	LY6E
GO Biological Process	GO:0007154	cell communication	140	4.446638e-1	1.000000e+0	1.000000e+0	2.248890e+0	4.446638e-1	1	4.446638e-1	1.000000e+0	150	4.676716e-1	1.000000e+0	1.000000e+0	1.849221e+0	5.407683e-1	1	4878	5.000000e-1	2.050021e-4	unnamed	LY6E
GO Biological Process	GO:0051716	cellular response to stimulus	141	4.562761e-1	1.000000e+0	1.000000e+0	2.191655e+0	4.562761e-1	1	4.562761e-1	1.000000e+0	103	8.743600e-2	1.000000e+0	1.000000e+0	3.381631e+0	5.914306e-1	2	5335	1.000000e+0	3.748828e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0032502	developmental process	142	4.657420e-1	1.000000e+0	1.000000e+0	2.147111e+0	4.657420e-1	1	4.657420e-1	1.000000e+0	147	4.306509e-1	1.000000e+0	1.000000e+0	2.037150e+0	4.908819e-1	1	4428	5.000000e-1	2.258356e-4	unnamed	LY6E
GO Biological Process	GO:0044707	single-multicellular organism process	143	5.372858e-1	1.000000e+0	1.000000e+0	1.861207e+0	5.372858e-1	1	5.372858e-1	1.000000e+0	105	9.848405e-2	1.000000e+0	1.000000e+0	3.186330e+0	6.276814e-1	2	5662	1.000000e+0	3.532321e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0050896	response to stimulus	144	5.533212e-1	1.000000e+0	1.000000e+0	1.807268e+0	5.533212e-1	1	5.533212e-1	1.000000e+0	113	1.457136e-1	1.000000e+0	1.000000e+0	2.619573e+0	7.634832e-1	2	6887	1.000000e+0	2.904022e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0032501	multicellular organismal process	145	5.539872e-1	1.000000e+0	1.000000e+0	1.805096e+0	5.539872e-1	1	5.539872e-1	1.000000e+0	108	1.064675e-1	1.000000e+0	1.000000e+0	3.064549e+0	6.526246e-1	2	5887	1.000000e+0	3.397316e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0044237	cellular metabolic process	146	6.001923e-1	1.000000e+0	1.000000e+0	1.666133e+0	6.001923e-1	1	6.001923e-1	1.000000e+0	122	2.082916e-1	1.000000e+0	1.000000e+0	2.191037e+0	9.128097e-1	2	8234	1.000000e+0	2.428953e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0044238	primary metabolic process	147	6.053666e-1	1.000000e+0	1.000000e+0	1.651892e+0	6.053666e-1	1	6.053666e-1	1.000000e+0	153	7.093792e-1	1.000000e+0	1.000000e+0	1.084847e+0	9.217893e-1	1	8315	5.000000e-1	1.202646e-4	unnamed	CYP11B2
GO Biological Process	GO:0071704	organic substance metabolic process	148	6.199145e-1	1.000000e+0	1.000000e+0	1.613126e+0	6.199145e-1	1	6.199145e-1	1.000000e+0	124	2.252177e-1	1.000000e+0	1.000000e+0	2.107101e+0	9.491713e-1	2	8562	1.000000e+0	2.335903e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0008152	metabolic process	149	6.507895e-1	1.000000e+0	1.000000e+0	1.536595e+0	6.507895e-1	1	6.507895e-1	1.000000e+0	127	2.598086e-1	1.000000e+0	1.000000e+0	1.961831e+0	1.019456e+0	2	9196	1.000000e+0	2.174859e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0050794	regulation of cellular process	150	6.759845e-1	1.000000e+0	1.000000e+0	1.479324e+0	6.759845e-1	1	6.759845e-1	1.000000e+0	154	7.406997e-1	1.000000e+0	1.000000e+0	1.018805e+0	9.815420e-1	1	8854	5.000000e-1	1.129433e-4	unnamed	LY6E
GO Biological Process	GO:0050789	regulation of biological process	151	6.921477e-1	1.000000e+0	1.000000e+0	1.444778e+0	6.921477e-1	1	6.921477e-1	1.000000e+0	155	7.668214e-1	1.000000e+0	1.000000e+0	9.669311e-1	1.034200e+0	1	9329	5.000000e-1	1.071926e-4	unnamed	LY6E
GO Biological Process	GO:0065007	biological regulation	152	7.151977e-1	1.000000e+0	1.000000e+0	1.398215e+0	7.151977e-1	1	7.151977e-1	1.000000e+0	131	2.982605e-1	1.000000e+0	1.000000e+0	1.831016e+0	1.092290e+0	2	9853	1.000000e+0	2.029839e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0044763	single-organism cellular process	153	7.497126e-1	1.000000e+0	1.000000e+0	1.333844e+0	7.497126e-1	1	7.497126e-1	1.000000e+0	133	3.141478e-1	1.000000e+0	1.000000e+0	1.784118e+0	1.121002e+0	2	10112	1.000000e+0	1.977848e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0044699	single-organism process	154	7.935590e-1	1.000000e+0	1.000000e+0	1.260146e+0	7.935590e-1	1	7.935590e-1	1.000000e+0	139	3.800402e-1	1.000000e+0	1.000000e+0	1.622100e+0	1.232969e+0	2	11122	1.000000e+0	1.798238e-4	unnamed	CYP11B2,LY6E
GO Biological Process	GO:0009987	cellular process	155	8.656787e-1	1.000000e+0	1.000000e+0	1.155163e+0	8.656787e-1	1	8.656787e-1	1.000000e+0	152	5.606826e-1	1.000000e+0	1.000000e+0	1.335480e+0	1.497589e+0	2	13509	1.000000e+0	1.480494e-4	unnamed	CYP11B2,LY6E
GO Cellular Component	GO:0031225	anchored to membrane	1	1.906652e-2	1.000000e+0	1.000000e+0	5.244796e+1	1.906652e-2	1	1.906652e-2	1.000000e+0	1	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	LY6E
GO Cellular Component	GO:0005743	mitochondrial inner membrane	2	2.386818e-2	1.000000e+0	1.000000e+0	4.189679e+1	2.386818e-2	1	2.386818e-2	1.000000e+0	2	4.103249e-2	1.000000e+0	1.000000e+0	2.411898e+1	4.146112e-2	1	374	5.000000e-1	2.673797e-3	unnamed	CYP11B2
GO Cellular Component	GO:0019866	organelle inner membrane	3	2.738529e-2	1.000000e+0	1.000000e+0	3.651595e+1	2.738529e-2	1	2.738529e-2	1.000000e+0	3	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	CYP11B2
GO Cellular Component	GO:0031966	mitochondrial membrane	4	3.702819e-2	1.000000e+0	1.000000e+0	2.700645e+1	3.702819e-2	1	3.702819e-2	1.000000e+0	4	5.800120e-2	1.000000e+0	1.000000e+0	1.698776e+1	5.886592e-2	1	531	5.000000e-1	1.883239e-3	unnamed	CYP11B2
GO Cellular Component	GO:0005740	mitochondrial envelope	5	3.831325e-2	1.000000e+0	1.000000e+0	2.610063e+1	3.831325e-2	1	3.831325e-2	1.000000e+0	5	6.090412e-2	1.000000e+0	1.000000e+0	1.616577e+1	6.185910e-2	1	558	5.000000e-1	1.792115e-3	unnamed	CYP11B2
GO Cellular Component	GO:0044429	mitochondrial part	6	5.499540e-2	1.000000e+0	1.000000e+0	1.818334e+1	5.499540e-2	1	5.499540e-2	1.000000e+0	6	8.598112e-2	1.000000e+0	1.000000e+0	1.137516e+1	8.791087e-2	1	793	5.000000e-1	1.261034e-3	unnamed	CYP11B2
GO Cellular Component	GO:0031967	organelle envelope	7	6.812257e-2	1.000000e+0	1.000000e+0	1.467942e+1	6.812257e-2	1	6.812257e-2	1.000000e+0	7	9.359637e-2	1.000000e+0	1.000000e+0	1.042832e+1	9.589269e-2	1	865	5.000000e-1	1.156069e-3	unnamed	CYP11B2
GO Cellular Component	GO:0031975	envelope	8	6.827720e-2	1.000000e+0	1.000000e+0	1.464618e+1	6.827720e-2	1	6.827720e-2	1.000000e+0	8	9.401850e-2	1.000000e+0	1.000000e+0	1.038032e+1	9.633612e-2	1	869	5.000000e-1	1.150748e-3	unnamed	CYP11B2
GO Cellular Component	GO:0005739	mitochondrion	9	1.171632e-1	1.000000e+0	1.000000e+0	8.535104e+0	1.171632e-1	1	1.171632e-1	1.000000e+0	11	1.680979e-1	1.000000e+0	1.000000e+0	5.687579e+0	1.758217e-1	1	1586	5.000000e-1	6.305170e-4	unnamed	CYP11B2
GO Cellular Component	GO:0005887	integral to plasma membrane	10	1.462434e-1	1.000000e+0	1.000000e+0	6.837917e+0	1.462434e-1	1	1.462434e-1	1.000000e+0	9	1.333634e-1	1.000000e+0	1.000000e+0	7.239567e+0	1.381298e-1	1	1246	5.000000e-1	8.025682e-4	unnamed	LY6E
GO Cellular Component	GO:0031226	intrinsic to plasma membrane	11	1.513797e-1	1.000000e+0	1.000000e+0	6.605906e+0	1.513797e-1	1	1.513797e-1	1.000000e+0	10	1.383102e-1	1.000000e+0	1.000000e+0	6.971020e+0	1.434510e-1	1	1294	5.000000e-1	7.727975e-4	unnamed	LY6E
GO Cellular Component	GO:0031090	organelle membrane	12	2.131131e-1	1.000000e+0	1.000000e+0	4.692344e+0	2.131131e-1	1	2.131131e-1	1.000000e+0	14	2.650007e-1	1.000000e+0	1.000000e+0	3.504468e+0	2.853500e-1	1	2574	5.000000e-1	3.885004e-4	unnamed	CYP11B2
GO Cellular Component	GO:0044459	plasma membrane part	13	2.354746e-1	1.000000e+0	1.000000e+0	4.246743e+0	2.354746e-1	1	2.354746e-1	1.000000e+0	13	2.174952e-1	1.000000e+0	1.000000e+0	4.332613e+0	2.308076e-1	1	2082	5.000000e-1	4.803074e-4	unnamed	LY6E
GO Cellular Component	GO:0005886	plasma membrane	14	4.126577e-1	1.000000e+0	1.000000e+0	2.423316e+0	4.126577e-1	1	4.126577e-1	1.000000e+0	15	4.264607e-1	1.000000e+0	1.000000e+0	2.060416e+0	4.853390e-1	1	4378	5.000000e-1	2.284148e-4	unnamed	LY6E
GO Cellular Component	GO:0071944	cell periphery	15	4.194602e-1	1.000000e+0	1.000000e+0	2.384017e+0	4.194602e-1	1	4.194602e-1	1.000000e+0	16	4.347424e-1	1.000000e+0	1.000000e+0	2.014854e+0	4.963140e-1	1	4477	5.000000e-1	2.233639e-4	unnamed	LY6E
GO Cellular Component	GO:0016021	integral to membrane	16	4.578656e-1	1.000000e+0	1.000000e+0	2.184047e+0	4.578656e-1	1	4.578656e-1	1.000000e+0	17	4.982001e-1	1.000000e+0	1.000000e+0	1.714598e+0	5.832271e-1	1	5261	5.000000e-1	1.900779e-4	unnamed	LY6E
GO Cellular Component	GO:0031224	intrinsic to membrane	17	4.694206e-1	1.000000e+0	1.000000e+0	2.130286e+0	4.694206e-1	1	4.694206e-1	1.000000e+0	18	5.070350e-1	1.000000e+0	1.000000e+0	1.678545e+0	5.957541e-1	1	5374	5.000000e-1	1.860811e-4	unnamed	LY6E
GO Cellular Component	GO:0044446	intracellular organelle part	18	4.732075e-1	1.000000e+0	1.000000e+0	2.113238e+0	4.732075e-1	1	4.732075e-1	1.000000e+0	20	5.897910e-1	1.000000e+0	1.000000e+0	1.390765e+0	7.190289e-1	1	6486	5.000000e-1	1.541782e-4	unnamed	CYP11B2
GO Cellular Component	GO:0044422	organelle part	19	4.814989e-1	1.000000e+0	1.000000e+0	2.076848e+0	4.814989e-1	1	4.814989e-1	1.000000e+0	21	5.977049e-1	1.000000e+0	1.000000e+0	1.367157e+0	7.314450e-1	1	6598	5.000000e-1	1.515611e-4	unnamed	CYP11B2
GO Cellular Component	GO:0044444	cytoplasmic part	20	5.199381e-1	1.000000e+0	1.000000e+0	1.923306e+0	5.199381e-1	1	5.199381e-1	1.000000e+0	22	6.277110e-1	1.000000e+0	1.000000e+0	1.282596e+0	7.796685e-1	1	7033	5.000000e-1	1.421868e-4	unnamed	CYP11B2
GO Cellular Component	GO:0044425	membrane part	21	5.293034e-1	1.000000e+0	1.000000e+0	1.889276e+0	5.293034e-1	1	5.293034e-1	1.000000e+0	19	5.687230e-1	1.000000e+0	1.000000e+0	1.456564e+0	6.865473e-1	1	6193	5.000000e-1	1.614726e-4	unnamed	LY6E
GO Cellular Component	GO:0016020	membrane	22	6.308744e-1	1.000000e+0	1.000000e+0	1.585102e+0	6.308744e-1	1	6.308744e-1	1.000000e+0	12	1.895088e-1	1.000000e+0	1.000000e+0	2.297046e+0	8.706834e-1	2	7854	1.000000e+0	2.546473e-4	unnamed	CYP11B2,LY6E
GO Cellular Component	GO:0005737	cytoplasm	23	6.734732e-1	1.000000e+0	1.000000e+0	1.484840e+0	6.734732e-1	1	6.734732e-1	1.000000e+0	25	7.735178e-1	1.000000e+0	1.000000e+0	9.540455e-1	1.048168e+0	1	9455	5.000000e-1	1.057641e-4	unnamed	CYP11B2
GO Cellular Component	GO:0043231	intracellular membrane-bounded organelle	24	6.973299e-1	1.000000e+0	1.000000e+0	1.434041e+0	6.973299e-1	1	6.973299e-1	1.000000e+0	26	8.019514e-1	1.000000e+0	1.000000e+0	9.009688e-1	1.109916e+0	1	10012	5.000000e-1	9.988014e-5	unnamed	CYP11B2
GO Cellular Component	GO:0043227	membrane-bounded organelle	25	6.992039e-1	1.000000e+0	1.000000e+0	1.430198e+0	6.992039e-1	1	6.992039e-1	1.000000e+0	27	8.036253e-1	1.000000e+0	1.000000e+0	8.979196e-1	1.113685e+0	1	10046	5.000000e-1	9.954211e-5	unnamed	CYP11B2
GO Cellular Component	GO:0043229	intracellular organelle	26	7.399473e-1	1.000000e+0	1.000000e+0	1.351448e+0	7.399473e-1	1	7.399473e-1	1.000000e+0	28	8.473502e-1	1.000000e+0	1.000000e+0	8.206423e-1	1.218558e+0	1	10992	5.000000e-1	9.097525e-5	unnamed	CYP11B2
GO Cellular Component	GO:0043226	organelle	27	7.415866e-1	1.000000e+0	1.000000e+0	1.348460e+0	7.415866e-1	1	7.415866e-1	1.000000e+0	29	8.487331e-1	1.000000e+0	1.000000e+0	8.182602e-1	1.222105e+0	1	11024	5.000000e-1	9.071118e-5	unnamed	CYP11B2
GO Cellular Component	GO:0044424	intracellular part	28	8.017695e-1	1.000000e+0	1.000000e+0	1.247241e+0	8.017695e-1	1	8.017695e-1	1.000000e+0	30	9.083176e-1	1.000000e+0	1.000000e+0	7.171649e-1	1.394379e+0	1	12578	5.000000e-1	7.950390e-5	unnamed	CYP11B2
GO Cellular Component	GO:0005622	intracellular	29	8.064789e-1	1.000000e+0	1.000000e+0	1.239958e+0	8.064789e-1	1	8.064789e-1	1.000000e+0	31	9.139354e-1	1.000000e+0	1.000000e+0	7.076012e-1	1.413225e+0	1	12748	5.000000e-1	7.844368e-5	unnamed	CYP11B2
GO Cellular Component	GO:0044464	cell part	30	8.908971e-1	1.000000e+0	1.000000e+0	1.122464e+0	8.908971e-1	1	8.908971e-1	1.000000e+0	23	6.728810e-1	1.000000e+0	1.000000e+0	1.219069e+0	1.640596e+0	2	14799	1.000000e+0	1.351443e-4	unnamed	CYP11B2,LY6E
GO Cellular Component	GO:0005623	cell	31	8.910977e-1	1.000000e+0	1.000000e+0	1.122211e+0	8.910977e-1	1	8.910977e-1	1.000000e+0	24	6.729719e-1	1.000000e+0	1.000000e+0	1.218986e+0	1.640707e+0	2	14800	1.000000e+0	1.351351e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0011546	increased urine progesterone level	1	6.211336e-5	4.918136e-1	4.918136e-1	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	4	2.217111e-4	1.000000e+0	4.388771e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0011553	increased urine deoxycorticosterone level	1	6.211336e-5	4.918136e-1	4.918136e-1	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	4	2.217111e-4	1.000000e+0	4.388771e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0011550	decreased urine corticosterone level	1	6.211336e-5	4.918136e-1	4.918136e-1	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	4	2.217111e-4	1.000000e+0	4.388771e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0001740	failure of adrenal epinephrine secretion	4	8.278228e-5	6.554701e-1	1.638675e-1	1.207988e+4	8.278228e-5	1	8.278228e-5	1.000000e+0	3	1.108586e-4	8.777784e-1	2.925928e-1	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LY6E
Mouse Phenotype	MP:0011541	decreased urine aldosterone level	5	1.201664e-4	9.514776e-1	1.902955e-1	8.321794e+3	1.201664e-4	1	1.201664e-4	1.000000e+0	9	5.542315e-4	1.000000e+0	4.876006e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0009078	adrenal gland hyperplasia	6	1.208640e-4	9.570012e-1	1.595002e-1	8.273765e+3	1.208640e-4	1	1.208640e-4	1.000000e+0	8	4.433975e-4	1.000000e+0	4.388527e-1	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0011538	abnormal urine hormone level	7	2.505640e-4	1.000000e+0	2.834237e-1	3.990997e+3	2.505640e-4	1	2.505640e-4	1.000000e+0	12	6.650594e-4	1.000000e+0	4.388284e-1	1.503417e+3	6.651516e-4	1	6	5.000000e-1	1.666667e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0008293	abnormal zona glomerulosa morphology	8	6.675697e-4	1.000000e+0	6.607271e-1	1.497971e+3	6.675697e-4	1	6.675697e-4	1.000000e+0	9	5.542315e-4	1.000000e+0	4.876006e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0009221	uterus adenomyosis	9	7.829502e-4	1.000000e+0	6.888222e-1	1.277220e+3	7.829502e-4	1	7.829502e-4	1.000000e+0	9	5.542315e-4	1.000000e+0	4.876006e-1	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0002667	decreased circulating aldosterone level	10	8.565036e-4	1.000000e+0	6.781796e-1	1.167537e+3	8.565036e-4	1	8.565036e-4	1.000000e+0	23	1.773000e-3	1.000000e+0	6.103745e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0000635	pituitary gland hyperplasia	11	9.476201e-4	1.000000e+0	6.821142e-1	1.055275e+3	9.476201e-4	1	9.476201e-4	1.000000e+0	14	7.758812e-4	1.000000e+0	4.388162e-1	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0004119	hypokalemia	12	9.698558e-4	1.000000e+0	6.399432e-1	1.031081e+3	9.698558e-4	1	9.698558e-4	1.000000e+0	18	1.219107e-3	1.000000e+0	5.362716e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0009092	endometrium hyperplasia	13	1.163462e-3	1.000000e+0	7.086379e-1	8.595038e+2	1.163462e-3	1	1.163462e-3	1.000000e+0	21	1.662234e-3	1.000000e+0	6.267414e-1	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003353	decreased circulating renin level	14	1.257837e-3	1.000000e+0	7.113967e-1	7.950155e+2	1.257837e-3	1	1.257837e-3	1.000000e+0	20	1.329898e-3	1.000000e+0	5.265066e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0008291	abnormal adrenocortical cell morphology	15	1.396232e-3	1.000000e+0	7.370243e-1	7.162134e+2	1.396232e-3	1	1.396232e-3	1.000000e+0	15	9.975062e-4	1.000000e+0	5.265503e-1	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0008055	increased urine osmolality	16	1.500431e-3	1.000000e+0	7.425258e-1	6.664753e+2	1.500431e-3	1	1.500431e-3	1.000000e+0	16	1.108309e-3	1.000000e+0	5.484744e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0003020	decreased circulating chloride level	17	1.530666e-3	1.000000e+0	7.129302e-1	6.533105e+2	1.530666e-3	1	1.530666e-3	1.000000e+0	29	2.216004e-3	1.000000e+0	6.050455e-1	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0009082	uterus cysts	18	1.685828e-3	1.000000e+0	7.415770e-1	5.931803e+2	1.685828e-3	1	1.685828e-3	1.000000e+0	16	1.108309e-3	1.000000e+0	5.484744e-1	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	CYP11B2
Mouse Phenotype	MP:0005628	decreased circulating potassium level	19	1.749693e-3	1.000000e+0	7.291615e-1	5.715288e+2	1.749693e-3	1	1.749693e-3	1.000000e+0	33	2.548193e-3	1.000000e+0	6.114119e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0000636	enlarged pituitary gland	20	1.878556e-3	1.000000e+0	7.437203e-1	5.323237e+2	1.878556e-3	1	1.878556e-3	1.000000e+0	18	1.219107e-3	1.000000e+0	5.362716e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0000642	enlarged adrenal glands	21	2.002666e-3	1.000000e+0	7.551004e-1	4.993344e+2	2.002666e-3	1	2.002666e-3	1.000000e+0	30	2.326740e-3	1.000000e+0	6.141042e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0008294	abnormal zona fasciculata morphology	22	2.088378e-3	1.000000e+0	7.516262e-1	4.788406e+2	2.088378e-3	1	2.088378e-3	1.000000e+0	23	1.773000e-3	1.000000e+0	6.103745e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003352	increased circulating renin level	23	2.244280e-3	1.000000e+0	7.726178e-1	4.455773e+2	2.244280e-3	1	2.244280e-3	1.000000e+0	27	2.105263e-3	1.000000e+0	6.173879e-1	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005582	increased renin activity	24	2.459792e-3	1.000000e+0	8.115264e-1	4.065385e+2	2.459792e-3	1	2.459792e-3	1.000000e+0	23	1.773000e-3	1.000000e+0	6.103745e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001748	increased circulating adrenocorticotropin level	25	2.872749e-3	1.000000e+0	9.098571e-1	3.480986e+2	2.872749e-3	1	2.872749e-3	1.000000e+0	23	1.773000e-3	1.000000e+0	6.103745e-1	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003349	abnormal circulating renin level	26	3.043414e-3	1.000000e+0	9.268366e-1	3.285784e+2	3.043414e-3	1	3.043414e-3	1.000000e+0	38	2.991025e-3	1.000000e+0	6.232352e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001596	hypotension	27	3.282248e-3	1.000000e+0	9.625496e-1	3.046693e+2	3.282248e-3	1	3.282248e-3	1.000000e+0	38	2.991025e-3	1.000000e+0	6.232352e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001739	abnormal adrenal gland secretion	28	3.291011e-3	1.000000e+0	9.306509e-1	3.038579e+2	3.291011e-3	1	3.291011e-3	1.000000e+0	31	2.437470e-3	1.000000e+0	6.225770e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	LY6E
Mouse Phenotype	MP:0003018	abnormal circulating chloride level	29	3.335179e-3	1.000000e+0	9.106189e-1	2.998340e+2	3.335179e-3	1	3.335179e-3	1.000000e+0	52	4.761371e-3	1.000000e+0	7.250103e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005627	increased circulating potassium level	30	3.356418e-3	1.000000e+0	8.858706e-1	2.979367e+2	3.356418e-3	1	3.356418e-3	1.000000e+0	33	2.548193e-3	1.000000e+0	6.114119e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005129	increased adrenocorticotropin level	31	3.494753e-3	1.000000e+0	8.926276e-1	2.861432e+2	3.494753e-3	1	3.494753e-3	1.000000e+0	31	2.437470e-3	1.000000e+0	6.225770e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005581	abnormal renin activity	32	3.592270e-3	1.000000e+0	8.888623e-1	2.783755e+2	3.592270e-3	1	3.592270e-3	1.000000e+0	33	2.548193e-3	1.000000e+0	6.114119e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0004906	enlarged uterus	33	3.601822e-3	1.000000e+0	8.642190e-1	2.776372e+2	3.601822e-3	1	3.601822e-3	1.000000e+0	40	3.323085e-3	1.000000e+0	6.578047e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003620	oliguria	34	3.661655e-3	1.000000e+0	8.527348e-1	2.731006e+2	3.661655e-3	1	3.661655e-3	1.000000e+0	37	2.880326e-3	1.000000e+0	6.163898e-1	3.469423e+2	2.882324e-3	1	26	5.000000e-1	3.846154e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002176	increased brain weight	35	3.767803e-3	1.000000e+0	8.523847e-1	2.654067e+2	3.767803e-3	1	3.767803e-3	1.000000e+0	40	3.323085e-3	1.000000e+0	6.578047e-1	3.006833e+2	3.325758e-3	1	30	5.000000e-1	3.333333e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002665	decreased circulating corticosterone level	36	3.838514e-3	1.000000e+0	8.442598e-1	2.605175e+2	3.838514e-3	1	3.838514e-3	1.000000e+0	45	3.765745e-3	1.000000e+0	6.626038e-1	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003368	decreased circulating glucocorticoid level	37	3.939444e-3	1.000000e+0	8.430410e-1	2.538429e+2	3.939444e-3	1	3.939444e-3	1.000000e+0	46	3.876395e-3	1.000000e+0	6.672456e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0011942	decreased fluid intake	38	4.001596e-3	1.000000e+0	8.338062e-1	2.499003e+2	4.001596e-3	1	4.001596e-3	1.000000e+0	44	3.655089e-3	1.000000e+0	6.577499e-1	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005346	abnormal circulating aldosterone level	39	4.371928e-3	1.000000e+0	8.876135e-1	2.287320e+2	4.371928e-3	1	4.371928e-3	1.000000e+0	46	3.876395e-3	1.000000e+0	6.672456e-1	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005663	abnormal circulating noradrenaline level	40	4.382197e-3	1.000000e+0	8.674559e-1	2.281960e+2	4.382197e-3	1	4.382197e-3	1.000000e+0	33	2.548193e-3	1.000000e+0	6.114119e-1	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	LY6E
Mouse Phenotype	MP:0004956	decreased thymus weight	41	4.399437e-3	1.000000e+0	8.496279e-1	2.273018e+2	4.399437e-3	1	4.399437e-3	1.000000e+0	48	3.987038e-3	1.000000e+0	6.576951e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0011415	abnormal aldosterone level	42	4.606551e-3	1.000000e+0	8.684445e-1	2.170821e+2	4.606551e-3	1	4.606551e-3	1.000000e+0	49	4.208307e-3	1.000000e+0	6.800281e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002668	abnormal circulating potassium level	43	5.010602e-3	1.000000e+0	9.226499e-1	1.995768e+2	5.010602e-3	1	5.010602e-3	1.000000e+0	52	4.761371e-3	1.000000e+0	7.250103e-1	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0012007	abnormal chloride level	44	5.041855e-3	1.000000e+0	9.073047e-1	1.983397e+2	5.041855e-3	1	5.041855e-3	1.000000e+0	63	6.640639e-3	1.000000e+0	8.346124e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002909	abnormal adrenal gland physiology	45	5.320882e-3	1.000000e+0	9.362387e-1	1.879388e+2	5.320882e-3	1	5.320882e-3	1.000000e+0	42	3.433759e-3	1.000000e+0	6.473453e-1	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	LY6E
Mouse Phenotype	MP:0004954	abnormal thymus weight	46	5.503155e-3	1.000000e+0	9.472605e-1	1.817140e+2	5.503155e-3	1	5.503155e-3	1.000000e+0	68	7.524386e-3	1.000000e+0	8.761484e-1	1.326544e+2	7.538385e-3	1	68	5.000000e-1	1.470588e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0004896	abnormal endometrium morphology	47	5.507406e-3	1.000000e+0	9.278221e-1	1.815737e+2	5.507406e-3	1	5.507406e-3	1.000000e+0	60	6.088097e-3	1.000000e+0	8.034259e-1	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0008288	abnormal adrenal cortex morphology	48	6.018133e-3	1.000000e+0	9.927412e-1	1.661645e+2	6.018133e-3	1	6.018133e-3	1.000000e+0	1	6.083704e-6	4.817077e-2	4.817077e-2	4.009111e+2	4.988637e-3	2	45	1.000000e+0	4.444444e-2	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002988	decreased urine osmolality	49	6.199998e-3	1.000000e+0	1.000000e+0	1.612904e+2	6.199998e-3	1	6.199998e-3	1.000000e+0	67	7.193027e-3	1.000000e+0	8.500655e-1	1.387769e+2	7.205809e-3	1	65	5.000000e-1	1.538462e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003966	abnormal adrenocorticotropin level	50	6.208137e-3	1.000000e+0	9.831206e-1	1.610789e+2	6.208137e-3	1	6.208137e-3	1.000000e+0	49	4.208307e-3	1.000000e+0	6.800281e-1	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0004564	enlarged myocardial fiber	51	6.291336e-3	1.000000e+0	9.767608e-1	1.589488e+2	6.291336e-3	1	6.291336e-3	1.000000e+0	61	6.198618e-3	1.000000e+0	8.046009e-1	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001745	increased circulating corticosterone level	52	6.347057e-3	1.000000e+0	9.664615e-1	1.575533e+2	6.347057e-3	1	6.347057e-3	1.000000e+0	56	5.645954e-3	1.000000e+0	7.982976e-1	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003917	increased kidney weight	53	6.487556e-3	1.000000e+0	9.692164e-1	1.541413e+2	6.487556e-3	1	6.487556e-3	1.000000e+0	66	7.082562e-3	1.000000e+0	8.496928e-1	1.409453e+2	7.094950e-3	1	64	5.000000e-1	1.562500e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0008936	abnormal pituitary gland size	54	6.679258e-3	1.000000e+0	9.793771e-1	1.497172e+2	6.679258e-3	1	6.679258e-3	1.000000e+0	55	5.203711e-3	1.000000e+0	7.491452e-1	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0011384	abnormal progesterone level	55	7.310504e-3	1.000000e+0	1.000000e+0	1.367895e+2	7.310504e-3	1	7.310504e-3	1.000000e+0	59	5.867038e-3	1.000000e+0	7.873764e-1	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0005238	increased brain size	56	7.490799e-3	1.000000e+0	1.000000e+0	1.334971e+2	7.490799e-3	1	7.490799e-3	1.000000e+0	62	6.530143e-3	1.000000e+0	8.339625e-1	1.528898e+2	6.540657e-3	1	59	5.000000e-1	1.694915e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001762	polyuria	57	7.596107e-3	1.000000e+0	1.000000e+0	1.316464e+2	7.596107e-3	1	7.596107e-3	1.000000e+0	78	9.511379e-3	1.000000e+0	9.655269e-1	1.048895e+2	9.533840e-3	1	86	5.000000e-1	1.162791e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0001134	absent corpus luteum	58	7.789151e-3	1.000000e+0	1.000000e+0	1.283837e+2	7.789151e-3	1	7.789151e-3	1.000000e+0	71	7.966112e-3	1.000000e+0	8.883898e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002987	abnormal urine osmolality	59	7.800398e-3	1.000000e+0	1.000000e+0	1.281986e+2	7.800398e-3	1	7.800398e-3	1.000000e+0	74	8.186938e-3	1.000000e+0	8.760024e-1	1.218986e+2	8.203536e-3	1	74	5.000000e-1	1.351351e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0011978	abnormal potassium ion homeostasis	60	8.234321e-3	1.000000e+0	1.000000e+0	1.214429e+2	8.234321e-3	1	8.234321e-3	1.000000e+0	70	7.855690e-3	1.000000e+0	8.885908e-1	1.270493e+2	7.870961e-3	1	71	5.000000e-1	1.408451e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003964	abnormal noradrenaline level	61	8.920505e-3	1.000000e+0	1.000000e+0	1.121013e+2	8.920505e-3	1	8.920505e-3	1.000000e+0	58	5.756499e-3	1.000000e+0	7.858614e-1	1.734712e+2	5.764647e-3	1	52	5.000000e-1	1.923077e-2	unnamed	LY6E
Mouse Phenotype	MP:0006144	increased systemic arterial systolic blood pressure	62	8.945795e-3	1.000000e+0	1.000000e+0	1.117844e+2	8.945795e-3	1	8.945795e-3	1.000000e+0	71	7.966112e-3	1.000000e+0	8.883898e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0002795	dilated cardiomyopathy	63	9.186114e-3	1.000000e+0	1.000000e+0	1.088600e+2	9.186114e-3	1	9.186114e-3	1.000000e+0	71	7.966112e-3	1.000000e+0	8.883898e-1	1.252847e+2	7.981819e-3	1	72	5.000000e-1	1.388889e-2	unnamed	LY6E
Mouse Phenotype	MP:0005345	abnormal circulating corticosterone level	64	9.236984e-3	1.000000e+0	1.000000e+0	1.082604e+2	9.236984e-3	1	9.236984e-3	1.000000e+0	75	8.849269e-3	1.000000e+0	9.342468e-1	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003366	abnormal circulating glucocorticoid level	65	9.337914e-3	1.000000e+0	1.000000e+0	1.070903e+2	9.337914e-3	1	9.337914e-3	1.000000e+0	76	8.959636e-3	1.000000e+0	9.334526e-1	1.113642e+2	8.979547e-3	1	81	5.000000e-1	1.234568e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003674	oxidative stress	66	9.340608e-3	1.000000e+0	1.000000e+0	1.070594e+2	9.340608e-3	1	9.340608e-3	1.000000e+0	79	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003963	abnormal corticosterone level	67	1.005190e-2	1.000000e+0	1.000000e+0	9.948371e+1	1.005190e-2	1	1.005190e-2	1.000000e+0	77	9.401043e-3	1.000000e+0	9.667202e-1	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0003140	dilated heart atrium	68	1.025275e-2	1.000000e+0	1.000000e+0	9.753480e+1	1.025275e-2	1	1.025275e-2	1.000000e+0	63	6.640639e-3	1.000000e+0	8.346124e-1	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	LY6E
Mouse Phenotype	MP:0003186	abnormal redox activity	69	1.047229e-2	1.000000e+0	1.000000e+0	9.549006e+1	1.047229e-2	1	1.047229e-2	1.000000e+0	81	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002981	increased liver weight	70	1.075693e-2	1.000000e+0	1.000000e+0	9.296330e+1	1.075693e-2	1	1.075693e-2	1.000000e+0	83	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002843	decreased systemic arterial blood pressure	71	1.169210e-2	1.000000e+0	1.000000e+0	8.552782e+1	1.169210e-2	1	1.169210e-2	1.000000e+0	81	1.138616e-2	1.000000e+0	1.000000e+0	8.757767e+1	1.141844e-2	1	103	5.000000e-1	9.708738e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003068	enlarged kidney	72	1.185456e-2	1.000000e+0	1.000000e+0	8.435569e+1	1.185456e-2	1	1.185456e-2	1.000000e+0	83	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0011947	abnormal fluid intake	73	1.248682e-2	1.000000e+0	1.000000e+0	8.008445e+1	1.248682e-2	1	1.248682e-2	1.000000e+0	86	1.193722e-2	1.000000e+0	1.000000e+0	8.352315e+1	1.197273e-2	1	108	5.000000e-1	9.259259e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002707	abnormal kidney weight	74	1.262894e-2	1.000000e+0	1.000000e+0	7.918322e+1	1.262894e-2	1	1.262894e-2	1.000000e+0	89	1.248814e-2	1.000000e+0	1.000000e+0	7.982743e+1	1.252702e-2	1	113	5.000000e-1	8.849558e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002679	abnormal corpus luteum morphology	75	1.280361e-2	1.000000e+0	1.000000e+0	7.810295e+1	1.280361e-2	1	1.280361e-2	1.000000e+0	87	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0004902	abnormal uterus size	76	1.298345e-2	1.000000e+0	1.000000e+0	7.702112e+1	1.298345e-2	1	1.298345e-2	1.000000e+0	80	1.072467e-2	1.000000e+0	1.000000e+0	9.299485e+1	1.075328e-2	1	97	5.000000e-1	1.030928e-2	unnamed	CYP11B2
Mouse Phenotype	MP:0000639	abnormal adrenal gland morphology	77	1.307140e-2	1.000000e+0	1.000000e+0	7.650289e+1	1.307140e-2	1	1.307140e-2	1.000000e+0	2	2.802191e-5	2.218775e-1	1.109387e-1	1.879271e+2	1.064243e-2	2	96	1.000000e+0	2.083333e-2	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005330	cardiomyopathy	78	1.390891e-2	1.000000e+0	1.000000e+0	7.189637e+1	1.390891e-2	1	1.390891e-2	1.000000e+0	90	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	LY6E
Mouse Phenotype	MP:0003638	abnormal response/metabolism to endogenous compounds	79	1.434182e-2	1.000000e+0	1.000000e+0	6.972614e+1	1.434182e-2	1	1.434182e-2	1.000000e+0	90	1.259830e-2	1.000000e+0	1.000000e+0	7.912719e+1	1.263788e-2	1	114	5.000000e-1	8.771930e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001422	abnormal drinking behavior	80	1.489840e-2	1.000000e+0	1.000000e+0	6.712131e+1	1.489840e-2	1	1.489840e-2	1.000000e+0	97	1.491033e-2	1.000000e+0	1.000000e+0	6.681852e+1	1.496591e-2	1	135	5.000000e-1	7.407407e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001756	abnormal urination	81	1.593671e-2	1.000000e+0	1.000000e+0	6.274822e+1	1.593671e-2	1	1.593671e-2	1.000000e+0	100	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005117	increased circulating pituitary hormone level	82	1.692720e-2	1.000000e+0	1.000000e+0	5.907653e+1	1.692720e-2	1	1.692720e-2	1.000000e+0	83	1.182702e-2	1.000000e+0	1.000000e+0	8.430374e+1	1.186187e-2	1	107	5.000000e-1	9.345794e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002833	increased heart weight	83	1.733210e-2	1.000000e+0	1.000000e+0	5.769640e+1	1.733210e-2	1	1.733210e-2	1.000000e+0	101	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002842	increased systemic arterial blood pressure	84	1.768863e-2	1.000000e+0	1.000000e+0	5.653349e+1	1.768863e-2	1	1.768863e-2	1.000000e+0	98	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003141	cardiac fibrosis	85	1.893141e-2	1.000000e+0	1.000000e+0	5.282226e+1	1.893141e-2	1	1.893141e-2	1.000000e+0	102	1.754933e-2	1.000000e+0	1.000000e+0	5.673270e+1	1.762652e-2	1	159	5.000000e-1	6.289308e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003973	increased pituitary hormone level	86	1.939799e-2	1.000000e+0	1.000000e+0	5.155173e+1	1.939799e-2	1	1.939799e-2	1.000000e+0	95	1.358950e-2	1.000000e+0	1.000000e+0	7.333740e+1	1.363561e-2	1	123	5.000000e-1	8.130081e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000633	abnormal pituitary gland morphology	87	1.943676e-2	1.000000e+0	1.000000e+0	5.144891e+1	1.943676e-2	1	1.943676e-2	1.000000e+0	92	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0006357	abnormal circulating mineral level	88	1.947111e-2	1.000000e+0	1.000000e+0	5.135815e+1	1.947111e-2	1	1.947111e-2	1.000000e+0	113	2.380277e-2	1.000000e+0	1.000000e+0	4.176157e+1	2.394546e-2	1	216	5.000000e-1	4.629630e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0011479	abnormal catecholamine level	89	1.959175e-2	1.000000e+0	1.000000e+0	5.104190e+1	1.959175e-2	1	1.959175e-2	1.000000e+0	96	1.425002e-2	1.000000e+0	1.000000e+0	6.992636e+1	1.430076e-2	1	129	5.000000e-1	7.751938e-3	unnamed	LY6E
Mouse Phenotype	MP:0005584	abnormal enzyme/coenzyme activity	90	2.049020e-2	1.000000e+0	1.000000e+0	4.880382e+1	2.049020e-2	1	2.049020e-2	1.000000e+0	108	2.172051e-2	1.000000e+0	1.000000e+0	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0004847	abnormal liver weight	91	2.063449e-2	1.000000e+0	1.000000e+0	4.846255e+1	2.063449e-2	1	2.063449e-2	1.000000e+0	104	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000599	enlarged liver	92	2.121194e-2	1.000000e+0	1.000000e+0	4.714327e+1	2.121194e-2	1	2.121194e-2	1.000000e+0	111	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000631	abnormal neuroendocrine gland morphology	93	2.257618e-2	1.000000e+0	1.000000e+0	4.429447e+1	2.257618e-2	1	2.257618e-2	1.000000e+0	98	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000192	abnormal mineral level	94	2.297205e-2	1.000000e+0	1.000000e+0	4.353116e+1	2.297205e-2	1	2.297205e-2	1.000000e+0	119	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000278	abnormal myocardial fiber morphology	95	2.321830e-2	1.000000e+0	1.000000e+0	4.306948e+1	2.321830e-2	1	2.321830e-2	1.000000e+0	107	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001120	abnormal uterus morphology	96	2.324027e-2	1.000000e+0	1.000000e+0	4.302877e+1	2.324027e-2	1	2.324027e-2	1.000000e+0	105	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0010025	decreased total body fat amount	97	2.407421e-2	1.000000e+0	1.000000e+0	4.153823e+1	2.407421e-2	1	2.407421e-2	1.000000e+0	115	2.435036e-2	1.000000e+0	1.000000e+0	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005116	abnormal circulating pituitary hormone level	98	2.415984e-2	1.000000e+0	1.000000e+0	4.139100e+1	2.415984e-2	1	2.415984e-2	1.000000e+0	103	1.864787e-2	1.000000e+0	1.000000e+0	5.337574e+1	1.873510e-2	1	169	5.000000e-1	5.917160e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005636	abnormal mineral homeostasis	99	2.432815e-2	1.000000e+0	1.000000e+0	4.110464e+1	2.432815e-2	1	2.432815e-2	1.000000e+0	124	3.145511e-2	1.000000e+0	1.000000e+0	3.154021e+1	3.170556e-2	1	286	5.000000e-1	3.496503e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002727	decreased circulating insulin level	100	2.672040e-2	1.000000e+0	1.000000e+0	3.742458e+1	2.672040e-2	1	2.672040e-2	1.000000e+0	111	2.358369e-2	1.000000e+0	1.000000e+0	4.215187e+1	2.372374e-2	1	214	5.000000e-1	4.672897e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000230	abnormal systemic arterial blood pressure	101	2.755926e-2	1.000000e+0	1.000000e+0	3.628545e+1	2.755926e-2	1	2.755926e-2	1.000000e+0	114	2.391230e-2	1.000000e+0	1.000000e+0	4.156912e+1	2.405632e-2	1	217	5.000000e-1	4.608295e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0004857	abnormal heart weight	102	2.777528e-2	1.000000e+0	1.000000e+0	3.600323e+1	2.777528e-2	1	2.777528e-2	1.000000e+0	110	2.325502e-2	1.000000e+0	1.000000e+0	4.275118e+1	2.339116e-2	1	211	5.000000e-1	4.739336e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003965	abnormal pituitary hormone level	103	2.885433e-2	1.000000e+0	1.000000e+0	3.465684e+1	2.885433e-2	1	2.885433e-2	1.000000e+0	109	2.193980e-2	1.000000e+0	1.000000e+0	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0004937	dilated heart	104	2.927139e-2	1.000000e+0	1.000000e+0	3.416305e+1	2.927139e-2	1	2.927139e-2	1.000000e+0	116	2.445986e-2	1.000000e+0	1.000000e+0	4.063288e+1	2.461061e-2	1	222	5.000000e-1	4.504505e-3	unnamed	LY6E
Mouse Phenotype	MP:0005293	impaired glucose tolerance	105	3.073714e-2	1.000000e+0	1.000000e+0	3.253393e+1	3.073714e-2	1	3.073714e-2	1.000000e+0	117	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001570	abnormal circulating enzyme level	106	3.191526e-2	1.000000e+0	1.000000e+0	3.133297e+1	3.191526e-2	1	3.191526e-2	1.000000e+0	132	3.559663e-2	1.000000e+0	1.000000e+0	2.784105e+1	3.591819e-2	1	324	5.000000e-1	3.086420e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003105	abnormal heart atrium morphology	107	3.222450e-2	1.000000e+0	1.000000e+0	3.103229e+1	3.222450e-2	1	3.222450e-2	1.000000e+0	106	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LY6E
Mouse Phenotype	MP:0000706	small thymus	108	3.301004e-2	1.000000e+0	1.000000e+0	3.029381e+1	3.301004e-2	1	3.301004e-2	1.000000e+0	126	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001765	abnormal ion homeostasis	109	3.480497e-2	1.000000e+0	1.000000e+0	2.873153e+1	3.480497e-2	1	3.480497e-2	1.000000e+0	134	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001126	abnormal ovary morphology	110	3.497291e-2	1.000000e+0	1.000000e+0	2.859356e+1	3.497291e-2	1	3.497291e-2	1.000000e+0	123	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001926	female infertility	111	3.525648e-2	1.000000e+0	1.000000e+0	2.836358e+1	3.525648e-2	1	3.525648e-2	1.000000e+0	129	3.319999e-2	1.000000e+0	1.000000e+0	2.986921e+1	3.347930e-2	1	302	5.000000e-1	3.311258e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000771	abnormal brain size	112	3.646588e-2	1.000000e+0	1.000000e+0	2.742289e+1	3.646588e-2	1	3.646588e-2	1.000000e+0	122	3.101865e-2	1.000000e+0	1.000000e+0	3.198759e+1	3.126213e-2	1	282	5.000000e-1	3.546099e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005319	abnormal enzyme/ coenzyme level	113	3.774804e-2	1.000000e+0	1.000000e+0	2.649144e+1	3.774804e-2	1	3.774804e-2	1.000000e+0	140	4.222631e-2	1.000000e+0	1.000000e+0	2.342987e+1	4.268056e-2	1	385	5.000000e-1	2.597403e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002706	abnormal kidney size	114	3.808311e-2	1.000000e+0	1.000000e+0	2.625836e+1	3.808311e-2	1	3.808311e-2	1.000000e+0	125	3.178240e-2	1.000000e+0	1.000000e+0	3.121280e+1	3.203814e-2	1	289	5.000000e-1	3.460208e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002364	abnormal thymus size	115	3.842994e-2	1.000000e+0	1.000000e+0	2.602138e+1	3.842994e-2	1	3.842994e-2	1.000000e+0	138	4.016378e-2	1.000000e+0	1.000000e+0	2.464617e+1	4.057425e-2	1	366	5.000000e-1	2.732240e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0010630	abnormal cardiac muscle tissue morphology	116	3.885933e-2	1.000000e+0	1.000000e+0	2.573385e+1	3.885933e-2	1	3.885933e-2	1.000000e+0	131	3.363597e-2	1.000000e+0	1.000000e+0	2.947876e+1	3.392273e-2	1	306	5.000000e-1	3.267974e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0009643	abnormal urine homeostasis	117	4.033522e-2	1.000000e+0	1.000000e+0	2.479223e+1	4.033522e-2	1	4.033522e-2	1.000000e+0	147	4.526178e-2	1.000000e+0	1.000000e+0	2.184140e+1	4.578460e-2	1	413	5.000000e-1	2.421308e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000281	abnormal interventricular septum morphology	118	4.050025e-2	1.000000e+0	1.000000e+0	2.469121e+1	4.050025e-2	1	4.050025e-2	1.000000e+0	119	2.959946e-2	1.000000e+0	1.000000e+0	3.353346e+1	2.982096e-2	1	269	5.000000e-1	3.717472e-3	unnamed	LY6E
Mouse Phenotype	MP:0004848	abnormal liver size	119	4.246240e-2	1.000000e+0	1.000000e+0	2.355025e+1	4.246240e-2	1	4.246240e-2	1.000000e+0	139	4.211781e-2	1.000000e+0	1.000000e+0	2.349089e+1	4.256970e-2	1	384	5.000000e-1	2.604167e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000830	abnormal diencephalon morphology	120	4.253763e-2	1.000000e+0	1.000000e+0	2.350860e+1	4.253763e-2	1	4.253763e-2	1.000000e+0	121	3.025460e-2	1.000000e+0	1.000000e+0	3.280182e+1	3.048611e-2	1	275	5.000000e-1	3.636364e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000274	enlarged heart	121	4.315159e-2	1.000000e+0	1.000000e+0	2.317412e+1	4.315159e-2	1	4.315159e-2	1.000000e+0	7	4.037551e-4	1.000000e+0	4.567047e-1	4.969972e+1	4.024167e-2	2	363	1.000000e+0	5.509642e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0001560	abnormal circulating insulin level	122	4.326502e-2	1.000000e+0	1.000000e+0	2.311336e+1	4.326502e-2	1	4.326502e-2	1.000000e+0	134	3.940334e-2	1.000000e+0	1.000000e+0	2.512674e+1	3.979824e-2	1	359	5.000000e-1	2.785515e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0004087	abnormal muscle fiber morphology	123	4.329978e-2	1.000000e+0	1.000000e+0	2.309480e+1	4.329978e-2	1	4.329978e-2	1.000000e+0	136	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005291	abnormal glucose tolerance	124	4.475825e-2	1.000000e+0	1.000000e+0	2.234225e+1	4.475825e-2	1	4.475825e-2	1.000000e+0	136	3.951200e-2	1.000000e+0	1.000000e+0	2.505694e+1	3.990910e-2	1	360	5.000000e-1	2.777778e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0011099	complete lethality throughout fetal growth and development	125	4.475847e-2	1.000000e+0	1.000000e+0	2.234214e+1	4.475847e-2	1	4.475847e-2	1.000000e+0	126	3.232775e-2	1.000000e+0	1.000000e+0	3.068197e+1	3.259243e-2	1	294	5.000000e-1	3.401361e-3	unnamed	LY6E
Mouse Phenotype	MP:0006113	abnormal heart septum morphology	126	4.640843e-2	1.000000e+0	1.000000e+0	2.154781e+1	4.640843e-2	1	4.640843e-2	1.000000e+0	130	3.352698e-2	1.000000e+0	1.000000e+0	2.957541e+1	3.381187e-2	1	305	5.000000e-1	3.278689e-3	unnamed	LY6E
Mouse Phenotype	MP:0009209	abnormal internal female genitalia morphology	127	4.760230e-2	1.000000e+0	1.000000e+0	2.100739e+1	4.760230e-2	1	4.760230e-2	1.000000e+0	141	4.287718e-2	1.000000e+0	1.000000e+0	2.307033e+1	4.334571e-2	1	391	5.000000e-1	2.557545e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0009208	abnormal female genitalia morphology	128	4.967210e-2	1.000000e+0	1.000000e+0	2.013202e+1	4.967210e-2	1	4.967210e-2	1.000000e+0	142	4.363624e-2	1.000000e+0	1.000000e+0	2.266457e+1	4.412172e-2	1	398	5.000000e-1	2.512563e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001119	abnormal female reproductive system morphology	129	4.984565e-2	1.000000e+0	1.000000e+0	2.006193e+1	4.984565e-2	1	4.984565e-2	1.000000e+0	145	4.396146e-2	1.000000e+0	1.000000e+0	2.249501e+1	4.445430e-2	1	401	5.000000e-1	2.493766e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000703	abnormal thymus morphology	130	5.279962e-2	1.000000e+0	1.000000e+0	1.893953e+1	5.279962e-2	1	5.279962e-2	1.000000e+0	151	5.433930e-2	1.000000e+0	1.000000e+0	1.814990e+1	5.509672e-2	1	497	5.000000e-1	2.012072e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005266	abnormal metabolism	131	5.387393e-2	1.000000e+0	1.000000e+0	1.856186e+1	5.387393e-2	1	5.387393e-2	1.000000e+0	153	6.036688e-2	1.000000e+0	1.000000e+0	1.631193e+1	6.130481e-2	1	553	5.000000e-1	1.808318e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005329	abnormal myocardium layer morphology	132	5.442259e-2	1.000000e+0	1.000000e+0	1.837472e+1	5.442259e-2	1	5.442259e-2	1.000000e+0	144	4.385306e-2	1.000000e+0	1.000000e+0	2.255125e+1	4.434344e-2	1	400	5.000000e-1	2.500000e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0010545	abnormal heart layer morphology	133	5.573559e-2	1.000000e+0	1.000000e+0	1.794186e+1	5.573559e-2	1	5.573559e-2	1.000000e+0	146	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003949	abnormal circulating lipid level	134	5.719536e-2	1.000000e+0	1.000000e+0	1.748394e+1	5.719536e-2	1	5.719536e-2	1.000000e+0	156	6.326615e-2	1.000000e+0	1.000000e+0	1.555259e+1	6.429799e-2	1	580	5.000000e-1	1.724138e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002164	abnormal gland physiology	135	5.844543e-2	1.000000e+0	1.000000e+0	1.710998e+1	5.844543e-2	1	5.844543e-2	1.000000e+0	150	5.358449e-2	1.000000e+0	1.000000e+0	1.840918e+1	5.432071e-2	1	490	5.000000e-1	2.040816e-3	unnamed	LY6E
Mouse Phenotype	MP:0005416	abnormal circulating protein level	136	5.998924e-2	1.000000e+0	1.000000e+0	1.666965e+1	5.998924e-2	1	5.998924e-2	1.000000e+0	161	7.215068e-2	1.000000e+0	1.000000e+0	1.360558e+1	7.349925e-2	1	663	5.000000e-1	1.508296e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005406	abnormal heart size	137	6.101337e-2	1.000000e+0	1.000000e+0	1.638985e+1	6.101337e-2	1	6.101337e-2	1.000000e+0	13	7.362203e-4	1.000000e+0	4.484148e-1	3.681837e+1	5.432071e-2	2	490	1.000000e+0	4.081633e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005452	abnormal adipose tissue amount	138	6.192463e-2	1.000000e+0	1.000000e+0	1.614866e+1	6.192463e-2	1	6.192463e-2	1.000000e+0	152	5.735550e-2	1.000000e+0	1.000000e+0	1.718190e+1	5.820076e-2	1	525	5.000000e-1	1.904762e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0006208	lethality throughout fetal growth and development	139	6.727622e-2	1.000000e+0	1.000000e+0	1.486409e+1	6.727622e-2	1	6.727622e-2	1.000000e+0	148	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	LY6E
Mouse Phenotype	MP:0005502	abnormal renal/urinary system physiology	140	6.955113e-2	1.000000e+0	1.000000e+0	1.437791e+1	6.955113e-2	1	6.955113e-2	1.000000e+0	159	7.001370e-2	1.000000e+0	1.000000e+0	1.402877e+1	7.128208e-2	1	643	5.000000e-1	1.555210e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0008469	abnormal protein level	141	6.968426e-2	1.000000e+0	1.000000e+0	1.435044e+1	6.968426e-2	1	6.968426e-2	1.000000e+0	167	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002069	abnormal consumption behavior	142	7.333329e-2	1.000000e+0	1.000000e+0	1.363637e+1	7.333329e-2	1	7.333329e-2	1.000000e+0	155	6.315885e-2	1.000000e+0	1.000000e+0	1.557945e+1	6.418713e-2	1	579	5.000000e-1	1.727116e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000003	abnormal adipose tissue morphology	143	7.628668e-2	1.000000e+0	1.000000e+0	1.310845e+1	7.628668e-2	1	7.628668e-2	1.000000e+0	157	6.894429e-2	1.000000e+0	1.000000e+0	1.425039e+1	7.017349e-2	1	633	5.000000e-1	1.579779e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001547	abnormal lipid level	144	7.658706e-2	1.000000e+0	1.000000e+0	1.305704e+1	7.658706e-2	1	7.658706e-2	1.000000e+0	167	8.322334e-2	1.000000e+0	1.000000e+0	1.176076e+1	8.502855e-2	1	767	5.000000e-1	1.303781e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005294	abnormal heart ventricle morphology	145	7.700612e-2	1.000000e+0	1.000000e+0	1.298598e+1	7.700612e-2	1	7.700612e-2	1.000000e+0	154	6.047434e-2	1.000000e+0	1.000000e+0	1.628249e+1	6.141566e-2	1	554	5.000000e-1	1.805054e-3	unnamed	LY6E
Mouse Phenotype	MP:0005375	adipose tissue phenotype	146	7.725086e-2	1.000000e+0	1.000000e+0	1.294484e+1	7.725086e-2	1	7.725086e-2	1.000000e+0	159	7.001370e-2	1.000000e+0	1.000000e+0	1.402877e+1	7.128208e-2	1	643	5.000000e-1	1.555210e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0001924	infertility	147	7.848077e-2	1.000000e+0	1.000000e+0	1.274198e+1	7.848077e-2	1	7.848077e-2	1.000000e+0	164	7.886609e-2	1.000000e+0	1.000000e+0	1.242493e+1	8.048334e-2	1	726	5.000000e-1	1.377410e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003699	abnormal female reproductive system physiology	148	7.951923e-2	1.000000e+0	1.000000e+0	1.257558e+1	7.951923e-2	1	7.951923e-2	1.000000e+0	158	6.979987e-2	1.000000e+0	1.000000e+0	1.407254e+1	7.106036e-2	1	641	5.000000e-1	1.560062e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002118	abnormal lipid homeostasis	149	8.181450e-2	1.000000e+0	1.000000e+0	1.222277e+1	8.181450e-2	1	8.181450e-2	1.000000e+0	171	8.936961e-2	1.000000e+0	1.000000e+0	1.093394e+1	9.145834e-2	1	825	5.000000e-1	1.212121e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000653	abnormal sex gland morphology	150	8.328551e-2	1.000000e+0	1.000000e+0	1.200689e+1	8.328551e-2	1	8.328551e-2	1.000000e+0	165	8.088659e-2	1.000000e+0	1.000000e+0	1.210805e+1	8.258966e-2	1	745	5.000000e-1	1.342282e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0005418	abnormal circulating hormone level	151	8.615845e-2	1.000000e+0	1.000000e+0	1.160652e+1	8.615845e-2	1	8.615845e-2	1.000000e+0	22	1.666664e-3	1.000000e+0	5.998475e-1	2.447897e+1	8.170279e-2	2	737	1.000000e+0	2.713704e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002221	abnormal lymph organ size	152	8.616517e-2	1.000000e+0	1.000000e+0	1.160562e+1	8.616517e-2	1	8.616517e-2	1.000000e+0	173	9.264620e-2	1.000000e+0	1.000000e+0	1.053797e+1	9.489496e-2	1	856	5.000000e-1	1.168224e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002078	abnormal glucose homeostasis	153	8.818097e-2	1.000000e+0	1.000000e+0	1.134032e+1	8.818097e-2	1	8.818097e-2	1.000000e+0	166	8.141793e-2	1.000000e+0	1.000000e+0	1.202733e+1	8.314395e-2	1	750	5.000000e-1	1.333333e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002135	abnormal kidney morphology	154	8.823365e-2	1.000000e+0	1.000000e+0	1.133354e+1	8.823365e-2	1	8.823365e-2	1.000000e+0	163	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000598	abnormal liver morphology	155	9.333181e-2	1.000000e+0	1.000000e+0	1.071446e+1	9.333181e-2	1	9.333181e-2	1.000000e+0	174	9.412402e-2	1.000000e+0	1.000000e+0	1.036839e+1	9.644698e-2	1	870	5.000000e-1	1.149425e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002138	abnormal hepatobiliary system morphology	156	9.450540e-2	1.000000e+0	1.000000e+0	1.058141e+1	9.450540e-2	1	9.450540e-2	1.000000e+0	176	9.549520e-2	1.000000e+0	1.000000e+0	1.021574e+1	9.788814e-2	1	883	5.000000e-1	1.132503e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0000516	abnormal renal/urinary system morphology	157	9.778842e-2	1.000000e+0	1.000000e+0	1.022616e+1	9.778842e-2	1	9.778842e-2	1.000000e+0	169	8.407233e-2	1.000000e+0	1.000000e+0	1.163935e+1	8.591541e-2	1	775	5.000000e-1	1.290323e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002106	abnormal muscle physiology	158	9.999719e-2	1.000000e+0	1.000000e+0	1.000028e+1	9.999719e-2	1	9.999719e-2	1.000000e+0	170	8.894639e-2	1.000000e+0	1.000000e+0	1.098721e+1	9.101491e-2	1	821	5.000000e-1	1.218027e-3	unnamed	LY6E
Mouse Phenotype	MP:0011086	partial postnatal lethality	159	1.002907e-1	1.000000e+0	1.000000e+0	9.971019e+0	1.002907e-1	1	1.002907e-1	1.000000e+0	162	7.822758e-2	1.000000e+0	1.000000e+0	1.252847e+1	7.981819e-2	1	720	5.000000e-1	1.388889e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0003953	abnormal hormone level	160	1.023291e-1	1.000000e+0	1.000000e+0	9.772394e+0	1.023291e-1	1	1.023291e-1	1.000000e+0	28	2.165430e-3	1.000000e+0	6.123527e-1	2.147738e+1	9.312122e-2	2	840	1.000000e+0	2.380952e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005370	liver/biliary system phenotype	161	1.044353e-1	1.000000e+0	1.000000e+0	9.575307e+0	1.044353e-1	1	1.044353e-1	1.000000e+0	177	1.082079e-1	1.000000e+0	1.000000e+0	8.984562e+0	1.113020e-1	1	1004	5.000000e-1	9.960159e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0002108	abnormal muscle morphology	162	1.058722e-1	1.000000e+0	1.000000e+0	9.445349e+0	1.058722e-1	1	1.058722e-1	1.000000e+0	172	8.989849e-2	1.000000e+0	1.000000e+0	1.086807e+1	9.201264e-2	1	830	5.000000e-1	1.204819e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002722	abnormal immune system organ morphology	163	1.102968e-1	1.000000e+0	1.000000e+0	9.066446e+0	1.102968e-1	1	1.102968e-1	1.000000e+0	180	1.202068e-1	1.000000e+0	1.000000e+0	8.061215e+0	1.240508e-1	1	1119	5.000000e-1	8.936550e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0002160	abnormal reproductive system morphology	164	1.137433e-1	1.000000e+0	1.000000e+0	8.791730e+0	1.137433e-1	1	1.137433e-1	1.000000e+0	179	1.128084e-1	1.000000e+0	1.000000e+0	8.607347e+0	1.161798e-1	1	1048	5.000000e-1	9.541985e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005367	renal/urinary system phenotype	165	1.190804e-1	1.000000e+0	1.000000e+0	8.397691e+0	1.190804e-1	1	1.190804e-1	1.000000e+0	178	1.092545e-1	1.000000e+0	1.000000e+0	8.895957e+0	1.124106e-1	1	1014	5.000000e-1	9.861933e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0000783	abnormal forebrain morphology	166	1.250634e-1	1.000000e+0	1.000000e+0	7.995943e+0	1.250634e-1	1	1.250634e-1	1.000000e+0	175	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	CYP11B2
Mouse Phenotype	MP:0002161	abnormal fertility/fecundity	167	1.345122e-1	1.000000e+0	1.000000e+0	7.434268e+0	1.345122e-1	1	1.345122e-1	1.000000e+0	181	1.310914e-1	1.000000e+0	1.000000e+0	7.369690e+0	1.356909e-1	1	1224	5.000000e-1	8.169935e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0000266	abnormal heart morphology	168	1.360125e-1	1.000000e+0	1.000000e+0	7.352265e+0	1.360125e-1	1	1.360125e-1	1.000000e+0	43	3.514506e-3	1.000000e+0	6.471595e-1	1.686075e+1	1.186187e-1	2	1070	1.000000e+0	1.869159e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005369	muscle phenotype	169	1.492399e-1	1.000000e+0	1.000000e+0	6.700621e+0	1.492399e-1	1	1.492399e-1	1.000000e+0	51	4.524622e-3	1.000000e+0	7.024697e-1	1.486079e+1	1.345823e-1	2	1214	1.000000e+0	1.647446e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0001919	abnormal reproductive system physiology	170	1.530473e-1	1.000000e+0	1.000000e+0	6.533929e+0	1.530473e-1	1	1.530473e-1	1.000000e+0	183	1.495931e-1	1.000000e+0	1.000000e+0	6.424858e+0	1.556455e-1	1	1404	5.000000e-1	7.122507e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0002163	abnormal gland morphology	171	1.548620e-1	1.000000e+0	1.000000e+0	6.457362e+0	1.548620e-1	1	1.548620e-1	1.000000e+0	57	5.754299e-3	1.000000e+0	7.993428e-1	1.317823e+1	1.517654e-1	2	1369	1.000000e+0	1.460920e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0001544	abnormal cardiovascular system physiology	172	1.606719e-1	1.000000e+0	1.000000e+0	6.223862e+0	1.606719e-1	1	1.606719e-1	1.000000e+0	54	5.148810e-3	1.000000e+0	7.549681e-1	1.393127e+1	1.435619e-1	2	1295	1.000000e+0	1.544402e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002082	postnatal lethality	173	1.637535e-1	1.000000e+0	1.000000e+0	6.106739e+0	1.637535e-1	1	1.637535e-1	1.000000e+0	182	1.329505e-1	1.000000e+0	1.000000e+0	7.262882e+0	1.376864e-1	1	1242	5.000000e-1	8.051530e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005379	endocrine/exocrine gland phenotype	174	1.670185e-1	1.000000e+0	1.000000e+0	5.987362e+0	1.670185e-1	1	1.670185e-1	1.000000e+0	65	6.982605e-3	1.000000e+0	8.505887e-1	1.196353e+1	1.671748e-1	2	1508	1.000000e+0	1.326260e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005389	reproductive system phenotype	175	1.774158e-1	1.000000e+0	1.000000e+0	5.636476e+0	1.774158e-1	1	1.774158e-1	1.000000e+0	185	1.715322e-1	1.000000e+0	1.000000e+0	5.568210e+0	1.795909e-1	1	1620	5.000000e-1	6.172840e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0000685	abnormal immune system morphology	176	1.819041e-1	1.000000e+0	1.000000e+0	5.497404e+0	1.819041e-1	1	1.819041e-1	1.000000e+0	187	2.020229e-1	1.000000e+0	1.000000e+0	4.685974e+0	2.134028e-1	1	1925	5.000000e-1	5.194805e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0002152	abnormal brain morphology	177	1.867872e-1	1.000000e+0	1.000000e+0	5.353687e+0	1.867872e-1	1	1.867872e-1	1.000000e+0	184	1.513302e-1	1.000000e+0	1.000000e+0	6.347994e+0	1.575301e-1	1	1421	5.000000e-1	7.037298e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0002127	abnormal cardiovascular system morphology	178	1.879460e-1	1.000000e+0	1.000000e+0	5.320677e+0	1.879460e-1	1	1.879460e-1	1.000000e+0	69	7.743375e-3	1.000000e+0	8.885803e-1	1.136083e+1	1.760435e-1	2	1588	1.000000e+0	1.259446e-3	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002396	abnormal hematopoietic system morphology/development	179	2.022701e-1	1.000000e+0	1.000000e+0	4.943885e+0	2.022701e-1	1	2.022701e-1	1.000000e+0	190	2.274661e-1	1.000000e+0	1.000000e+0	4.130266e+0	2.421152e-1	1	2184	5.000000e-1	4.578755e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005397	hematopoietic system phenotype	180	2.068614e-1	1.000000e+0	1.000000e+0	4.834154e+0	2.068614e-1	1	2.068614e-1	1.000000e+0	191	2.333986e-1	1.000000e+0	1.000000e+0	4.018040e+0	2.488776e-1	1	2245	5.000000e-1	4.454343e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0009642	abnormal blood homeostasis	181	2.077260e-1	1.000000e+0	1.000000e+0	4.814034e+0	2.077260e-1	1	2.077260e-1	1.000000e+0	93	1.344060e-2	1.000000e+0	1.000000e+0	8.623805e+0	2.319162e-1	2	2092	1.000000e+0	9.560229e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002080	prenatal lethality	182	2.134127e-1	1.000000e+0	1.000000e+0	4.685758e+0	2.134127e-1	1	2.134127e-1	1.000000e+0	189	2.134693e-1	1.000000e+0	1.000000e+0	4.419647e+0	2.262624e-1	1	2041	5.000000e-1	4.899559e-4	unnamed	LY6E
Mouse Phenotype	MP:0005385	cardiovascular system phenotype	183	2.326762e-1	1.000000e+0	1.000000e+0	4.297818e+0	2.326762e-1	1	2.326762e-1	1.000000e+0	88	1.239500e-2	1.000000e+0	1.000000e+0	8.980090e+0	2.227149e-1	2	2009	1.000000e+0	9.955202e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0001265	decreased body size	184	2.412513e-1	1.000000e+0	1.000000e+0	4.145055e+0	2.412513e-1	1	2.412513e-1	1.000000e+0	188	2.125842e-1	1.000000e+0	1.000000e+0	4.439222e+0	2.252647e-1	1	2032	5.000000e-1	4.921260e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005387	immune system phenotype	185	2.446842e-1	1.000000e+0	1.000000e+0	4.086901e+0	2.446842e-1	1	2.446842e-1	1.000000e+0	196	2.754183e-1	1.000000e+0	1.000000e+0	3.360842e+0	2.975445e-1	1	2684	5.000000e-1	3.725782e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0003956	abnormal body size	186	2.623454e-1	1.000000e+0	1.000000e+0	3.811768e+0	2.623454e-1	1	2.623454e-1	1.000000e+0	193	2.384377e-1	1.000000e+0	1.000000e+0	3.927079e+0	2.546422e-1	1	2297	5.000000e-1	4.353505e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0010832	lethality during fetal growth through weaning	187	2.758093e-1	1.000000e+0	1.000000e+0	3.625694e+0	2.758093e-1	1	2.758093e-1	1.000000e+0	94	1.349206e-2	1.000000e+0	1.000000e+0	8.607347e+0	2.323596e-1	2	2096	1.000000e+0	9.541985e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0002089	abnormal postnatal growth/weight/body size	188	2.800528e-1	1.000000e+0	1.000000e+0	3.570755e+0	2.800528e-1	1	2.800528e-1	1.000000e+0	195	2.591915e-1	1.000000e+0	1.000000e+0	3.589534e+0	2.785877e-1	1	2513	5.000000e-1	3.979308e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0003632	abnormal nervous system morphology	189	2.827167e-1	1.000000e+0	1.000000e+0	3.537110e+0	2.827167e-1	1	2.827167e-1	1.000000e+0	192	2.350478e-1	1.000000e+0	1.000000e+0	3.987843e+0	2.507622e-1	1	2262	5.000000e-1	4.420866e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0004924	abnormal behavior	190	2.945352e-1	1.000000e+0	1.000000e+0	3.395180e+0	2.945352e-1	1	2.945352e-1	1.000000e+0	194	2.543172e-1	1.000000e+0	1.000000e+0	3.663891e+0	2.729339e-1	1	2462	5.000000e-1	4.061738e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0001764	abnormal homeostasis	191	2.990593e-1	1.000000e+0	1.000000e+0	3.343818e+0	2.990593e-1	1	2.990593e-1	1.000000e+0	118	2.755190e-2	1.000000e+0	1.000000e+0	6.023706e+0	3.320215e-1	2	2995	1.000000e+0	6.677796e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0005621	abnormal cell physiology	192	3.078333e-1	1.000000e+0	1.000000e+0	3.248512e+0	3.078333e-1	1	3.078333e-1	1.000000e+0	198	3.046545e-1	1.000000e+0	1.000000e+0	3.009843e+0	3.322432e-1	1	2997	5.000000e-1	3.336670e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005384	cellular phenotype	193	3.121556e-1	1.000000e+0	1.000000e+0	3.203530e+0	3.121556e-1	1	3.121556e-1	1.000000e+0	199	3.123982e-1	1.000000e+0	1.000000e+0	2.927783e+0	3.415553e-1	1	3081	5.000000e-1	3.245699e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005376	homeostasis/metabolism phenotype	194	3.389663e-1	1.000000e+0	1.000000e+0	2.950146e+0	3.389663e-1	1	3.389663e-1	1.000000e+0	133	3.677304e-2	1.000000e+0	1.000000e+0	5.214162e+0	3.835708e-1	2	3460	1.000000e+0	5.780347e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0003631	nervous system phenotype	195	3.410385e-1	1.000000e+0	1.000000e+0	2.932220e+0	3.410385e-1	1	3.410385e-1	1.000000e+0	197	2.844493e-1	1.000000e+0	1.000000e+0	3.244784e+0	3.081869e-1	1	2780	5.000000e-1	3.597122e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0005378	growth/size phenotype	196	3.447235e-1	1.000000e+0	1.000000e+0	2.900875e+0	3.447235e-1	1	3.447235e-1	1.000000e+0	200	3.172618e-1	1.000000e+0	1.000000e+0	2.878271e+0	3.474309e-1	1	3134	5.000000e-1	3.190810e-4	unnamed	CYP11B2
Mouse Phenotype	MP:0010770	preweaning lethality	197	3.585301e-1	1.000000e+0	1.000000e+0	2.789166e+0	3.585301e-1	1	3.585301e-1	1.000000e+0	128	3.262408e-2	1.000000e+0	1.000000e+0	5.535747e+0	3.612882e-1	2	3259	1.000000e+0	6.136852e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0010769	abnormal survival	198	3.982821e-1	1.000000e+0	1.000000e+0	2.510783e+0	3.982821e-1	1	3.982821e-1	1.000000e+0	143	4.382095e-2	1.000000e+0	1.000000e+0	4.776542e+0	4.187129e-1	2	3777	1.000000e+0	5.295208e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0010768	mortality/aging	199	4.155501e-1	1.000000e+0	1.000000e+0	2.406449e+0	4.155501e-1	1	4.155501e-1	1.000000e+0	149	5.028602e-2	1.000000e+0	1.000000e+0	4.458972e+0	4.485339e-1	2	4046	1.000000e+0	4.943154e-4	unnamed	CYP11B2,LY6E
Mouse Phenotype	MP:0000001	mammalian phenotype	200	6.422596e-1	1.000000e+0	1.000000e+0	1.557003e+0	6.422596e-1	1	6.422596e-1	1.000000e+0	186	1.739173e-1	1.000000e+0	1.000000e+0	2.397794e+0	8.341001e-1	2	7524	1.000000e+0	2.658161e-4	unnamed	CYP11B2,LY6E
Human Phenotype	HP:0004319	Hypoaldosteronism	1	6.593554e-4	1.000000e+0	1.000000e+0	1.516633e+3	6.593554e-4	1	6.593554e-4	1.000000e+0	2	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	CYP11B2
Human Phenotype	HP:0002924	Decreased circulating aldosterone level	2	6.800813e-4	1.000000e+0	1.000000e+0	1.470412e+3	6.800813e-4	1	6.800813e-4	1.000000e+0	1	4.433975e-4	1.000000e+0	1.000000e+0	2.255125e+3	4.434344e-4	1	4	5.000000e-1	2.500000e-1	unnamed	CYP11B2
Human Phenotype	HP:0001278	Orthostatic hypotension	3	6.910275e-4	1.000000e+0	1.000000e+0	1.447120e+3	6.910275e-4	1	6.910275e-4	1.000000e+0	4	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	CYP11B2
Human Phenotype	HP:0000848	Increased circulating renin level	4	8.842689e-4	1.000000e+0	1.000000e+0	1.130878e+3	8.842689e-4	1	8.842689e-4	1.000000e+0	2	7.758812e-4	1.000000e+0	1.000000e+0	1.288643e+3	7.760102e-4	1	7	5.000000e-1	1.428571e-1	unnamed	CYP11B2
Human Phenotype	HP:0000127	Renal salt wasting	5	9.431201e-4	1.000000e+0	1.000000e+0	1.060310e+3	9.431201e-4	1	9.431201e-4	1.000000e+0	6	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Human Phenotype	HP:0000847	Abnormality of renin-angiotensin system	6	1.113471e-3	1.000000e+0	1.000000e+0	8.980926e+2	1.113471e-3	1	1.113471e-3	1.000000e+0	6	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	CYP11B2
Human Phenotype	HP:0003623	Neonatal onset	7	1.495455e-3	1.000000e+0	1.000000e+0	6.686926e+2	1.495455e-3	1	1.495455e-3	1.000000e+0	11	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	CYP11B2
Human Phenotype	HP:0001954	Episodic fever	8	1.532050e-3	1.000000e+0	1.000000e+0	6.527201e+2	1.532050e-3	1	1.532050e-3	1.000000e+0	8	1.883760e-3	1.000000e+0	1.000000e+0	5.306176e+2	1.884596e-3	1	17	5.000000e-1	5.882353e-2	unnamed	CYP11B2
Human Phenotype	HP:0002902	Hyponatremia	9	1.695173e-3	1.000000e+0	1.000000e+0	5.899103e+2	1.695173e-3	1	1.695173e-3	1.000000e+0	9	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	CYP11B2
Human Phenotype	HP:0012332	Abnormal autonomic nervous system physiology	10	1.713408e-3	1.000000e+0	1.000000e+0	5.836321e+2	1.713408e-3	1	1.713408e-3	1.000000e+0	10	2.326740e-3	1.000000e+0	1.000000e+0	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP11B2
Human Phenotype	HP:0002153	Hyperkalemia	11	1.784853e-3	1.000000e+0	9.972460e-1	5.602701e+2	1.784853e-3	1	1.784853e-3	1.000000e+0	5	1.551461e-3	1.000000e+0	1.000000e+0	6.443214e+2	1.552020e-3	1	14	5.000000e-1	7.142857e-2	unnamed	CYP11B2
Human Phenotype	HP:0010931	Abnormality of sodium homeostasis	12	1.941215e-3	1.000000e+0	9.942256e-1	5.151412e+2	1.941215e-3	1	1.941215e-3	1.000000e+0	11	2.548193e-3	1.000000e+0	1.000000e+0	3.921957e+2	2.549748e-3	1	23	5.000000e-1	4.347826e-2	unnamed	CYP11B2
Human Phenotype	HP:0011865	Abnormal urine cation concentration	13	2.141274e-3	1.000000e+0	1.000000e+0	4.670116e+2	2.141274e-3	1	2.141274e-3	1.000000e+0	16	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	CYP11B2
Human Phenotype	HP:0011042	Abnormality of potassium homeostasis	14	2.990928e-3	1.000000e+0	1.000000e+0	3.343444e+2	2.990928e-3	1	2.990928e-3	1.000000e+0	13	3.655089e-3	1.000000e+0	1.000000e+0	2.733485e+2	3.658334e-3	1	33	5.000000e-1	3.030303e-2	unnamed	CYP11B2
Human Phenotype	HP:0002615	Hypotension	15	3.081645e-3	1.000000e+0	1.000000e+0	3.245021e+2	3.081645e-3	1	3.081645e-3	1.000000e+0	14	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CYP11B2
Human Phenotype	HP:0010930	Abnormality of monovalent inorganic cation homeostasis	16	3.896835e-3	1.000000e+0	1.000000e+0	2.566185e+2	3.896835e-3	1	3.896835e-3	1.000000e+0	17	4.761371e-3	1.000000e+0	1.000000e+0	2.097791e+2	4.766920e-3	1	43	5.000000e-1	2.325581e-2	unnamed	CYP11B2
Human Phenotype	HP:0001945	Fever	17	3.941407e-3	1.000000e+0	1.000000e+0	2.537165e+2	3.941407e-3	1	3.941407e-3	1.000000e+0	20	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	CYP11B2
Human Phenotype	HP:0008207	Primary adrenal insufficiency	18	4.426750e-3	1.000000e+0	1.000000e+0	2.258994e+2	4.426750e-3	1	4.426750e-3	1.000000e+0	15	4.097676e-3	1.000000e+0	1.000000e+0	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	CYP11B2
Human Phenotype	HP:0001944	Dehydration	19	4.742302e-3	1.000000e+0	1.000000e+0	2.108681e+2	4.742302e-3	1	4.742302e-3	1.000000e+0	19	5.203711e-3	1.000000e+0	1.000000e+0	1.919255e+2	5.210354e-3	1	47	5.000000e-1	2.127660e-2	unnamed	CYP11B2
Human Phenotype	HP:0000846	Adrenal insufficiency	20	5.377337e-3	1.000000e+0	1.000000e+0	1.859656e+2	5.377337e-3	1	5.377337e-3	1.000000e+0	18	4.871965e-3	1.000000e+0	1.000000e+0	2.050114e+2	4.877778e-3	1	44	5.000000e-1	2.272727e-2	unnamed	CYP11B2
Human Phenotype	HP:0011733	Abnormality of adrenal physiology	21	7.020090e-3	1.000000e+0	1.000000e+0	1.424483e+2	7.020090e-3	1	7.020090e-3	1.000000e+0	21	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	CYP11B2
Human Phenotype	HP:0002013	Vomiting	22	8.572818e-3	1.000000e+0	1.000000e+0	1.166478e+2	8.572818e-3	1	8.572818e-3	1.000000e+0	23	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	CYP11B2
Human Phenotype	HP:0010929	Abnormality of cation homeostasis	23	8.949772e-3	1.000000e+0	1.000000e+0	1.117347e+2	8.949772e-3	1	8.949772e-3	1.000000e+0	25	1.303889e-2	1.000000e+0	1.000000e+0	7.644492e+1	1.308131e-2	1	118	5.000000e-1	8.474576e-3	unnamed	CYP11B2
Human Phenotype	HP:0000834	Abnormality of the adrenal glands	24	9.026950e-3	1.000000e+0	1.000000e+0	1.107794e+2	9.026950e-3	1	9.026950e-3	1.000000e+0	22	1.017327e-2	1.000000e+0	1.000000e+0	9.804891e+1	1.019899e-2	1	92	5.000000e-1	1.086957e-2	unnamed	CYP11B2
Human Phenotype	HP:0004370	Abnormality of temperature regulation	25	1.075062e-2	1.000000e+0	1.000000e+0	9.301791e+1	1.075062e-2	1	1.075062e-2	1.000000e+0	26	1.469025e-2	1.000000e+0	1.000000e+0	6.782331e+1	1.474419e-2	1	133	5.000000e-1	7.518797e-3	unnamed	CYP11B2
Human Phenotype	HP:0003111	Abnormality of ion homeostasis	26	1.104281e-2	1.000000e+0	1.000000e+0	9.055669e+1	1.104281e-2	1	1.104281e-2	1.000000e+0	27	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	CYP11B2
Human Phenotype	HP:0002270	Abnormality of the autonomic nervous system	27	1.291642e-2	1.000000e+0	1.000000e+0	7.742084e+1	1.291642e-2	1	1.291642e-2	1.000000e+0	24	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	CYP11B2
Human Phenotype	HP:0002017	Nausea and vomiting	28	1.584584e-2	1.000000e+0	1.000000e+0	6.310803e+1	1.584584e-2	1	1.584584e-2	1.000000e+0	29	1.809867e-2	1.000000e+0	1.000000e+0	5.500305e+1	1.818081e-2	1	164	5.000000e-1	6.097561e-3	unnamed	CYP11B2
Human Phenotype	HP:0000822	Hypertension	29	1.731318e-2	1.000000e+0	1.000000e+0	5.775946e+1	1.731318e-2	1	1.731318e-2	1.000000e+0	28	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	CYP11B2
Human Phenotype	HP:0003110	Abnormality of urine homeostasis	30	2.316703e-2	1.000000e+0	1.000000e+0	4.316480e+1	2.316703e-2	1	2.316703e-2	1.000000e+0	33	3.090952e-2	1.000000e+0	1.000000e+0	3.210142e+1	3.115127e-2	1	281	5.000000e-1	3.558719e-3	unnamed	CYP11B2
Human Phenotype	HP:0011032	Abnormality of fluid regulation	31	2.390611e-2	1.000000e+0	1.000000e+0	4.183031e+1	2.390611e-2	1	2.390611e-2	1.000000e+0	31	2.708603e-2	1.000000e+0	1.000000e+0	3.666870e+1	2.727122e-2	1	246	5.000000e-1	4.065041e-3	unnamed	CYP11B2
Human Phenotype	HP:0000082	Abnormality of renal physiology	32	2.423866e-2	1.000000e+0	1.000000e+0	4.125641e+1	2.423866e-2	1	2.423866e-2	1.000000e+0	32	2.850706e-2	1.000000e+0	1.000000e+0	3.482819e+1	2.871238e-2	1	259	5.000000e-1	3.861004e-3	unnamed	CYP11B2
Human Phenotype	HP:0008872	Feeding difficulties in infancy	33	2.531351e-2	1.000000e+0	1.000000e+0	3.950459e+1	2.531351e-2	1	2.531351e-2	1.000000e+0	30	2.621103e-2	1.000000e+0	1.000000e+0	3.790126e+1	2.638435e-2	1	238	5.000000e-1	4.201681e-3	unnamed	CYP11B2
Human Phenotype	HP:0001508	Failure to thrive	34	2.902184e-2	1.000000e+0	1.000000e+0	3.445681e+1	2.902184e-2	1	2.902184e-2	1.000000e+0	35	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	CYP11B2
Human Phenotype	HP:0011968	Feeding difficulties	35	3.142552e-2	1.000000e+0	1.000000e+0	3.182127e+1	3.142552e-2	1	3.142552e-2	1.000000e+0	34	3.210963e-2	1.000000e+0	1.000000e+0	3.089212e+1	3.237071e-2	1	292	5.000000e-1	3.424658e-3	unnamed	CYP11B2
Human Phenotype	HP:0011277	Abnormality of the urinary system physiology	36	3.851912e-2	1.000000e+0	1.000000e+0	2.596113e+1	3.851912e-2	1	3.851912e-2	1.000000e+0	36	4.623645e-2	1.000000e+0	1.000000e+0	2.137559e+1	4.678233e-2	1	422	5.000000e-1	2.369668e-3	unnamed	CYP11B2
Human Phenotype	HP:0011025	Abnormality of cardiovascular system physiology	37	4.649297e-2	1.000000e+0	1.000000e+0	2.150863e+1	4.649297e-2	1	4.649297e-2	1.000000e+0	38	4.958982e-2	1.000000e+0	1.000000e+0	1.991280e+1	5.021895e-2	1	453	5.000000e-1	2.207506e-3	unnamed	CYP11B2
Human Phenotype	HP:0004325	Decreased body weight	38	4.649404e-2	1.000000e+0	1.000000e+0	2.150813e+1	4.649404e-2	1	4.649404e-2	1.000000e+0	37	4.872500e-2	1.000000e+0	1.000000e+0	2.027079e+1	4.933208e-2	1	445	5.000000e-1	2.247191e-3	unnamed	CYP11B2
Human Phenotype	HP:0011007	Age of onset	39	5.358267e-2	1.000000e+0	1.000000e+0	1.866275e+1	5.358267e-2	1	5.358267e-2	1.000000e+0	41	6.380257e-2	1.000000e+0	1.000000e+0	1.541966e+1	6.485228e-2	1	585	5.000000e-1	1.709402e-3	unnamed	CYP11B2
Human Phenotype	HP:0003674	Onset	40	5.502040e-2	1.000000e+0	1.000000e+0	1.817508e+1	5.502040e-2	1	5.502040e-2	1.000000e+0	42	6.530370e-2	1.000000e+0	1.000000e+0	1.505927e+1	6.640430e-2	1	599	5.000000e-1	1.669449e-3	unnamed	CYP11B2
Human Phenotype	HP:0011458	Abdominal symptom	41	5.682180e-2	1.000000e+0	1.000000e+0	1.759888e+1	5.682180e-2	1	5.682180e-2	1.000000e+0	39	6.004447e-2	1.000000e+0	1.000000e+0	1.640091e+1	6.097223e-2	1	550	5.000000e-1	1.818182e-3	unnamed	CYP11B2
Human Phenotype	HP:0000818	Abnormality of the endocrine system	42	5.830630e-2	1.000000e+0	1.000000e+0	1.715081e+1	5.830630e-2	1	5.830630e-2	1.000000e+0	40	6.294423e-2	1.000000e+0	1.000000e+0	1.563345e+1	6.396541e-2	1	577	5.000000e-1	1.733102e-3	unnamed	CYP11B2
Human Phenotype	HP:0004323	Abnormality of body weight	43	6.465988e-2	1.000000e+0	1.000000e+0	1.546554e+1	6.465988e-2	1	6.465988e-2	1.000000e+0	43	6.541088e-2	1.000000e+0	1.000000e+0	1.503417e+1	6.651516e-2	1	600	5.000000e-1	1.666667e-3	unnamed	CYP11B2
Human Phenotype	HP:0001510	Growth delay	44	7.829812e-2	1.000000e+0	1.000000e+0	1.277170e+1	7.829812e-2	1	7.829812e-2	1.000000e+0	44	7.875969e-2	1.000000e+0	1.000000e+0	1.244207e+1	8.037248e-2	1	725	5.000000e-1	1.379310e-3	unnamed	CYP11B2
Human Phenotype	HP:0000004	Onset and clinical course	45	8.609761e-2	1.000000e+0	1.000000e+0	1.161472e+1	8.609761e-2	1	8.609761e-2	1.000000e+0	46	9.886599e-2	1.000000e+0	1.000000e+0	9.858470e+0	1.014356e-1	1	915	5.000000e-1	1.092896e-3	unnamed	CYP11B2
Human Phenotype	HP:0000079	Abnormality of the urinary system	46	8.807497e-2	1.000000e+0	1.000000e+0	1.135396e+1	8.807497e-2	1	8.807497e-2	1.000000e+0	45	9.053295e-2	1.000000e+0	1.000000e+0	1.079007e+1	9.267779e-2	1	836	5.000000e-1	1.196172e-3	unnamed	CYP11B2
Human Phenotype	HP:0001626	Abnormality of the cardiovascular system	47	1.079230e-1	1.000000e+0	1.000000e+0	9.265867e+0	1.079230e-1	1	1.079230e-1	1.000000e+0	47	1.132260e-1	1.000000e+0	1.000000e+0	8.574620e+0	1.166232e-1	1	1052	5.000000e-1	9.505703e-4	unnamed	CYP11B2
Human Phenotype	HP:0001507	Growth abnormality	48	1.155115e-1	1.000000e+0	1.000000e+0	8.657146e+0	1.155115e-1	1	1.155115e-1	1.000000e+0	48	1.160425e-1	1.000000e+0	1.000000e+0	8.360056e+0	1.196164e-1	1	1079	5.000000e-1	9.267841e-4	unnamed	CYP11B2
Human Phenotype	HP:0000119	Abnormality of the genitourinary system	49	1.156102e-1	1.000000e+0	1.000000e+0	8.649757e+0	1.156102e-1	1	1.156102e-1	1.000000e+0	49	1.209346e-1	1.000000e+0	1.000000e+0	8.011101e+0	1.248268e-1	1	1126	5.000000e-1	8.880995e-4	unnamed	CYP11B2
Human Phenotype	HP:0001939	Abnormality of metabolism/homeostasis	50	1.159749e-1	1.000000e+0	1.000000e+0	8.622554e+0	1.159749e-1	1	1.159749e-1	1.000000e+0	51	1.414974e-1	1.000000e+0	1.000000e+0	6.807925e+0	1.468876e-1	1	1325	5.000000e-1	7.547170e-4	unnamed	CYP11B2
Human Phenotype	HP:0001438	Abnormality of the abdomen	51	1.198484e-1	1.000000e+0	1.000000e+0	8.343876e+0	1.198484e-1	1	1.198484e-1	1.000000e+0	50	1.315047e-1	1.000000e+0	1.000000e+0	7.345684e+0	1.361344e-1	1	1228	5.000000e-1	8.143322e-4	unnamed	CYP11B2
Human Phenotype	HP:0000007	Autosomal recessive inheritance	52	1.382544e-1	1.000000e+0	1.000000e+0	7.233043e+0	1.382544e-1	1	1.382544e-1	1.000000e+0	52	1.705229e-1	1.000000e+0	1.000000e+0	5.602795e+0	1.784823e-1	1	1610	5.000000e-1	6.211180e-4	unnamed	CYP11B2
Human Phenotype	HP:0000707	Abnormality of the nervous system	53	1.846645e-1	1.000000e+0	1.000000e+0	5.415226e+0	1.846645e-1	1	1.846645e-1	1.000000e+0	53	1.902943e-1	1.000000e+0	1.000000e+0	4.991976e+0	2.003215e-1	1	1807	5.000000e-1	5.534034e-4	unnamed	CYP11B2
Human Phenotype	HP:0000005	Mode of inheritance	54	2.495240e-1	1.000000e+0	1.000000e+0	4.007630e+0	2.495240e-1	1	2.495240e-1	1.000000e+0	54	2.693662e-1	1.000000e+0	1.000000e+0	3.442939e+0	2.904495e-1	1	2620	5.000000e-1	3.816794e-4	unnamed	CYP11B2
Human Phenotype	HP:0000118	Phenotypic abnormality	55	2.682332e-1	1.000000e+0	1.000000e+0	3.728099e+0	2.682332e-1	1	2.682332e-1	1.000000e+0	55	2.856679e-1	1.000000e+0	1.000000e+0	3.229681e+0	3.096281e-1	1	2793	5.000000e-1	3.580380e-4	unnamed	CYP11B2
Human Phenotype	HP:0000001	All	56	2.696410e-1	1.000000e+0	1.000000e+0	3.708635e+0	2.696410e-1	1	2.696410e-1	1.000000e+0	56	2.883826e-1	1.000000e+0	1.000000e+0	3.196492e+0	3.128430e-1	1	2822	5.000000e-1	3.543586e-4	unnamed	CYP11B2
Disease Ontology	DOID:14080	glucocorticoid-remediable aldosteronism	1	6.211336e-5	1.388234e-1	1.388234e-1	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	1	2.217111e-4	4.955243e-1	4.955243e-1	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
Disease Ontology	DOID:9651	systolic heart failure	2	5.713106e-4	1.000000e+0	6.384396e-1	1.750361e+3	5.713106e-4	1	5.713106e-4	1.000000e+0	2	9.975062e-4	1.000000e+0	1.000000e+0	1.002278e+3	9.977274e-4	1	9	5.000000e-1	1.111111e-1	unnamed	CYP11B2
Disease Ontology	DOID:11396	pulmonary edema	3	9.015562e-4	1.000000e+0	6.716594e-1	1.109193e+3	9.015562e-4	1	9.015562e-4	1.000000e+0	4	1.329898e-3	1.000000e+0	7.430805e-1	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	CYP11B2
Disease Ontology	DOID:446	hyperaldosteronism	4	1.032780e-3	1.000000e+0	5.770658e-1	9.682602e+2	1.032780e-3	1	1.032780e-3	1.000000e+0	5	1.440682e-3	1.000000e+0	6.439849e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CYP11B2
Disease Ontology	DOID:13593	eclampsia	5	1.263357e-3	1.000000e+0	5.647206e-1	7.915418e+2	1.263357e-3	1	1.263357e-3	1.000000e+0	3	1.219107e-3	1.000000e+0	9.082347e-1	8.200455e+2	1.219445e-3	1	11	5.000000e-1	9.090909e-2	unnamed	CYP11B2
Disease Ontology	DOID:2449	acromegaly	6	1.792207e-3	1.000000e+0	6.675971e-1	5.579714e+2	1.792207e-3	1	1.792207e-3	1.000000e+0	7	2.437470e-3	1.000000e+0	7.782494e-1	4.100227e+2	2.438889e-3	1	22	5.000000e-1	4.545455e-2	unnamed	CYP11B2
Disease Ontology	DOID:13133	HELLP syndrome	7	2.361511e-3	1.000000e+0	7.539967e-1	4.234577e+2	2.361511e-3	1	2.361511e-3	1.000000e+0	6	2.326740e-3	1.000000e+0	8.667106e-1	4.295476e+2	2.328031e-3	1	21	5.000000e-1	4.761905e-2	unnamed	CYP11B2
Disease Ontology	DOID:13129	severe pre-eclampsia	8	2.887714e-3	1.000000e+0	8.067551e-1	3.462947e+2	2.887714e-3	1	2.887714e-3	1.000000e+0	8	2.991025e-3	1.000000e+0	8.356176e-1	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	CYP11B2
Disease Ontology	DOID:3947	adrenal gland hyperfunction	9	3.238176e-3	1.000000e+0	8.041470e-1	3.088158e+2	3.238176e-3	1	3.238176e-3	1.000000e+0	10	4.097676e-3	1.000000e+0	9.158306e-1	2.437973e+2	4.101768e-3	1	37	5.000000e-1	2.702703e-2	unnamed	CYP11B2
Disease Ontology	DOID:2256	osteochondrodysplasia	10	3.312208e-3	1.000000e+0	7.402785e-1	3.019134e+2	3.312208e-3	1	3.312208e-3	1.000000e+0	9	3.987038e-3	1.000000e+0	9.901144e-1	2.505694e+2	3.990910e-3	1	36	5.000000e-1	2.777778e-2	unnamed	CYP11B2
Disease Ontology	DOID:11162	respiratory failure	11	4.816393e-3	1.000000e+0	9.786035e-1	2.076243e+2	4.816393e-3	1	4.816393e-3	1.000000e+0	11	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CYP11B2
Disease Ontology	DOID:1588	thrombocytopenia	12	6.097374e-3	1.000000e+0	1.000000e+0	1.640050e+2	6.097374e-3	1	6.097374e-3	1.000000e+0	17	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	CYP11B2
Disease Ontology	DOID:3952	adrenal cortex disease	13	6.874333e-3	1.000000e+0	1.000000e+0	1.454687e+2	6.874333e-3	1	6.874333e-3	1.000000e+0	13	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	CYP11B2
Disease Ontology	DOID:11984	hypertrophic cardiomyopathy	14	7.116705e-3	1.000000e+0	1.000000e+0	1.405145e+2	7.116705e-3	1	7.116705e-3	1.000000e+0	13	6.861613e-3	1.000000e+0	1.000000e+0	1.454919e+2	6.873233e-3	1	62	5.000000e-1	1.612903e-2	unnamed	CYP11B2
Disease Ontology	DOID:0080006	bone development disease	15	7.348004e-3	1.000000e+0	1.000000e+0	1.360914e+2	7.348004e-3	1	7.348004e-3	1.000000e+0	12	6.309133e-3	1.000000e+0	1.000000e+0	1.582544e+2	6.318940e-3	1	57	5.000000e-1	1.754386e-2	unnamed	CYP11B2
Disease Ontology	DOID:2986	IgA glomerulonephritis	16	8.313087e-3	1.000000e+0	1.000000e+0	1.202923e+2	8.313087e-3	1	8.313087e-3	1.000000e+0	16	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	CYP11B2
Disease Ontology	DOID:9553	adrenal gland disease	17	9.008516e-3	1.000000e+0	1.000000e+0	1.110061e+2	9.008516e-3	1	9.008516e-3	1.000000e+0	17	8.849269e-3	1.000000e+0	1.000000e+0	1.127562e+2	8.868688e-3	1	80	5.000000e-1	1.250000e-2	unnamed	CYP11B2
Disease Ontology	DOID:2218	blood platelet disease	18	1.030053e-2	1.000000e+0	1.000000e+0	9.708242e+1	1.030053e-2	1	1.030053e-2	1.000000e+0	19	1.270846e-2	1.000000e+0	1.000000e+0	7.843913e+1	1.274874e-2	1	115	5.000000e-1	8.695652e-3	unnamed	CYP11B2
Disease Ontology	DOID:10825	essential hypertension	19	1.289069e-2	1.000000e+0	1.000000e+0	7.757539e+1	1.289069e-2	1	1.289069e-2	1.000000e+0	20	1.281861e-2	1.000000e+0	1.000000e+0	7.776293e+1	1.285960e-2	1	116	5.000000e-1	8.620690e-3	unnamed	CYP11B2
Disease Ontology	DOID:2921	glomerulonephritis	20	1.510282e-2	1.000000e+0	1.000000e+0	6.621281e+1	1.510282e-2	1	1.510282e-2	1.000000e+0	23	1.557041e-2	1.000000e+0	1.000000e+0	6.397518e+1	1.563106e-2	1	141	5.000000e-1	7.092199e-3	unnamed	CYP11B2
Disease Ontology	DOID:0060036	intrinsic cardiomyopathy	21	1.695991e-2	1.000000e+0	1.000000e+0	5.896257e+1	1.695991e-2	1	1.695991e-2	1.000000e+0	22	1.458020e-2	1.000000e+0	1.000000e+0	6.833712e+1	1.463334e-2	1	132	5.000000e-1	7.575758e-3	unnamed	CYP11B2
Disease Ontology	DOID:14330	Parkinson's disease	22	1.924662e-2	1.000000e+0	1.000000e+0	5.195717e+1	1.924662e-2	1	1.924662e-2	1.000000e+0	24	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	LY6E
Disease Ontology	DOID:2370	diabetic nephropathy	23	2.028896e-2	1.000000e+0	1.000000e+0	4.928788e+1	2.028896e-2	1	2.028896e-2	1.000000e+0	25	1.787895e-2	1.000000e+0	1.000000e+0	5.568210e+1	1.795909e-2	1	162	5.000000e-1	6.172840e-3	unnamed	CYP11B2
Disease Ontology	DOID:10952	nephritis	24	2.069794e-2	1.000000e+0	1.000000e+0	4.831398e+1	2.069794e-2	1	2.069794e-2	1.000000e+0	28	2.292630e-2	1.000000e+0	1.000000e+0	4.336779e+1	2.305859e-2	1	208	5.000000e-1	4.807692e-3	unnamed	CYP11B2
Disease Ontology	DOID:679	basal ganglia disease	25	2.127083e-2	1.000000e+0	1.000000e+0	4.701274e+1	2.127083e-2	1	2.127083e-2	1.000000e+0	26	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	LY6E
Disease Ontology	DOID:6000	heart failure	26	2.511073e-2	1.000000e+0	1.000000e+0	3.982361e+1	2.511073e-2	1	2.511073e-2	1.000000e+0	30	2.500727e-2	1.000000e+0	1.000000e+0	3.973789e+1	2.516490e-2	1	227	5.000000e-1	4.405286e-3	unnamed	CYP11B2
Disease Ontology	DOID:9352	diabetes mellitus type 2	27	2.639624e-2	1.000000e+0	1.000000e+0	3.788418e+1	2.639624e-2	1	2.639624e-2	1.000000e+0	29	2.435036e-2	1.000000e+0	1.000000e+0	4.081674e+1	2.449975e-2	1	221	5.000000e-1	4.524887e-3	unnamed	CYP11B2
Disease Ontology	DOID:10591	pre-eclampsia	28	2.656005e-2	1.000000e+0	1.000000e+0	3.765053e+1	2.656005e-2	1	2.656005e-2	1.000000e+0	31	2.938103e-2	1.000000e+0	1.000000e+0	3.378464e+1	2.959925e-2	1	267	5.000000e-1	3.745318e-3	unnamed	CYP11B2
Disease Ontology	DOID:3455	cerebrovascular accident	29	2.682361e-2	1.000000e+0	1.000000e+0	3.728059e+1	2.682361e-2	1	2.682361e-2	1.000000e+0	32	3.036376e-2	1.000000e+0	1.000000e+0	3.268297e+1	3.059697e-2	1	276	5.000000e-1	3.623188e-3	unnamed	CYP11B2
Disease Ontology	DOID:1936	atherosclerosis	30	3.199454e-2	1.000000e+0	1.000000e+0	3.125533e+1	3.199454e-2	1	3.199454e-2	1.000000e+0	34	3.679384e-2	1.000000e+0	1.000000e+0	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	CYP11B2
Disease Ontology	DOID:2348	arteriosclerotic cardiovascular disease	31	3.203444e-2	1.000000e+0	1.000000e+0	3.121640e+1	3.203444e-2	1	3.203444e-2	1.000000e+0	35	3.690264e-2	1.000000e+0	1.000000e+0	2.684673e+1	3.724849e-2	1	336	5.000000e-1	2.976190e-3	unnamed	CYP11B2
Disease Ontology	DOID:8857	lupus erythematosus	32	3.295243e-2	1.000000e+0	1.000000e+0	3.034678e+1	3.295243e-2	1	3.295243e-2	1.000000e+0	36	3.929468e-2	1.000000e+0	1.000000e+0	2.519693e+1	3.968738e-2	1	358	5.000000e-1	2.793296e-3	unnamed	LY6E
Disease Ontology	DOID:6713	cerebrovascular disease	33	3.298186e-2	1.000000e+0	1.000000e+0	3.031970e+1	3.298186e-2	1	3.298186e-2	1.000000e+0	33	3.614091e-2	1.000000e+0	1.000000e+0	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	CYP11B2
Disease Ontology	DOID:2349	arteriosclerosis	34	3.511376e-2	1.000000e+0	1.000000e+0	2.847886e+1	3.511376e-2	1	3.511376e-2	1.000000e+0	37	3.962064e-2	1.000000e+0	1.000000e+0	2.498753e+1	4.001995e-2	1	361	5.000000e-1	2.770083e-3	unnamed	CYP11B2
Disease Ontology	DOID:2868	arterial occlusive disease	35	3.554737e-2	1.000000e+0	1.000000e+0	2.813148e+1	3.554737e-2	1	3.554737e-2	1.000000e+0	38	4.048959e-2	1.000000e+0	1.000000e+0	2.444580e+1	4.090682e-2	1	369	5.000000e-1	2.710027e-3	unnamed	CYP11B2
Disease Ontology	DOID:2213	hemorrhagic disease	36	3.724211e-2	1.000000e+0	1.000000e+0	2.685133e+1	3.724211e-2	1	3.724211e-2	1.000000e+0	39	4.309408e-2	1.000000e+0	1.000000e+0	2.295293e+1	4.356743e-2	1	393	5.000000e-1	2.544529e-3	unnamed	CYP11B2
Disease Ontology	DOID:1247	blood coagulation disease	37	3.813833e-2	1.000000e+0	1.000000e+0	2.622034e+1	3.813833e-2	1	3.813833e-2	1.000000e+0	40	4.417824e-2	1.000000e+0	1.000000e+0	2.238337e+1	4.467602e-2	1	403	5.000000e-1	2.481390e-3	unnamed	CYP11B2
Disease Ontology	DOID:2869	arteriopathy	38	3.890202e-2	1.000000e+0	1.000000e+0	2.570561e+1	3.890202e-2	1	3.890202e-2	1.000000e+0	41	4.472009e-2	1.000000e+0	1.000000e+0	2.210907e+1	4.523031e-2	1	408	5.000000e-1	2.450980e-3	unnamed	CYP11B2
Disease Ontology	DOID:657	adenoma	39	4.777118e-2	1.000000e+0	1.000000e+0	2.093312e+1	4.777118e-2	1	4.777118e-2	1.000000e+0	42	4.656123e-2	1.000000e+0	1.000000e+0	2.122471e+1	4.711490e-2	1	425	5.000000e-1	2.352941e-3	unnamed	CYP11B2
Disease Ontology	DOID:10763	hypertension	40	6.448833e-2	1.000000e+0	1.000000e+0	1.550668e+1	6.448833e-2	1	6.448833e-2	1.000000e+0	43	6.197814e-2	1.000000e+0	1.000000e+0	1.588116e+1	6.296768e-2	1	568	5.000000e-1	1.760563e-3	unnamed	CYP11B2
Disease Ontology	DOID:114	heart disease	41	7.093406e-2	1.000000e+0	1.000000e+0	1.409760e+1	7.093406e-2	1	7.093406e-2	1.000000e+0	44	7.012061e-2	1.000000e+0	1.000000e+0	1.400699e+1	7.139294e-2	1	644	5.000000e-1	1.552795e-3	unnamed	CYP11B2
Disease Ontology	DOID:417	autoimmune disease	42	7.426329e-2	1.000000e+0	1.000000e+0	1.346560e+1	7.426329e-2	1	7.426329e-2	1.000000e+0	47	8.820552e-2	1.000000e+0	1.000000e+0	1.108170e+1	9.023890e-2	1	814	5.000000e-1	1.228501e-3	unnamed	LY6E
Disease Ontology	DOID:850	lung disease	43	7.639029e-2	1.000000e+0	1.000000e+0	1.309067e+1	7.639029e-2	1	7.639029e-2	1.000000e+0	45	8.375400e-2	1.000000e+0	1.000000e+0	1.168459e+1	8.558284e-2	1	772	5.000000e-1	1.295337e-3	unnamed	CYP11B2
Disease Ontology	DOID:0050161	lower respiratory tract disease	44	7.950492e-2	1.000000e+0	1.000000e+0	1.257784e+1	7.950492e-2	1	7.950492e-2	1.000000e+0	46	8.672289e-2	1.000000e+0	1.000000e+0	1.127562e+1	8.868688e-2	1	800	5.000000e-1	1.250000e-3	unnamed	CYP11B2
Disease Ontology	DOID:1579	respiratory system disease	45	8.437815e-2	1.000000e+0	1.000000e+0	1.185141e+1	8.437815e-2	1	8.437815e-2	1.000000e+0	51	9.707604e-2	1.000000e+0	1.000000e+0	1.004510e+1	9.955102e-2	1	898	5.000000e-1	1.113586e-3	unnamed	CYP11B2
Disease Ontology	DOID:0080001	bone disease	46	8.760496e-2	1.000000e+0	1.000000e+0	1.141488e+1	8.760496e-2	1	8.760496e-2	1.000000e+0	48	8.831138e-2	1.000000e+0	1.000000e+0	1.106810e+1	9.034976e-2	1	815	5.000000e-1	1.226994e-3	unnamed	CYP11B2
Disease Ontology	DOID:1289	neurodegenerative disease	47	9.274080e-2	1.000000e+0	1.000000e+0	1.078274e+1	9.274080e-2	1	9.274080e-2	1.000000e+0	53	9.981289e-2	1.000000e+0	1.000000e+0	9.762446e+0	1.024333e-1	1	924	5.000000e-1	1.082251e-3	unnamed	LY6E
Disease Ontology	DOID:9351	diabetes mellitus	48	9.310870e-2	1.000000e+0	1.000000e+0	1.074013e+1	9.310870e-2	1	9.310870e-2	1.000000e+0	49	9.465152e-2	1.000000e+0	1.000000e+0	1.030914e+1	9.700127e-2	1	875	5.000000e-1	1.142857e-3	unnamed	CYP11B2
Disease Ontology	DOID:1428	endocrine pancreas disease	49	9.553022e-2	1.000000e+0	1.000000e+0	1.046789e+1	9.553022e-2	1	9.553022e-2	1.000000e+0	50	9.654925e-2	1.000000e+0	1.000000e+0	1.010134e+1	9.899673e-2	1	893	5.000000e-1	1.119821e-3	unnamed	CYP11B2
Disease Ontology	DOID:4194	glucose metabolism disease	50	9.709597e-2	1.000000e+0	1.000000e+0	1.029909e+1	9.709597e-2	1	9.709597e-2	1.000000e+0	52	9.844499e-2	1.000000e+0	1.000000e+0	9.901756e+0	1.009922e-1	1	911	5.000000e-1	1.097695e-3	unnamed	CYP11B2
Disease Ontology	DOID:26	pancreas disease	51	9.807021e-2	1.000000e+0	1.000000e+0	1.019678e+1	9.807021e-2	1	9.807021e-2	1.000000e+0	54	1.001284e-1	1.000000e+0	1.000000e+0	9.730852e+0	1.027659e-1	1	927	5.000000e-1	1.078749e-3	unnamed	CYP11B2
Disease Ontology	DOID:0050013	carbohydrate metabolism disease	52	1.011074e-1	1.000000e+0	1.000000e+0	9.890476e+0	1.011074e-1	1	1.011074e-1	1.000000e+0	55	1.026506e-1	1.000000e+0	1.000000e+0	9.485279e+0	1.054265e-1	1	951	5.000000e-1	1.051525e-3	unnamed	CYP11B2
Disease Ontology	DOID:178	vascular disease	53	1.205522e-1	1.000000e+0	1.000000e+0	8.295164e+0	1.205522e-1	1	1.205522e-1	1.000000e+0	57	1.288165e-1	1.000000e+0	1.000000e+0	7.504576e+0	1.332520e-1	1	1202	5.000000e-1	8.319468e-4	unnamed	CYP11B2
Disease Ontology	DOID:28	endocrine system disease	54	1.359578e-1	1.000000e+0	1.000000e+0	7.355222e+0	1.359578e-1	1	1.359578e-1	1.000000e+0	58	1.392361e-1	1.000000e+0	1.000000e+0	6.922870e+0	1.444488e-1	1	1303	5.000000e-1	7.674597e-4	unnamed	CYP11B2
Disease Ontology	DOID:0014667	disease of metabolism	55	1.387898e-1	1.000000e+0	1.000000e+0	7.205143e+0	1.387898e-1	1	1.387898e-1	1.000000e+0	59	1.487750e-1	1.000000e+0	1.000000e+0	6.461676e+0	1.547586e-1	1	1396	5.000000e-1	7.163324e-4	unnamed	CYP11B2
Disease Ontology	DOID:77	gastrointestinal system disease	56	1.566959e-1	1.000000e+0	1.000000e+0	6.381787e+0	1.566959e-1	1	1.566959e-1	1.000000e+0	61	1.749595e-1	1.000000e+0	1.000000e+0	5.453748e+0	1.833601e-1	1	1654	5.000000e-1	6.045949e-4	unnamed	CYP11B2
Disease Ontology	DOID:74	hematopoietic system disease	57	1.634383e-1	1.000000e+0	1.000000e+0	6.118517e+0	1.634383e-1	1	1.634383e-1	1.000000e+0	60	1.726418e-1	1.000000e+0	1.000000e+0	5.530656e+0	1.808104e-1	1	1631	5.000000e-1	6.131208e-4	unnamed	CYP11B2
Disease Ontology	DOID:197	glandular cell epithelial neoplasm	58	1.860840e-1	1.000000e+0	1.000000e+0	5.373918e+0	1.860840e-1	1	1.860840e-1	1.000000e+0	62	1.850986e-1	1.000000e+0	1.000000e+0	5.139886e+0	1.945568e-1	1	1755	5.000000e-1	5.698006e-4	unnamed	CYP11B2
Disease Ontology	DOID:936	brain disease	59	1.872681e-1	1.000000e+0	1.000000e+0	5.339937e+0	1.872681e-1	1	1.872681e-1	1.000000e+0	15	8.390460e-3	1.000000e+0	1.000000e+0	1.091410e+1	1.832493e-1	2	1653	1.000000e+0	1.209921e-3	unnamed	CYP11B2,LY6E
Disease Ontology	DOID:225	syndrome	60	2.011593e-1	1.000000e+0	1.000000e+0	4.971185e+0	2.011593e-1	1	2.011593e-1	1.000000e+0	64	1.993468e-1	1.000000e+0	1.000000e+0	4.752634e+0	2.104096e-1	1	1898	5.000000e-1	5.268704e-4	unnamed	CYP11B2
Disease Ontology	DOID:17	musculoskeletal system disease	61	2.136568e-1	1.000000e+0	1.000000e+0	4.680403e+0	2.136568e-1	1	2.136568e-1	1.000000e+0	66	2.140591e-1	1.000000e+0	1.000000e+0	4.406693e+0	2.269276e-1	1	2047	5.000000e-1	4.885198e-4	unnamed	CYP11B2
Disease Ontology	DOID:157	epithelial carcinoma	62	2.158701e-1	1.000000e+0	1.000000e+0	4.632416e+0	2.158701e-1	1	2.158701e-1	1.000000e+0	67	2.169067e-1	1.000000e+0	1.000000e+0	4.345135e+0	2.301425e-1	1	2076	5.000000e-1	4.816956e-4	unnamed	CYP11B2
Disease Ontology	DOID:155	glandular and epithelial neoplasm	63	2.196335e-1	1.000000e+0	1.000000e+0	4.553039e+0	2.196335e-1	1	2.196335e-1	1.000000e+0	65	2.107139e-1	1.000000e+0	1.000000e+0	4.481123e+0	2.231584e-1	1	2013	5.000000e-1	4.967710e-4	unnamed	CYP11B2
Disease Ontology	DOID:331	central nervous system disease	64	2.247960e-1	1.000000e+0	1.000000e+0	4.448477e+0	2.247960e-1	1	2.247960e-1	1.000000e+0	21	1.365998e-2	1.000000e+0	1.000000e+0	8.554291e+0	2.338008e-1	2	2109	1.000000e+0	9.483167e-4	unnamed	CYP11B2,LY6E
Disease Ontology	DOID:1287	cardiovascular system disease	65	2.464292e-1	1.000000e+0	1.000000e+0	4.057961e+0	2.464292e-1	1	2.464292e-1	1.000000e+0	68	2.586189e-1	1.000000e+0	1.000000e+0	3.598125e+0	2.779225e-1	1	2507	5.000000e-1	3.988831e-4	unnamed	CYP11B2
Disease Ontology	DOID:863	nervous system disease	66	2.662634e-1	1.000000e+0	1.000000e+0	3.755680e+0	2.662634e-1	1	2.662634e-1	1.000000e+0	27	2.039685e-2	1.000000e+0	1.000000e+0	7.000776e+0	2.856826e-1	2	2577	1.000000e+0	7.760962e-4	unnamed	CYP11B2,LY6E
Disease Ontology	DOID:557	kidney disease	67	2.854845e-1	1.000000e+0	1.000000e+0	3.502817e+0	2.854845e-1	1	2.854845e-1	1.000000e+0	69	3.062252e-1	1.000000e+0	1.000000e+0	2.992867e+0	3.341278e-1	1	3014	5.000000e-1	3.317850e-4	unnamed	CYP11B2
Disease Ontology	DOID:18	urinary system disease	68	2.923209e-1	1.000000e+0	1.000000e+0	3.420898e+0	2.923209e-1	1	2.923209e-1	1.000000e+0	70	3.122143e-1	1.000000e+0	1.000000e+0	2.929685e+0	3.413336e-1	1	3079	5.000000e-1	3.247808e-4	unnamed	CYP11B2
Disease Ontology	DOID:2914	immune system disease	69	3.205063e-1	1.000000e+0	1.000000e+0	3.120063e+0	3.205063e-1	1	3.205063e-1	1.000000e+0	72	3.434783e-1	1.000000e+0	1.000000e+0	2.635261e+0	3.794690e-1	1	3423	5.000000e-1	2.921414e-4	unnamed	LY6E
Disease Ontology	DOID:305	carcinoma	70	3.218892e-1	1.000000e+0	1.000000e+0	3.106659e+0	3.218892e-1	1	3.218892e-1	1.000000e+0	71	3.253901e-1	1.000000e+0	1.000000e+0	2.798790e+0	3.572973e-1	1	3223	5.000000e-1	3.102699e-4	unnamed	CYP11B2
Disease Ontology	DOID:162	cancer	71	4.681931e-1	1.000000e+0	1.000000e+0	2.135871e+0	4.681931e-1	1	4.681931e-1	1.000000e+0	73	4.854768e-1	1.000000e+0	1.000000e+0	1.768725e+0	5.653789e-1	1	5100	5.000000e-1	1.960784e-4	unnamed	CYP11B2
Disease Ontology	DOID:7	disease of anatomical entity	72	5.144599e-1	1.000000e+0	1.000000e+0	1.943786e+0	5.144599e-1	1	5.144599e-1	1.000000e+0	56	1.068296e-1	1.000000e+0	1.000000e+0	3.059352e+0	6.537332e-1	2	5897	1.000000e+0	3.391555e-4	unnamed	CYP11B2,LY6E
Disease Ontology	DOID:4	disease	73	6.581397e-1	1.000000e+0	1.000000e+0	1.519434e+0	6.581397e-1	1	6.581397e-1	1.000000e+0	63	1.910563e-1	1.000000e+0	1.000000e+0	2.287725e+0	8.742309e-1	2	7886	1.000000e+0	2.536140e-4	unnamed	CYP11B2,LY6E
Placenta Disorders	00002	Genes with SNPs studied in association with pre-eclampsia	1	1.556817e-2	4.670451e-2	4.670451e-2	6.423364e+1	1.556817e-2	1	1.556817e-2	1.000000e+0	1	1.645017e-2	4.935051e-2	4.935051e-2	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	CYP11B2
BioCyc Pathway	PWY66-382	mineralocorticoid biosynthesis	1	6.211336e-5	2.062164e-2	2.062164e-2	1.609960e+4	6.211336e-5	1	6.211336e-5	1.000000e+0	1	2.217111e-4	7.360809e-2	7.360809e-2	4.510250e+3	2.217172e-4	1	2	5.000000e-1	5.000000e-1	unnamed	CYP11B2
BioCyc Pathway	PWY-7305	superpathway of steroid hormone biosynthesis	2	9.266667e-4	3.076533e-1	1.538267e-1	1.079137e+3	9.266667e-4	1	9.266667e-4	1.000000e+0	2	1.440682e-3	4.783064e-1	2.391532e-1	6.938846e+2	1.441162e-3	1	13	5.000000e-1	7.692308e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_ENDOGENOUS_STEROLS	Genes involved in Endogenous sterols	1	1.287299e-3	1.000000e+0	1.000000e+0	7.768201e+2	1.287299e-3	1	1.287299e-3	1.000000e+0	1	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_STEROID_HORMONES	Genes involved in Steroid hormones	2	2.236931e-3	1.000000e+0	1.000000e+0	4.470411e+2	2.236931e-3	1	2.236931e-3	1.000000e+0	2	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D	Genes involved in Metabolism of steroid hormones and vitamins A and D	3	2.441597e-3	1.000000e+0	1.000000e+0	4.095680e+2	2.441597e-3	1	2.441597e-3	1.000000e+0	3	3.765745e-3	1.000000e+0	1.000000e+0	2.653088e+2	3.769192e-3	1	34	5.000000e-1	2.941176e-2	unnamed	CYP11B2
MSigDB Pathway	KEGG_STEROID_HORMONE_BIOSYNTHESIS	Steroid hormone biosynthesis	4	3.167185e-3	1.000000e+0	1.000000e+0	3.157378e+2	3.167185e-3	1	3.167185e-3	1.000000e+0	5	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE	Genes involved in Cytochrome P450 - arranged by substrate type	5	3.299688e-3	1.000000e+0	8.711176e-1	3.030590e+2	3.299688e-3	1	3.299688e-3	1.000000e+0	4	5.424845e-3	1.000000e+0	1.000000e+0	1.840918e+2	5.432071e-3	1	49	5.000000e-1	2.040816e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_PHASE1_FUNCTIONALIZATION_OF_COMPOUNDS	Genes involved in Phase 1 - Functionalization of compounds	6	4.733687e-3	1.000000e+0	1.000000e+0	2.112518e+2	4.733687e-3	1	4.733687e-3	1.000000e+0	6	7.413939e-3	1.000000e+0	1.000000e+0	1.346343e+2	7.427526e-3	1	67	5.000000e-1	1.492537e-2	unnamed	CYP11B2
MSigDB Pathway	REACTOME_BIOLOGICAL_OXIDATIONS	Genes involved in Biological oxidations	7	8.699493e-3	1.000000e+0	1.000000e+0	1.149492e+2	8.699493e-3	1	8.699493e-3	1.000000e+0	7	1.502036e-2	1.000000e+0	1.000000e+0	6.632721e+1	1.507677e-2	1	136	5.000000e-1	7.352941e-3	unnamed	CYP11B2
MSigDB Pathway	REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS	Genes involved in Metabolism of lipids and lipoproteins	8	4.109831e-2	1.000000e+0	1.000000e+0	2.433190e+1	4.109831e-2	1	4.109831e-2	1.000000e+0	8	5.153422e-2	1.000000e+0	1.000000e+0	1.915180e+1	5.221440e-2	1	471	5.000000e-1	2.123142e-3	unnamed	CYP11B2
MGI Expression: Detected	7762	TS25_adrenal gland	1	3.375729e-3	1.000000e+0	1.000000e+0	2.962323e+2	3.375729e-3	1	3.375729e-3	1.000000e+0	5	3.433759e-3	1.000000e+0	1.000000e+0	2.909839e+2	3.436617e-3	1	31	5.000000e-1	3.225806e-2	unnamed	CYP11B2
MGI Expression: Detected	7761	TS24_adrenal gland	2	3.415814e-3	1.000000e+0	1.000000e+0	2.927560e+2	3.415814e-3	1	3.415814e-3	1.000000e+0	3	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	CYP11B2
MGI Expression: Detected	7763	TS26_adrenal gland	3	4.413915e-3	1.000000e+0	1.000000e+0	2.265562e+2	4.413915e-3	1	4.413915e-3	1.000000e+0	2	2.991025e-3	1.000000e+0	1.000000e+0	3.340926e+2	2.993182e-3	1	27	5.000000e-1	3.703704e-2	unnamed	CYP11B2
MGI Expression: Detected	7568	TS26_gland	4	4.549246e-3	1.000000e+0	1.000000e+0	2.198166e+2	4.549246e-3	1	4.549246e-3	1.000000e+0	3	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	CYP11B2
MGI Expression: Detected	12750	TS23_rest of cerebellum marginal layer	5	2.761358e-2	1.000000e+0	1.000000e+0	3.621406e+1	2.761358e-2	1	2.761358e-2	1.000000e+0	7	1.842821e-2	1.000000e+0	1.000000e+0	5.401497e+1	1.851339e-2	1	167	5.000000e-1	5.988024e-3	unnamed	LY6E
MGI Expression: Detected	16160	TS22_pancreas epithelium	6	3.483643e-2	1.000000e+0	1.000000e+0	2.870558e+1	3.483643e-2	1	3.483643e-2	1.000000e+0	8	4.114105e-2	1.000000e+0	1.000000e+0	2.405467e+1	4.157197e-2	1	375	5.000000e-1	2.666667e-3	unnamed	LY6E
MGI Expression: Detected	7760	TS23_adrenal gland	7	4.451279e-2	1.000000e+0	1.000000e+0	2.246545e+1	4.451279e-2	1	4.451279e-2	1.000000e+0	1	3.839554e-4	1.000000e+0	1.000000e+0	5.096328e+1	3.924394e-2	2	354	1.000000e+0	5.649718e-3	unnamed	CYP11B2,LY6E
MGI Expression: Detected	7465	TS23_vertebral axis muscle system	8	7.743613e-2	1.000000e+0	1.000000e+0	1.291387e+1	7.743613e-2	1	7.743613e-2	1.000000e+0	11	7.247101e-2	1.000000e+0	1.000000e+0	1.354429e+1	7.383183e-2	1	666	5.000000e-1	1.501502e-3	unnamed	LY6E
MGI Expression: Detected	7897	TS23_liver	9	8.884109e-2	1.000000e+0	1.000000e+0	1.125605e+1	8.884109e-2	1	8.884109e-2	1.000000e+0	15	1.088360e-1	1.000000e+0	1.000000e+0	8.931188e+0	1.119672e-1	1	1010	5.000000e-1	9.900990e-4	unnamed	LY6E
MGI Expression: Detected	7632	TS23_liver and biliary system	10	8.889924e-2	1.000000e+0	1.000000e+0	1.124869e+1	8.889924e-2	1	8.889924e-2	1.000000e+0	16	1.091499e-1	1.000000e+0	1.000000e+0	8.904738e+0	1.122998e-1	1	1013	5.000000e-1	9.871668e-4	unnamed	LY6E
MGI Expression: Detected	7379	TS22_adrenal gland	11	9.915582e-2	1.000000e+0	1.000000e+0	1.008514e+1	9.915582e-2	1	9.915582e-2	1.000000e+0	14	8.682883e-2	1.000000e+0	1.000000e+0	1.126155e+1	8.879774e-2	1	801	5.000000e-1	1.248439e-3	unnamed	CYP11B2
MGI Expression: Detected	12702	TS23_rest of cerebellum	12	1.120447e-1	1.000000e+0	1.000000e+0	8.925009e+0	1.120447e-1	1	1.120447e-1	1.000000e+0	9	6.165600e-2	1.000000e+0	1.000000e+0	1.596549e+1	6.263511e-2	1	565	5.000000e-1	1.769912e-3	unnamed	LY6E
MGI Expression: Detected	8522	TS23_thymus primordium	13	1.165455e-1	1.000000e+0	1.000000e+0	8.580336e+0	1.165455e-1	1	1.165455e-1	1.000000e+0	17	1.237388e-1	1.000000e+0	1.000000e+0	7.823504e+0	1.278200e-1	1	1153	5.000000e-1	8.673027e-4	unnamed	LY6E
MGI Expression: Detected	7776	TS23_haemolymphoid system	14	1.177883e-1	1.000000e+0	1.000000e+0	8.489804e+0	1.177883e-1	1	1.177883e-1	1.000000e+0	18	1.252947e-1	1.000000e+0	1.000000e+0	7.723031e+0	1.294828e-1	1	1168	5.000000e-1	8.561644e-4	unnamed	LY6E
MGI Expression: Detected	10135	TS23_olfactory epithelium	15	1.433281e-1	1.000000e+0	1.000000e+0	6.976998e+0	1.433281e-1	1	1.433281e-1	1.000000e+0	19	1.373837e-1	1.000000e+0	1.000000e+0	7.019844e+0	1.424533e-1	1	1285	5.000000e-1	7.782101e-4	unnamed	LY6E
MGI Expression: Detected	6048	TS22_pancreas	16	1.480883e-1	1.000000e+0	1.000000e+0	6.752730e+0	1.480883e-1	1	1.480883e-1	1.000000e+0	21	1.441660e-1	1.000000e+0	1.000000e+0	6.676906e+0	1.497700e-1	1	1351	5.000000e-1	7.401925e-4	unnamed	LY6E
MGI Expression: Detected	7565	TS23_gland	17	1.482368e-1	1.000000e+0	1.000000e+0	6.745964e+0	1.482368e-1	1	1.482368e-1	1.000000e+0	6	6.473466e-3	1.000000e+0	1.000000e+0	1.242493e+1	1.609667e-1	2	1452	1.000000e+0	1.377410e-3	unnamed	CYP11B2,LY6E
MGI Expression: Detected	9053	TS23_nasal cavity epithelium	18	1.491816e-1	1.000000e+0	1.000000e+0	6.703241e+0	1.491816e-1	1	1.491816e-1	1.000000e+0	20	1.417028e-1	1.000000e+0	1.000000e+0	6.797664e+0	1.471094e-1	1	1327	5.000000e-1	7.535795e-4	unnamed	LY6E
MGI Expression: Detected	8141	TS23_nasal cavity	19	1.559269e-1	1.000000e+0	1.000000e+0	6.413261e+0	1.559269e-1	1	1.559269e-1	1.000000e+0	22	1.447813e-1	1.000000e+0	1.000000e+0	6.647384e+0	1.504351e-1	1	1357	5.000000e-1	7.369197e-4	unnamed	LY6E
MGI Expression: Detected	7372	TS22_gland	20	1.711188e-1	1.000000e+0	1.000000e+0	5.843894e+0	1.711188e-1	1	1.711188e-1	1.000000e+0	23	1.530655e-1	1.000000e+0	1.000000e+0	6.272949e+0	1.594147e-1	1	1438	5.000000e-1	6.954103e-4	unnamed	CYP11B2
MGI Expression: Detected	7447	TS25_organ system	21	1.725636e-1	1.000000e+0	1.000000e+0	5.794963e+0	1.725636e-1	1	1.725636e-1	1.000000e+0	24	1.537795e-1	1.000000e+0	1.000000e+0	6.242561e+0	1.601907e-1	1	1445	5.000000e-1	6.920415e-4	unnamed	CYP11B2
MGI Expression: Detected	7612	TS23_nose	22	2.118241e-1	1.000000e+0	1.000000e+0	4.720898e+0	2.118241e-1	1	2.118241e-1	1.000000e+0	25	1.912916e-1	1.000000e+0	1.000000e+0	4.964502e+0	2.014301e-1	1	1817	5.000000e-1	5.503577e-4	unnamed	LY6E
MGI Expression: Detected	6931	TS25_embryo	23	2.493552e-1	1.000000e+0	1.000000e+0	4.010344e+0	2.493552e-1	1	2.493552e-1	1.000000e+0	29	2.315532e-1	1.000000e+0	1.000000e+0	4.052336e+0	2.467712e-1	1	2226	5.000000e-1	4.492363e-4	unnamed	CYP11B2
MGI Expression: Detected	6930	Theiler_stage_25	24	2.502634e-1	1.000000e+0	1.000000e+0	3.995791e+0	2.502634e-1	1	2.502634e-1	1.000000e+0	30	2.329132e-1	1.000000e+0	1.000000e+0	4.027009e+0	2.483233e-1	1	2240	5.000000e-1	4.464286e-4	unnamed	CYP11B2
MGI Expression: Detected	12476	TS23_cerebellum	25	2.660723e-1	1.000000e+0	1.000000e+0	3.758377e+0	2.660723e-1	1	2.660723e-1	1.000000e+0	27	2.025180e-1	1.000000e+0	1.000000e+0	4.673834e+0	2.139571e-1	1	1930	5.000000e-1	5.181347e-4	unnamed	LY6E
MGI Expression: Detected	6020	TS22_gut	26	2.671263e-1	1.000000e+0	1.000000e+0	3.743547e+0	2.671263e-1	1	2.671263e-1	1.000000e+0	33	2.480816e-1	1.000000e+0	1.000000e+0	3.763246e+0	2.657281e-1	1	2397	5.000000e-1	4.171882e-4	unnamed	LY6E
MGI Expression: Detected	11875	TS23_metencephalon alar plate	27	2.727186e-1	1.000000e+0	1.000000e+0	3.666783e+0	2.727186e-1	1	2.727186e-1	1.000000e+0	28	2.070656e-1	1.000000e+0	1.000000e+0	4.565030e+0	2.190566e-1	1	1976	5.000000e-1	5.060729e-4	unnamed	LY6E
MGI Expression: Detected	7448	TS26_organ system	28	2.750733e-1	1.000000e+0	1.000000e+0	3.635395e+0	2.750733e-1	1	2.750733e-1	1.000000e+0	36	2.630034e-1	1.000000e+0	1.000000e+0	3.533294e+0	2.830220e-1	1	2553	5.000000e-1	3.916960e-4	unnamed	CYP11B2
MGI Expression: Detected	6019	TS22_alimentary system	29	2.958102e-1	1.000000e+0	1.000000e+0	3.380547e+0	2.958102e-1	1	2.958102e-1	1.000000e+0	38	2.795646e-1	1.000000e+0	1.000000e+0	3.306635e+0	3.024223e-1	1	2728	5.000000e-1	3.665689e-4	unnamed	LY6E
MGI Expression: Detected	7446	TS24_organ system	30	2.979509e-1	1.000000e+0	1.000000e+0	3.356258e+0	2.979509e-1	1	2.979509e-1	1.000000e+0	35	2.626226e-1	1.000000e+0	1.000000e+0	3.538839e+0	2.825786e-1	1	2549	5.000000e-1	3.923107e-4	unnamed	CYP11B2
MGI Expression: Detected	6934	TS26_embryo	31	3.006505e-1	1.000000e+0	1.000000e+0	3.326122e+0	3.006505e-1	1	3.006505e-1	1.000000e+0	39	2.916520e-1	1.000000e+0	1.000000e+0	3.157333e+0	3.167230e-1	1	2857	5.000000e-1	3.500175e-4	unnamed	CYP11B2
MGI Expression: Detected	6933	Theiler_stage_26	32	3.012560e-1	1.000000e+0	1.000000e+0	3.319436e+0	3.012560e-1	1	3.012560e-1	1.000000e+0	40	2.923983e-1	1.000000e+0	1.000000e+0	3.148517e+0	3.176099e-1	1	2865	5.000000e-1	3.490401e-4	unnamed	CYP11B2
MGI Expression: Detected	11175	TS23_metencephalon lateral wall	33	3.223304e-1	1.000000e+0	1.000000e+0	3.102407e+0	3.223304e-1	1	3.223304e-1	1.000000e+0	34	2.482739e-1	1.000000e+0	1.000000e+0	3.760108e+0	2.659498e-1	1	2399	5.000000e-1	4.168404e-4	unnamed	LY6E
MGI Expression: Detected	6928	TS24_embryo	34	3.290828e-1	1.000000e+0	1.000000e+0	3.038749e+0	3.290828e-1	1	3.290828e-1	1.000000e+0	41	2.959376e-1	1.000000e+0	1.000000e+0	3.107303e+0	3.218225e-1	1	2903	5.000000e-1	3.444712e-4	unnamed	CYP11B2
MGI Expression: Detected	6927	Theiler_stage_24	35	3.296590e-1	1.000000e+0	1.000000e+0	3.033437e+0	3.296590e-1	1	3.296590e-1	1.000000e+0	42	2.964026e-1	1.000000e+0	1.000000e+0	3.101960e+0	3.223768e-1	1	2908	5.000000e-1	3.438790e-4	unnamed	CYP11B2
MGI Expression: Detected	9987	TS23_metencephalon	36	3.375115e-1	1.000000e+0	1.000000e+0	2.962862e+0	3.375115e-1	1	3.375115e-1	1.000000e+0	37	2.656658e-1	1.000000e+0	1.000000e+0	3.494963e+0	2.861260e-1	1	2581	5.000000e-1	3.874467e-4	unnamed	LY6E
MGI Expression: Detected	6018	TS22_visceral organ	37	3.446359e-1	1.000000e+0	1.000000e+0	2.901613e+0	3.446359e-1	1	3.446359e-1	1.000000e+0	44	3.321114e-1	1.000000e+0	1.000000e+0	2.735972e+0	3.655008e-1	1	3297	5.000000e-1	3.033060e-4	unnamed	LY6E
MGI Expression: Detected	7485	TS23_sensory organ	38	3.817293e-1	1.000000e+0	1.000000e+0	2.619657e+0	3.817293e-1	1	3.817293e-1	1.000000e+0	45	3.416806e-1	1.000000e+0	1.000000e+0	2.650749e+0	3.772518e-1	1	3403	5.000000e-1	2.938584e-4	unnamed	LY6E
MGI Expression: Detected	8824	TS23_hindbrain	39	3.841897e-1	1.000000e+0	1.000000e+0	2.602881e+0	3.841897e-1	1	3.841897e-1	1.000000e+0	43	3.099139e-1	1.000000e+0	1.000000e+0	2.953667e+0	3.385622e-1	1	3054	5.000000e-1	3.274394e-4	unnamed	LY6E
MGI Expression: Detected	5784	TS22_organ system	40	4.769468e-1	1.000000e+0	1.000000e+0	2.096670e+0	4.769468e-1	1	4.769468e-1	1.000000e+0	10	6.517131e-2	1.000000e+0	1.000000e+0	3.916848e+0	5.106147e-1	2	4606	1.000000e+0	4.342162e-4	unnamed	CYP11B2,LY6E
MGI Expression: Detected	5741	TS22_embryo	41	5.012384e-1	1.000000e+0	1.000000e+0	1.995059e+0	5.012384e-1	1	5.012384e-1	1.000000e+0	12	7.591070e-2	1.000000e+0	1.000000e+0	3.629250e+0	5.510781e-1	2	4971	1.000000e+0	4.023335e-4	unnamed	CYP11B2,LY6E
MGI Expression: Detected	7901	TS23_brain	42	5.025340e-1	1.000000e+0	1.000000e+0	1.989915e+0	5.025340e-1	1	5.025340e-1	1.000000e+0	46	4.293954e-1	1.000000e+0	1.000000e+0	2.044074e+0	4.892190e-1	1	4413	5.000000e-1	2.266032e-4	unnamed	LY6E
MGI Expression: Detected	5740	Theiler_stage_22	43	5.025708e-1	1.000000e+0	1.000000e+0	1.989769e+0	5.025708e-1	1	5.025708e-1	1.000000e+0	13	7.664554e-2	1.000000e+0	1.000000e+0	3.611812e+0	5.537387e-1	2	4995	1.000000e+0	4.004004e-4	unnamed	CYP11B2,LY6E
MGI Expression: Detected	7489	TS23_visceral organ	44	5.150818e-1	1.000000e+0	1.000000e+0	1.941439e+0	5.150818e-1	1	5.150818e-1	1.000000e+0	49	5.216365e-1	1.000000e+0	1.000000e+0	1.621517e+0	6.167064e-1	1	5563	5.000000e-1	1.797591e-4	unnamed	LY6E
MGI Expression: Detected	7608	TS23_central nervous system	45	5.265571e-1	1.000000e+0	1.000000e+0	1.899129e+0	5.265571e-1	1	5.265571e-1	1.000000e+0	47	4.610183e-1	1.000000e+0	1.000000e+0	1.880838e+0	5.316778e-1	1	4796	5.000000e-1	2.085071e-4	unnamed	LY6E
MGI Expression: Detected	7501	TS23_nervous system	46	5.331601e-1	1.000000e+0	1.000000e+0	1.875609e+0	5.331601e-1	1	5.331601e-1	1.000000e+0	48	4.686418e-1	1.000000e+0	1.000000e+0	1.844683e+0	5.420986e-1	1	4890	5.000000e-1	2.044990e-4	unnamed	LY6E
MGI Expression: Detected	7445	TS23_organ system	47	6.921258e-1	1.000000e+0	1.000000e+0	1.444824e+0	6.921258e-1	1	6.921258e-1	1.000000e+0	26	1.994819e-1	1.000000e+0	1.000000e+0	2.238893e+0	8.932986e-1	2	8058	1.000000e+0	2.482005e-4	unnamed	CYP11B2,LY6E
MGI Expression: Detected	6925	TS23_embryo	48	7.220129e-1	1.000000e+0	1.000000e+0	1.385017e+0	7.220129e-1	1	7.220129e-1	1.000000e+0	31	2.342505e-1	1.000000e+0	1.000000e+0	2.066079e+0	9.680173e-1	2	8732	1.000000e+0	2.290426e-4	unnamed	CYP11B2,LY6E
MGI Expression: Detected	6924	Theiler_stage_23	49	7.220179e-1	1.000000e+0	1.000000e+0	1.385007e+0	7.220179e-1	1	7.220179e-1	1.000000e+0	32	2.344115e-1	1.000000e+0	1.000000e+0	2.065369e+0	9.683499e-1	2	8735	1.000000e+0	2.289639e-4	unnamed	CYP11B2,LY6E
MSigDB Perturbation	WORSCHECH_TUMOR_REJECTION_DN	Down-regulated genes defining rejection of mammary carcinoma (MMC) tumors.	1	8.532153e-4	1.000000e+0	1.000000e+0	1.172037e+3	8.532153e-4	1	8.532153e-4	1.000000e+0	3	1.108309e-3	1.000000e+0	1.000000e+0	9.020500e+2	1.108586e-3	1	10	5.000000e-1	1.000000e-1	unnamed	LY6E
MSigDB Perturbation	BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	Genes significantly up-regulated in the blood mononuclear cells from patients with systemic lupus erythematosus compared to those from healthy persons.	2	1.363383e-3	1.000000e+0	1.000000e+0	7.334696e+2	1.363383e-3	1	1.363383e-3	1.000000e+0	9	3.544427e-3	1.000000e+0	1.000000e+0	2.818906e+2	3.547475e-3	1	32	5.000000e-1	3.125000e-2	unnamed	LY6E
MSigDB Perturbation	EHLERS_ANEUPLOIDY_DN	Down-regulated genes in the expression signature of aneuploidy in uveal melanoma tumors: low vs high aneuploidy.	3	1.581348e-3	1.000000e+0	1.000000e+0	6.323718e+2	1.581348e-3	1	1.581348e-3	1.000000e+0	4	1.329898e-3	1.000000e+0	1.000000e+0	7.517083e+2	1.330303e-3	1	12	5.000000e-1	8.333333e-2	unnamed	LY6E
MSigDB Perturbation	CHOW_RASSF1_TARGETS_DN	Genes down-regulated in C666-1 cells (nasopharyngeal carcinoma) by stable expression of RASSF1 [GeneID=11186].	4	1.650279e-3	1.000000e+0	1.000000e+0	6.059582e+2	1.650279e-3	1	1.650279e-3	1.000000e+0	8	3.212404e-3	1.000000e+0	1.000000e+0	3.110517e+2	3.214899e-3	1	29	5.000000e-1	3.448276e-2	unnamed	LY6E
MSigDB Perturbation	EINAV_INTERFERON_SIGNATURE_IN_CANCER	A gene expression signature found in a subset of cancer patients suggestive of a deregulated immune or inflammatory response.	5	1.915448e-3	1.000000e+0	1.000000e+0	5.220711e+2	1.915448e-3	1	1.915448e-3	1.000000e+0	7	3.101718e-3	1.000000e+0	1.000000e+0	3.221607e+2	3.104041e-3	1	28	5.000000e-1	3.571429e-2	unnamed	LY6E
MSigDB Perturbation	WOTTON_RUNX_TARGETS_UP	Common target genes up-regulated by all three Runx family members (RUNX1, RUNX2, and RUNX3 [GeneID=861;860;864]) in MEF cells (embryonic fibroblasts).	6	2.302288e-3	1.000000e+0	1.000000e+0	4.343506e+2	2.302288e-3	1	2.302288e-3	1.000000e+0	6	2.216004e-3	1.000000e+0	1.000000e+0	4.510250e+2	2.217172e-3	1	20	5.000000e-1	5.000000e-2	unnamed	LY6E
MSigDB Perturbation	WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	Top down-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	7	2.614837e-3	1.000000e+0	1.000000e+0	3.824330e+2	2.614837e-3	1	2.614837e-3	1.000000e+0	5	2.105263e-3	1.000000e+0	1.000000e+0	4.747632e+2	2.106313e-3	1	19	5.000000e-1	5.263158e-2	unnamed	CYP11B2
MSigDB Perturbation	DAZARD_UV_RESPONSE_CLUSTER_G2	Cluster G2: genes increasingly up-regulated in NHEK cells (normal keratinocyte) and reaching maximum levels at 12 h and 24 h after UV-B irradiation.	8	2.628618e-3	1.000000e+0	1.000000e+0	3.804281e+2	2.628618e-3	1	2.628618e-3	1.000000e+0	10	3.876395e-3	1.000000e+0	1.000000e+0	2.577286e+2	3.880051e-3	1	35	5.000000e-1	2.857143e-2	unnamed	LY6E
MSigDB Perturbation	LEE_CALORIE_RESTRICTION_MUSCLE_DN	Down-regulated in the gastrocnemius muscle of aged (30-month) mice subjected to caloric restriction diet since young adulthood.	9	3.496581e-3	1.000000e+0	1.000000e+0	2.859936e+2	3.496581e-3	1	3.496581e-3	1.000000e+0	13	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	LY6E
MSigDB Perturbation	PARK_HSC_AND_MULTIPOTENT_PROGENITORS	Genes commonly expressed in long term hematopoietic stem cells (HSC) and multipotent progenitors (MPP).	10	3.498529e-3	1.000000e+0	1.000000e+0	2.858344e+2	3.498529e-3	1	3.498529e-3	1.000000e+0	12	5.535402e-3	1.000000e+0	1.000000e+0	1.804100e+2	5.542930e-3	1	50	5.000000e-1	2.000000e-2	unnamed	LY6E
MSigDB Perturbation	PRAMOONJAGO_SOX4_TARGETS_DN	Genes down-regulated in ACC3 cells (adenoid cystic carcinoma) after knockdown of SOX4 [GeneID=6659] by RNAi.	11	3.555044e-3	1.000000e+0	1.000000e+0	2.812905e+2	3.555044e-3	1	3.555044e-3	1.000000e+0	13	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_MYC_UP	Genes up-regulated in hepatocellular carcinoma (HCC) induced by overexpression of MYC [GeneID=4609].	12	3.873174e-3	1.000000e+0	1.000000e+0	2.581862e+2	3.873174e-3	1	3.873174e-3	1.000000e+0	15	5.867038e-3	1.000000e+0	1.000000e+0	1.701981e+2	5.875506e-3	1	53	5.000000e-1	1.886792e-2	unnamed	LY6E
MSigDB Perturbation	ZHAN_MULTIPLE_MYELOMA_LB_DN	Top 50 down-regulated genes in cluster LB of multiple myeloma samples belonging to the low bone disease group.	13	4.078009e-3	1.000000e+0	1.000000e+0	2.452177e+2	4.078009e-3	1	4.078009e-3	1.000000e+0	11	4.208307e-3	1.000000e+0	1.000000e+0	2.373816e+2	4.212627e-3	1	38	5.000000e-1	2.631579e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_MYC_E2F1_UP	Genes up-regulated in hepatocellular carcinoma (HCC) from MYC and E2F1 [GeneID=4609;1869] double transgenic mice.	14	4.608519e-3	1.000000e+0	1.000000e+0	2.169895e+2	4.608519e-3	1	4.608519e-3	1.000000e+0	16	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LY6E
MSigDB Perturbation	LIN_APC_TARGETS	Genes up-regulated by forced expression of APC [GeneID=324] in the APC-deficient SW480  cell line (colon cancer).	15	4.661012e-3	1.000000e+0	1.000000e+0	2.145457e+2	4.661012e-3	1	4.661012e-3	1.000000e+0	23	8.518131e-3	1.000000e+0	1.000000e+0	1.171494e+2	8.536112e-3	1	77	5.000000e-1	1.298701e-2	unnamed	LY6E
MSigDB Perturbation	DASU_IL6_SIGNALING_UP	Genes up-regulated in normal fibroblasts in response to IL6 [GeneID=3569].	16	4.802916e-3	1.000000e+0	1.000000e+0	2.082068e+2	4.802916e-3	1	4.802916e-3	1.000000e+0	20	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	LY6E
MSigDB Perturbation	HECKER_IFNB1_TARGETS	Genes transcriptionally modulated in the blood of multiple sclerosis patients in response to subcutaneous treatment with recombinant IFNB1 [GeneID = 3456].	17	5.256113e-3	1.000000e+0	1.000000e+0	1.902546e+2	5.256113e-3	1	5.256113e-3	1.000000e+0	25	9.952663e-3	1.000000e+0	1.000000e+0	1.002278e+2	9.977274e-3	1	90	5.000000e-1	1.111111e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_MYC_TGFA_UP	Genes up-regulated in hepatocellular carcinoma (HCC) tissue of MYC and TGFA [GeneID=4609;7039] double transgenic mice.	18	5.305065e-3	1.000000e+0	9.914577e-1	1.884991e+2	5.305065e-3	1	5.305065e-3	1.000000e+0	19	6.640639e-3	1.000000e+0	1.000000e+0	1.503417e+2	6.651516e-3	1	60	5.000000e-1	1.666667e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_DENA_UP	Genes up-regulated in hepatocellular carcinoma (HCC) induced by diethylnitrosamine (DENA) [PubChem=5921].	19	5.757637e-3	1.000000e+0	1.000000e+0	1.736824e+2	5.757637e-3	1	5.757637e-3	1.000000e+0	18	6.419641e-3	1.000000e+0	1.000000e+0	1.555259e+2	6.429799e-3	1	58	5.000000e-1	1.724138e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_ACOX1_UP	Genes up-regulated in hepatocellular carcinoma of ACOX1 [GeneID=51] knockout mice.	20	5.862861e-3	1.000000e+0	9.861332e-1	1.705652e+2	5.862861e-3	1	5.862861e-3	1.000000e+0	22	6.972090e-3	1.000000e+0	1.000000e+0	1.431825e+2	6.984092e-3	1	63	5.000000e-1	1.587302e-2	unnamed	LY6E
MSigDB Perturbation	LEE_LIVER_CANCER_E2F1_UP	Genes up-regulated in hepatocellular carcinoma (HCC) induced by overexpression of E2F1 [GeneID=1869].	21	6.191594e-3	1.000000e+0	9.918344e-1	1.615093e+2	6.191594e-3	1	6.191594e-3	1.000000e+0	20	6.751129e-3	1.000000e+0	1.000000e+0	1.478770e+2	6.762375e-3	1	61	5.000000e-1	1.639344e-2	unnamed	LY6E
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	Genes up-regulated in granulocytes by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	22	7.961875e-3	1.000000e+0	1.000000e+0	1.255986e+2	7.961875e-3	1	7.961875e-3	1.000000e+0	16	6.088097e-3	1.000000e+0	1.000000e+0	1.640091e+2	6.097223e-3	1	55	5.000000e-1	1.818182e-2	unnamed	LY6E
MSigDB Perturbation	MISSIAGLIA_REGULATED_BY_METHYLATION_UP	Genes up-regulated in PaCa44 and CFPAC1 cells (pancreatic cancer) after treatment with decitabine [PubChem=451668], a DNA hypomethylating agent similar to azacitidine [PubChem=9444].	23	8.011843e-3	1.000000e+0	1.000000e+0	1.248152e+2	8.011843e-3	1	8.011843e-3	1.000000e+0	28	1.391979e-2	1.000000e+0	1.000000e+0	7.159127e+1	1.396818e-2	1	126	5.000000e-1	7.936508e-3	unnamed	LY6E
MSigDB Perturbation	JOHNSTONE_PARVB_TARGETS_2_UP	Genes up-regulated upon overexpression of PARVB [GeneID=29780] in MDA-MB-231 cells (breast cancer) cultured in 3D collagen I and 3D Matrigel only.	24	8.820807e-3	1.000000e+0	1.000000e+0	1.133683e+2	8.820807e-3	1	8.820807e-3	1.000000e+0	30	1.535041e-2	1.000000e+0	1.000000e+0	6.489568e+1	1.540935e-2	1	139	5.000000e-1	7.194245e-3	unnamed	LY6E
MSigDB Perturbation	NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	Genes within amplicon 8q23-q24 identified in a copy number alterations study of 191 breast tumor samples.	25	9.242506e-3	1.000000e+0	1.000000e+0	1.081958e+2	9.242506e-3	1	9.242506e-3	1.000000e+0	1	6.684700e-5	2.248733e-1	2.248733e-1	1.218986e+2	1.640707e-2	2	148	1.000000e+0	1.351351e-2	unnamed	CYP11B2,LY6E
MSigDB Perturbation	DARWICHE_SKIN_TUMOR_PROMOTER_UP	Genes up-regulated during skin tumor progression: epidermis treated with the carcinogen DMBA [PubChem=6001] followed by 20 weekly applications of the tumor promoter TPA [PubChem=4792], compared to the untreated skin.	26	9.796613e-3	1.000000e+0	1.000000e+0	1.020761e+2	9.796613e-3	1	9.796613e-3	1.000000e+0	29	1.513038e-2	1.000000e+0	1.000000e+0	6.584307e+1	1.518763e-2	1	137	5.000000e-1	7.299270e-3	unnamed	LY6E
MSigDB Perturbation	ROESSLER_LIVER_CANCER_METASTASIS_UP	Genes up-regulated in liver samples containing tumor thrombi in the major branches of the portal vein at surgery (PT) compared to those from metastasis-free HCC patients (PN) at the time of surgery and at follow-up.	27	1.026454e-2	1.000000e+0	1.000000e+0	9.742279e+1	1.026454e-2	1	1.026454e-2	1.000000e+0	26	1.171681e-2	1.000000e+0	1.000000e+0	8.509906e+1	1.175101e-2	1	106	5.000000e-1	9.433962e-3	unnamed	LY6E
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_HIGH_UP	Genes up-regulated during skin tumor progression from normal skin to high risk papilloma.	28	1.029191e-2	1.000000e+0	1.000000e+0	9.716370e+1	1.029191e-2	1	1.029191e-2	1.000000e+0	32	1.579039e-2	1.000000e+0	1.000000e+0	6.308042e+1	1.585278e-2	1	143	5.000000e-1	6.993007e-3	unnamed	LY6E
MSigDB Perturbation	DARWICHE_PAPILLOMA_RISK_LOW_UP	Genes up-regulated during skin tumor progression from low risk papilloma vs normal skin.	29	1.129285e-2	1.000000e+0	1.000000e+0	8.855161e+1	1.129285e-2	1	1.129285e-2	1.000000e+0	34	1.688991e-2	1.000000e+0	1.000000e+0	5.895752e+1	1.696137e-2	1	153	5.000000e-1	6.535948e-3	unnamed	LY6E
MSigDB Perturbation	DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	Genes up-regulated in squamous cell carcinoma (SCC) compared to normal skin.	30	1.138715e-2	1.000000e+0	1.000000e+0	8.781828e+1	1.138715e-2	1	1.138715e-2	1.000000e+0	31	1.546041e-2	1.000000e+0	1.000000e+0	6.443214e+1	1.552020e-2	1	140	5.000000e-1	7.142857e-3	unnamed	LY6E
MSigDB Perturbation	LABBE_WNT3A_TARGETS_UP	Up-regulated genes in NMuMG cells (mammary epithelium) after stimulation with WNT3A [GeneID=89780].	31	1.201048e-2	1.000000e+0	1.000000e+0	8.326063e+1	1.201048e-2	1	1.201048e-2	1.000000e+0	27	1.226779e-2	1.000000e+0	1.000000e+0	8.126577e+1	1.230530e-2	1	111	5.000000e-1	9.009009e-3	unnamed	LY6E
MSigDB Perturbation	HOOI_ST7_TARGETS_UP	Genes up-regulated in PC-3 cells (prostate cancer) stably expressing ST7 [GeneID=7982] off a plasmid vector.	32	1.279709e-2	1.000000e+0	1.000000e+0	7.814274e+1	1.279709e-2	1	1.279709e-2	1.000000e+0	24	9.401043e-3	1.000000e+0	1.000000e+0	1.061235e+2	9.422981e-3	1	85	5.000000e-1	1.176471e-2	unnamed	LY6E
MSigDB Perturbation	JISON_SICKLE_CELL_DISEASE_UP	Genes up-regulated in peripheral blood mononuclear cells (PBMC) from sickle cell disease patients compared to those from healthy subjects.	33	1.334860e-2	1.000000e+0	1.000000e+0	7.491424e+1	1.334860e-2	1	1.334860e-2	1.000000e+0	42	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	LY6E
MSigDB Perturbation	LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	Overexpressed genes with amplified copy number across 27 non-small cell lung cancer (NSCLC) cell lines.	34	1.371205e-2	1.000000e+0	1.000000e+0	7.292854e+1	1.371205e-2	1	1.371205e-2	1.000000e+0	47	2.336458e-2	1.000000e+0	1.000000e+0	4.254953e+1	2.350202e-2	1	212	5.000000e-1	4.716981e-3	unnamed	LY6E
MSigDB Perturbation	DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	Genes up-regulated in fibroblasts expressing mutant forms of ERCC3 [GeneID=2071] after UV irradiation.	35	1.435576e-2	1.000000e+0	1.000000e+0	6.965846e+1	1.435576e-2	1	1.435576e-2	1.000000e+0	55	3.341799e-2	1.000000e+0	1.000000e+0	2.967270e+1	3.370101e-2	1	304	5.000000e-1	3.289474e-3	unnamed	LY6E
MSigDB Perturbation	AMIT_EGF_RESPONSE_480_HELA	Genes whose expression peaked at 480 min after stimulation of HeLa cells with EGF [GeneID=1950].	36	1.494327e-2	1.000000e+0	1.000000e+0	6.691976e+1	1.494327e-2	1	1.494327e-2	1.000000e+0	37	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	LY6E
MSigDB Perturbation	TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	Genes up-regulated in monocytes by RUNX1-RUNX1T1 [GeneID=861;862] fusion.	37	1.693383e-2	1.000000e+0	1.000000e+0	5.905338e+1	1.693383e-2	1	1.693383e-2	1.000000e+0	44	2.204943e-2	1.000000e+0	1.000000e+0	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	LY6E
MSigDB Perturbation	SERVITJA_LIVER_HNF1A_TARGETS_DN	Genes down-regulated in liver tissue upon knockout of HNF1A [GeneID=6927].	38	1.712039e-2	1.000000e+0	1.000000e+0	5.840990e+1	1.712039e-2	1	1.712039e-2	1.000000e+0	35	1.710974e-2	1.000000e+0	1.000000e+0	5.819677e+1	1.718308e-2	1	155	5.000000e-1	6.451613e-3	unnamed	LY6E
MSigDB Perturbation	DAZARD_RESPONSE_TO_UV_NHEK_UP	Genes up-regulated in NHEK cells (normal keratinocytes) by UV-B irradiation.	39	1.991262e-2	1.000000e+0	1.000000e+0	5.021941e+1	1.991262e-2	1	1.991262e-2	1.000000e+0	50	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	LY6E
MSigDB Perturbation	WANG_TUMOR_INVASIVENESS_DN	Down-regulated genes in the subpopulation of invasive PyMT cells (breast cancer) compared to the general population of PyMT cells.	40	2.010684e-2	1.000000e+0	1.000000e+0	4.973433e+1	2.010684e-2	1	2.010684e-2	1.000000e+0	45	2.226868e-2	1.000000e+0	1.000000e+0	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	LY6E
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 8 days after transduction.	41	2.091328e-2	1.000000e+0	1.000000e+0	4.781650e+1	2.091328e-2	1	2.091328e-2	1.000000e+0	33	1.645017e-2	1.000000e+0	1.000000e+0	6.054027e+1	1.651793e-2	1	149	5.000000e-1	6.711409e-3	unnamed	LY6E
MSigDB Perturbation	DAIRKEE_TERT_TARGETS_UP	Genes up-regulated in non-spontaneously immortalizing (NSI) primary breast cancer tumor cultures upon expression of TERT [GeneID=7015] off a retroviral vector.	42	2.095337e-2	1.000000e+0	1.000000e+0	4.772503e+1	2.095337e-2	1	2.095337e-2	1.000000e+0	61	3.983792e-2	1.000000e+0	1.000000e+0	2.484986e+1	4.024167e-2	1	363	5.000000e-1	2.754821e-3	unnamed	LY6E
MSigDB Perturbation	ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	Genes down-regulated in liver tumor compared to the normal adjacent tissue.	43	2.113154e-2	1.000000e+0	1.000000e+0	4.732263e+1	2.113154e-2	1	2.113154e-2	1.000000e+0	52	2.905334e-2	1.000000e+0	1.000000e+0	3.416856e+1	2.926667e-2	1	264	5.000000e-1	3.787879e-3	unnamed	LY6E
MSigDB Perturbation	ZWANG_EGF_INTERVAL_DN	Genes repressed in the time interval between two pulses of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	44	2.135277e-2	1.000000e+0	1.000000e+0	4.683233e+1	2.135277e-2	1	2.135277e-2	1.000000e+0	43	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LY6E
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 16 days after transduction.	45	2.140041e-2	1.000000e+0	1.000000e+0	4.672808e+1	2.140041e-2	1	2.140041e-2	1.000000e+0	36	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	LY6E
MSigDB Perturbation	GRADE_COLON_AND_RECTAL_CANCER_UP	Up-regulated genes in both rectal and colon carcinoma compared to normal mucosa samples.	46	2.230579e-2	1.000000e+0	1.000000e+0	4.483142e+1	2.230579e-2	1	2.230579e-2	1.000000e+0	53	3.123689e-2	1.000000e+0	1.000000e+0	3.176232e+1	3.148384e-2	1	284	5.000000e-1	3.521127e-3	unnamed	LY6E
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 3 days after transduction.	47	2.318581e-2	1.000000e+0	1.000000e+0	4.312983e+1	2.318581e-2	1	2.318581e-2	1.000000e+0	38	1.886750e-2	1.000000e+0	1.000000e+0	5.275146e+1	1.895682e-2	1	171	5.000000e-1	5.847953e-3	unnamed	LY6E
MSigDB Perturbation	ALFANO_MYC_TARGETS	Genes up-regulated hT-RPE cells (immortalized retinal pigment epithelium) by MYC [GeneID=4609].	48	2.389972e-2	1.000000e+0	1.000000e+0	4.184149e+1	2.389972e-2	1	2.389972e-2	1.000000e+0	49	2.632043e-2	1.000000e+0	1.000000e+0	3.774268e+1	2.649521e-2	1	239	5.000000e-1	4.184100e-3	unnamed	LY6E
MSigDB Perturbation	KARLSSON_TGFB1_TARGETS_DN	Genes down-regulated by TGFB1 [GeneID=7040] in MEF cells (embryonic fibroblast) via TGFB1R [GeneID=7046].	49	2.417575e-2	1.000000e+0	1.000000e+0	4.136376e+1	2.417575e-2	1	2.417575e-2	1.000000e+0	46	2.281671e-2	1.000000e+0	1.000000e+0	4.357729e+1	2.294773e-2	1	207	5.000000e-1	4.830918e-3	unnamed	LY6E
MSigDB Perturbation	LEI_MYB_TARGETS	Myb-regulated genes in MCF7 (breast cancer) and lung epithelial cell lines overexpressing MYBL2, MYBL1 or MYB [GeneID=4605;4603;4602].	50	2.437585e-2	1.000000e+0	1.000000e+0	4.102422e+1	2.437585e-2	1	2.437585e-2	1.000000e+0	56	3.439869e-2	1.000000e+0	1.000000e+0	2.881949e+1	3.469874e-2	1	313	5.000000e-1	3.194888e-3	unnamed	LY6E
MSigDB Perturbation	BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	Genes whose expression in optimally debulked ovarian tumors is associated with survival prognosis.	51	2.457305e-2	1.000000e+0	1.000000e+0	4.069499e+1	2.457305e-2	1	2.457305e-2	1.000000e+0	48	2.566396e-2	1.000000e+0	1.000000e+0	3.871459e+1	2.583005e-2	1	233	5.000000e-1	4.291845e-3	unnamed	LY6E
MSigDB Perturbation	DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	Genes down-regulated in mARMS (molecular ARMS) compared to the mERMS (molecular ERMS) class of rhabdomyosarcoma tumors.	52	2.472012e-2	1.000000e+0	1.000000e+0	4.045288e+1	2.472012e-2	1	2.472012e-2	1.000000e+0	39	1.908711e-2	1.000000e+0	1.000000e+0	5.214162e+1	1.917854e-2	1	173	5.000000e-1	5.780347e-3	unnamed	LY6E
MSigDB Perturbation	FOSTER_KDM1A_TARGETS_UP	Genes up-regulated in ES cells (embryonic stem) heterozygotic for KDM1A [GeneID=23028] loss of function mutant compared to the homozygotic loss of the gene.	53	2.557514e-2	1.000000e+0	1.000000e+0	3.910048e+1	2.557514e-2	1	2.557514e-2	1.000000e+0	50	2.730472e-2	1.000000e+0	1.000000e+0	3.637298e+1	2.749293e-2	1	248	5.000000e-1	4.032258e-3	unnamed	LY6E
MSigDB Perturbation	GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	Up-regualted genes from the set F (Fig. 5a): specific signature shared by cells expressing AF4-MLL [GeneID=4299;4297] alone and those expressing both AF4-MLL and MLL-AF4 fusion proteins.	54	2.665058e-2	1.000000e+0	1.000000e+0	3.752263e+1	2.665058e-2	1	2.665058e-2	1.000000e+0	41	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	LY6E
MSigDB Perturbation	TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	Genes up-regulated in CD34+ [GeneID=947] hematopoetic cells by expression of NUP98-HOXA9 fusion [GeneID=4928;3205] off a retroviral vector at 10 days after transduction.	55	2.741763e-2	1.000000e+0	1.000000e+0	3.647288e+1	2.741763e-2	1	2.741763e-2	1.000000e+0	40	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	LY6E
MSigDB Perturbation	WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	Genes down-regulated in RS4;11 cells (MLL, mixed lineage leukemia) in response to SB216763 [PubChemID=176158], an inhibitor of GSK3B [GeneID=2932].	56	2.928641e-2	1.000000e+0	1.000000e+0	3.414553e+1	2.928641e-2	1	2.928641e-2	1.000000e+0	62	4.157523e-2	1.000000e+0	1.000000e+0	2.380079e+1	4.201541e-2	1	379	5.000000e-1	2.638522e-3	unnamed	LY6E
MSigDB Perturbation	MOOTHA_HUMAN_MITODB_6_2002	Mitochondrial genes; based on literature and sequence annotation resources and converted to Affymetrix HG-U133A probe sets.	57	3.082442e-2	1.000000e+0	1.000000e+0	3.244181e+1	3.082442e-2	1	3.082442e-2	1.000000e+0	65	4.710240e-2	1.000000e+0	1.000000e+0	2.097791e+1	4.766920e-2	1	430	5.000000e-1	2.325581e-3	unnamed	CYP11B2
MSigDB Perturbation	MOOTHA_MITOCHONDRIA	Mitochondrial genes	58	3.109557e-2	1.000000e+0	1.000000e+0	3.215893e+1	3.109557e-2	1	3.109557e-2	1.000000e+0	69	4.904935e-2	1.000000e+0	1.000000e+0	2.013504e+1	4.966465e-2	1	448	5.000000e-1	2.232143e-3	unnamed	CYP11B2
MSigDB Perturbation	SHEN_SMARCA2_TARGETS_DN	Genes whose expression negatively correlated with that of SMARCA2 [GeneID=6595] in prostate cancer samples.	59	3.136499e-2	1.000000e+0	1.000000e+0	3.188269e+1	3.136499e-2	1	3.136499e-2	1.000000e+0	57	3.614091e-2	1.000000e+0	1.000000e+0	2.741793e+1	3.647248e-2	1	329	5.000000e-1	3.039514e-3	unnamed	CYP11B2
MSigDB Perturbation	ENK_UV_RESPONSE_KERATINOCYTE_UP	Genes up-regulated in NHEK cells (normal epidermal keratinocytes) after UVB irradiation.	60	3.205700e-2	1.000000e+0	1.000000e+0	3.119443e+1	3.205700e-2	1	3.205700e-2	1.000000e+0	77	5.961449e-2	1.000000e+0	1.000000e+0	1.652106e+1	6.052880e-2	1	546	5.000000e-1	1.831502e-3	unnamed	LY6E
MSigDB Perturbation	ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	Genes up-regulated during prostate cancer progression in the JOCK1 model due to inducible activation of FGFR1 [GeneID=2260] gene in prostate.	61	3.608544e-2	1.000000e+0	1.000000e+0	2.771201e+1	3.608544e-2	1	3.608544e-2	1.000000e+0	54	3.134601e-2	1.000000e+0	1.000000e+0	3.165088e+1	3.159470e-2	1	285	5.000000e-1	3.508772e-3	unnamed	LY6E
MSigDB Perturbation	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	Transcripts depleted in pseudopodia of NIH/3T3 cells (fibroblast) in response to the chemotactic migration stimulus by lysophosphatidic acid (LPA) [PubChem=3988].	62	3.695199e-2	1.000000e+0	1.000000e+0	2.706214e+1	3.695199e-2	1	3.695199e-2	1.000000e+0	71	4.937365e-2	1.000000e+0	1.000000e+0	2.000111e+1	4.999723e-2	1	451	5.000000e-1	2.217295e-3	unnamed	LY6E
MSigDB Perturbation	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	Genes down-regulated in HCT116 cells (colon cancer) upon expression of MIR34B or MIR34C [GeneID=407041;407042] microRNAs.	63	3.724676e-2	1.000000e+0	1.000000e+0	2.684797e+1	3.724676e-2	1	3.724676e-2	1.000000e+0	67	4.807612e-2	1.000000e+0	1.000000e+0	2.054784e+1	4.866693e-2	1	439	5.000000e-1	2.277904e-3	unnamed	LY6E
MSigDB Perturbation	COLINA_TARGETS_OF_4EBP1_AND_4EBP2	Genes up-regulated in MEF cells (embryonic fibroblast) with double knockout of the translation repressors 4EBP1 [GeneID=1978] and 4EBP2 [GeneID=1979].	64	3.828136e-2	1.000000e+0	1.000000e+0	2.612237e+1	3.828136e-2	1	3.828136e-2	1.000000e+0	59	3.907735e-2	1.000000e+0	1.000000e+0	2.533848e+1	3.946566e-2	1	356	5.000000e-1	2.808989e-3	unnamed	LY6E
MSigDB Perturbation	ACEVEDO_LIVER_CANCER_DN	Genes down-regulated in hepatocellular carcinoma (HCC) compared to normal liver samples.	65	4.027354e-2	1.000000e+0	1.000000e+0	2.483020e+1	4.027354e-2	1	4.027354e-2	1.000000e+0	75	5.810880e-2	1.000000e+0	1.000000e+0	1.695583e+1	5.897678e-2	1	532	5.000000e-1	1.879699e-3	unnamed	LY6E
MSigDB Perturbation	RODWELL_AGING_KIDNEY_UP	Genes whose expression increases with age in normal kidney.	66	4.139156e-2	1.000000e+0	1.000000e+0	2.415951e+1	4.139156e-2	1	4.139156e-2	1.000000e+0	70	4.926556e-2	1.000000e+0	1.000000e+0	2.004556e+1	4.988637e-2	1	450	5.000000e-1	2.222222e-3	unnamed	LY6E
MSigDB Perturbation	PEREZ_TP63_TARGETS	Genes up-regulated in the HMEC cells (primary mammary epithelium) upon expression of the transcriptionally active isoform of TP63 [GeneID=8626] off adenoviral vector.	67	4.252072e-2	1.000000e+0	1.000000e+0	2.351795e+1	4.252072e-2	1	4.252072e-2	1.000000e+0	58	3.679384e-2	1.000000e+0	1.000000e+0	2.692687e+1	3.713763e-2	1	335	5.000000e-1	2.985075e-3	unnamed	CYP11B2
MSigDB Perturbation	WANG_SMARCE1_TARGETS_DN	Genes down-regulated in BT549 cells (breast cancer) by expression of SMARCE1 [GeneID=6605] off a retroviral vector.	68	4.334967e-2	1.000000e+0	1.000000e+0	2.306822e+1	4.334967e-2	1	4.334967e-2	1.000000e+0	60	3.918602e-2	1.000000e+0	1.000000e+0	2.526751e+1	3.957652e-2	1	357	5.000000e-1	2.801120e-3	unnamed	LY6E
MSigDB Perturbation	FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	Genes down-regulated in monocyte-derived dendritic cells (MDDC) after stimulation with galecin-1 (lectin, LGALS1) [GeneID=3956] compared to that with bacterial lipopolysaccharide (LPS).	69	4.480598e-2	1.000000e+0	1.000000e+0	2.231845e+1	4.480598e-2	1	4.480598e-2	1.000000e+0	66	4.764342e-2	1.000000e+0	1.000000e+0	2.073678e+1	4.822349e-2	1	435	5.000000e-1	2.298851e-3	unnamed	LY6E
MSigDB Perturbation	REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	Genes commonly down-regulated in human alveolar rhabdomyosarcoma (ARMS) and its mouse model overexpressing PAX3-FOXO1 [GeneID=5077;2308] fusion.	70	4.599214e-2	1.000000e+0	1.000000e+0	2.174284e+1	4.599214e-2	1	4.599214e-2	1.000000e+0	63	4.461173e-2	1.000000e+0	1.000000e+0	2.216339e+1	4.511945e-2	1	407	5.000000e-1	2.457002e-3	unnamed	LY6E
MSigDB Perturbation	DELYS_THYROID_CANCER_UP	Genes up-regulated in papillary thyroid carcinoma (PTC) compared to normal tissue.	71	4.616743e-2	1.000000e+0	1.000000e+0	2.166029e+1	4.616743e-2	1	4.616743e-2	1.000000e+0	68	4.850873e-2	1.000000e+0	1.000000e+0	2.036230e+1	4.911036e-2	1	443	5.000000e-1	2.257336e-3	unnamed	LY6E
MSigDB Perturbation	YAGI_AML_WITH_INV_16_TRANSLOCATION	Genes specifically expressed in samples from patients with pediatric acute myeloid leukemia (AML) bearing inv(16) translocation.	72	4.636429e-2	1.000000e+0	1.000000e+0	2.156832e+1	4.636429e-2	1	4.636429e-2	1.000000e+0	64	4.537010e-2	1.000000e+0	1.000000e+0	2.178865e+1	4.589546e-2	1	414	5.000000e-1	2.415459e-3	unnamed	LY6E
MSigDB Perturbation	FEVR_CTNNB1_TARGETS_UP	Genes up-regulated in intestinal crypt cells upon deletion of CTNNB1 [GeneID=1499].	73	5.094385e-2	1.000000e+0	1.000000e+0	1.962946e+1	5.094385e-2	1	5.094385e-2	1.000000e+0	80	7.257778e-2	1.000000e+0	1.000000e+0	1.352399e+1	7.394269e-2	1	667	5.000000e-1	1.499250e-3	unnamed	LY6E
MSigDB Perturbation	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	Transcripts depleted from pseudopodia of NIH/3T3 cells (fibroblast) in response to haptotactic migratory stimulus by fibronectin, FN1 [GeneID=2335].	74	5.127776e-2	1.000000e+0	1.000000e+0	1.950163e+1	5.127776e-2	1	5.127776e-2	1.000000e+0	79	7.161666e-2	1.000000e+0	1.000000e+0	1.370897e+1	7.294496e-2	1	658	5.000000e-1	1.519757e-3	unnamed	LY6E
MSigDB Perturbation	KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP	Genes whose expression was significantly and positively correlated with the number of perineuronal oligodendrocytes in the layer III of BA9 brain region.	75	5.338595e-2	1.000000e+0	1.000000e+0	1.873152e+1	5.338595e-2	1	5.338595e-2	1.000000e+0	81	8.141793e-2	1.000000e+0	1.000000e+0	1.202733e+1	8.314395e-2	1	750	5.000000e-1	1.333333e-3	unnamed	LY6E
MSigDB Perturbation	MEISSNER_NPC_HCP_WITH_H3K4ME2	Genes with high-CpG-density promoters (HCP) bearing histone H3 dimethylation mark at K4 (H3K4me2) in neural precursor cells (NPC).	76	5.352102e-2	1.000000e+0	1.000000e+0	1.868425e+1	5.352102e-2	1	5.352102e-2	1.000000e+0	72	5.023817e-2	1.000000e+0	1.000000e+0	1.965251e+1	5.088410e-2	1	459	5.000000e-1	2.178649e-3	unnamed	LY6E
MSigDB Perturbation	BROWNE_HCMV_INFECTION_48HR_DN	Genes down-regulated in primary fibroblast cell culture after infection with HCMV (AD169 strain) at 48 h time point that were not down-regulated at the previous time point, 24 h.	77	5.544365e-2	1.000000e+0	1.000000e+0	1.803633e+1	5.544365e-2	1	5.544365e-2	1.000000e+0	74	5.369234e-2	1.000000e+0	1.000000e+0	1.837169e+1	5.443157e-2	1	491	5.000000e-1	2.036660e-3	unnamed	LY6E
MSigDB Perturbation	WEST_ADRENOCORTICAL_TUMOR_DN	Down-regulated genes in pediatric adrenocortical tumors (ACT) compared to the normal tissue.	78	5.877938e-2	1.000000e+0	1.000000e+0	1.701277e+1	5.877938e-2	1	5.877938e-2	1.000000e+0	2	8.843862e-4	1.000000e+0	1.000000e+0	3.359590e+1	5.953107e-2	2	537	1.000000e+0	3.724395e-3	unnamed	CYP11B2,LY6E
MSigDB Perturbation	RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP	Genes up-regulated in poorly differentiated thyroid carcinoma (PDTC) compared to normal thyroid tissue.	79	5.883486e-2	1.000000e+0	1.000000e+0	1.699673e+1	5.883486e-2	1	5.883486e-2	1.000000e+0	78	6.680363e-2	1.000000e+0	1.000000e+0	1.471533e+1	6.795632e-2	1	613	5.000000e-1	1.631321e-3	unnamed	LY6E
MSigDB Perturbation	SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	Genes up-regulated in the urogenital sinus (UGS) of day E16 females exposed to the androgen dihydrotestosterone [PubChem=10635] for 48 h.	80	6.278376e-2	1.000000e+0	1.000000e+0	1.592768e+1	6.278376e-2	1	6.278376e-2	1.000000e+0	73	5.164219e-2	1.000000e+0	1.000000e+0	1.911123e+1	5.232526e-2	1	472	5.000000e-1	2.118644e-3	unnamed	LY6E
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 6 h.	81	6.654607e-2	1.000000e+0	1.000000e+0	1.502718e+1	6.654607e-2	1	6.654607e-2	1.000000e+0	83	9.285739e-2	1.000000e+0	1.000000e+0	1.051340e+1	9.511668e-2	1	858	5.000000e-1	1.165501e-3	unnamed	LY6E
MSigDB Perturbation	CHICAS_RB1_TARGETS_CONFLUENT	Genes up-regulated in confluent IMR90 cells (fibroblast) after knockdown of RB1 [GeneID=5925] by RNAi.	82	7.290419e-2	1.000000e+0	1.000000e+0	1.371663e+1	7.290419e-2	1	7.290419e-2	1.000000e+0	76	5.939946e-2	1.000000e+0	1.000000e+0	1.658180e+1	6.030708e-2	1	544	5.000000e-1	1.838235e-3	unnamed	LY6E
MSigDB Perturbation	KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN	Genes down-regulated in HL-60 cells (acute promyelocytic leukemia, APL) after treatment with the aminopeptidase inhibitor tosedostat (CHR-2797) [PubChem=15547703] for 24 h.	83	7.774937e-2	1.000000e+0	1.000000e+0	1.286184e+1	7.774937e-2	1	7.774937e-2	1.000000e+0	84	1.027556e-1	1.000000e+0	1.000000e+0	9.475315e+0	1.055374e-1	1	952	5.000000e-1	1.050420e-3	unnamed	LY6E
MSigDB Perturbation	ONKEN_UVEAL_MELANOMA_UP	Genes up-regulated in uveal melanoma: class 2 vs class 1 tumors.	84	8.290379e-2	1.000000e+0	1.000000e+0	1.206218e+1	8.290379e-2	1	8.290379e-2	1.000000e+0	82	8.311719e-2	1.000000e+0	1.000000e+0	1.177611e+1	8.491769e-2	1	766	5.000000e-1	1.305483e-3	unnamed	LY6E
MSigDB Perturbation	DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP	Genes up-regulated in CD34+ [GeneID=947] cells isolated from bone marrow of CML (chronic myelogenous leukemia) patients, compared to those from normal donors.	85	1.224048e-1	1.000000e+0	1.000000e+0	8.169613e+0	1.224048e-1	1	1.224048e-1	1.000000e+0	85	1.472401e-1	1.000000e+0	1.000000e+0	6.531861e+0	1.530957e-1	1	1381	5.000000e-1	7.241130e-4	unnamed	LY6E
MSigDB Perturbation	ZWANG_TRANSIENTLY_UP_BY_1ST_EGF_PULSE_ONLY	Genes transiently induced only by the first pulse of EGF [GeneID =1950] in 184A1 cells (mammary epithelium).	86	1.656740e-1	1.000000e+0	1.000000e+0	6.035952e+0	1.656740e-1	1	1.656740e-1	1.000000e+0	86	1.708257e-1	1.000000e+0	1.000000e+0	5.592374e+0	1.788149e-1	1	1613	5.000000e-1	6.199628e-4	unnamed	LY6E
MSigDB Perturbation	PILON_KLF1_TARGETS_DN	Genes down-regulated in erythroid progenitor cells from fetal livers of E13.5 embryos with KLF1 [GeneID=10661] knockout compared to those from the wild type embryos.	87	1.766774e-1	1.000000e+0	1.000000e+0	5.660033e+0	1.766774e-1	1	1.766774e-1	1.000000e+0	87	2.003385e-1	1.000000e+0	1.000000e+0	4.727725e+0	2.115182e-1	1	1908	5.000000e-1	5.241090e-4	unnamed	LY6E
MSigDB miRNA Motifs	CCTGCTG,MIR-214	Targets of MicroRNA CCTGCTG,MIR-214	1	2.896412e-2	1.000000e+0	1.000000e+0	3.452547e+1	2.896412e-2	1	2.896412e-2	1.000000e+0	1	2.489780e-2	1.000000e+0	1.000000e+0	3.991372e+1	2.505404e-2	1	226	5.000000e-1	4.424779e-3	unnamed	LY6E
MSigDB miRNA Motifs	TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	Targets of MicroRNA TGCTGCT,MIR-15A,MIR-16,MIR-15B,MIR-195,MIR-424,MIR-497	2	7.670739e-2	1.000000e+0	1.000000e+0	1.303655e+1	7.670739e-2	1	7.670739e-2	1.000000e+0	2	6.369530e-2	1.000000e+0	1.000000e+0	1.544606e+1	6.474142e-2	1	584	5.000000e-1	1.712329e-3	unnamed	LY6E
InterPro	IPR002399	Cytochrome P450, mitochondrial	1	1.306751e-4	1.000000e+0	1.000000e+0	7.652569e+3	1.306751e-4	1	1.306751e-4	1.000000e+0	1	3.325574e-4	1.000000e+0	1.000000e+0	3.006833e+3	3.325758e-4	1	3	5.000000e-1	3.333333e-1	unnamed	CYP11B2
InterPro	IPR001526	CD59 antigen	2	4.148861e-4	1.000000e+0	1.000000e+0	2.410300e+3	4.148861e-4	1	4.148861e-4	1.000000e+0	3	1.773000e-3	1.000000e+0	1.000000e+0	5.637812e+2	1.773738e-3	1	16	5.000000e-1	6.250000e-2	unnamed	LY6E
InterPro	IPR016054	Ly-6 antigen / uPA receptor -like	3	9.826756e-4	1.000000e+0	1.000000e+0	1.017630e+3	9.826756e-4	1	9.826756e-4	1.000000e+0	2	1.662234e-3	1.000000e+0	1.000000e+0	6.013667e+2	1.662879e-3	1	15	5.000000e-1	6.666667e-2	unnamed	LY6E
InterPro	IPR017972	Cytochrome P450, conserved site	4	2.824642e-3	1.000000e+0	1.000000e+0	3.540271e+2	2.824642e-3	1	2.824642e-3	1.000000e+0	4	5.645954e-3	1.000000e+0	1.000000e+0	1.768725e+2	5.653789e-3	1	51	5.000000e-1	1.960784e-2	unnamed	CYP11B2
InterPro	IPR001128	Cytochrome P450	5	3.500906e-3	1.000000e+0	1.000000e+0	2.856403e+2	3.500906e-3	1	3.500906e-3	1.000000e+0	5	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	CYP11B2
TreeFam	TF336080	LY6D, LY6E, LYPD2, PSCA, SLURP1	1	1.422965e-4	1.000000e+0	1.000000e+0	7.027579e+3	1.422965e-4	1	1.422965e-4	1.000000e+0	1	5.542315e-4	1.000000e+0	1.000000e+0	1.804100e+3	5.542930e-4	1	5	5.000000e-1	2.000000e-1	unnamed	LY6E
HGNC Gene Families	CYP	CYP	1	3.500906e-3	1.000000e+0	1.000000e+0	2.856403e+2	3.500906e-3	1	3.500906e-3	1.000000e+0	1	6.198618e-3	1.000000e+0	1.000000e+0	1.610804e+2	6.208082e-3	1	56	5.000000e-1	1.785714e-2	unnamed	CYP11B2
Ensembl Genes	18516	CYP11B2	1	4.497249e-5	8.113487e-1	8.113487e-1	2.223582e+4	4.497249e-5	1	4.497249e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	CYP11B2
Ensembl Genes	18517	LY6E	2	8.278228e-5	1.000000e+0	7.467376e-1	1.207988e+4	8.278228e-5	1	8.278228e-5	1.000000e+0	1	1.108586e-4	1.000000e+0	1.000000e+0	9.020500e+3	1.108586e-4	1	1	5.000000e-1	1.000000e+0	unnamed	LY6E
MSigDB Oncogenic Signatures	PTEN_DN.V2_DN	Genes up-regulated in HCT116 cells (colon carcinoma) upon knockdown of PTEN [Gene ID=5728] by RNAi.	1	1.357712e-2	1.000000e+0	1.000000e+0	7.365331e+1	1.357712e-2	1	1.357712e-2	1.000000e+0	3	1.765921e-2	1.000000e+0	1.000000e+0	5.637812e+1	1.773738e-2	1	160	5.000000e-1	6.250000e-3	unnamed	CYP11B2
MSigDB Oncogenic Signatures	VEGF_A_UP.V1_UP	Genes up-regulated in HUVEC cells (endothelium) by treatment with VEGFA [Gene ID=7422].	2	1.614018e-2	1.000000e+0	1.000000e+0	6.195718e+1	1.614018e-2	1	1.614018e-2	1.000000e+0	5	2.062369e-2	1.000000e+0	7.713260e-1	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	LY6E
MSigDB Oncogenic Signatures	PIGF_UP.V1_DN	Genes down-regulated in HUVEC cells (endothelium) by treatment with PIGF [Gene ID=5281].	3	1.839052e-2	1.000000e+0	1.000000e+0	5.437585e+1	1.839052e-2	1	1.839052e-2	1.000000e+0	4	2.040425e-2	1.000000e+0	9.538987e-1	4.875946e+1	2.050884e-2	1	185	5.000000e-1	5.405405e-3	unnamed	LY6E
MSigDB Oncogenic Signatures	BMI1_DN_MEL18_DN.V1_DN	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of BMI1 and PCGF2 [Gene ID=648, 7703] genes by RNAi.	4	1.939760e-2	1.000000e+0	9.068378e-1	5.155277e+1	1.939760e-2	1	1.939760e-2	1.000000e+0	1	1.590037e-2	1.000000e+0	1.000000e+0	6.264236e+1	1.596364e-2	1	144	5.000000e-1	6.944444e-3	unnamed	LY6E
MSigDB Oncogenic Signatures	MEL18_DN.V1_DN	Genes down-regulated in DAOY cells (medulloblastoma) upon knockdown of PCGF2 [Gene ID=7703] gene by RNAi.	5	2.258892e-2	1.000000e+0	8.448256e-1	4.426950e+1	2.258892e-2	1	2.258892e-2	1.000000e+0	2	1.743944e-2	1.000000e+0	1.000000e+0	5.709177e+1	1.751566e-2	1	158	5.000000e-1	6.329114e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute influenza infection.	1	1.017118e-2	1.000000e+0	1.000000e+0	9.831704e+1	1.017118e-2	1	1.017118e-2	1.000000e+0	2	1.776908e-2	1.000000e+0	1.000000e+0	5.602795e+1	1.784823e-2	1	161	5.000000e-1	6.211180e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from infancts with acute RSV infection versus PBMCs from infants with acute influenza infection.	2	1.134990e-2	1.000000e+0	1.000000e+0	8.810647e+1	1.134990e-2	1	1.134990e-2	1.000000e+0	9	1.996530e-2	1.000000e+0	1.000000e+0	4.983702e+1	2.006541e-2	1	181	5.000000e-1	5.524862e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. pneumoniae infection.	3	1.152625e-2	1.000000e+0	1.000000e+0	8.675848e+1	1.152625e-2	1	1.152625e-2	1.000000e+0	4	1.853804e-2	1.000000e+0	1.000000e+0	5.369345e+1	1.862424e-2	1	168	5.000000e-1	5.952381e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE12366_GC_BCELL_VS_PLASMA_CELL_DN	Genes down-regulated in comparison of germinal center B cells versus plasma cells.	4	1.307827e-2	1.000000e+0	1.000000e+0	7.646273e+1	1.307827e-2	1	1.307827e-2	1.000000e+0	8	1.985555e-2	1.000000e+0	1.000000e+0	5.011389e+1	1.995455e-2	1	180	5.000000e-1	5.555556e-3	unnamed	CYP11B2
MSigDB Immunologic Signatures	GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMCs from infanct with acute influenza infection.	5	1.311139e-2	1.000000e+0	1.000000e+0	7.626956e+1	1.311139e-2	1	1.311139e-2	1.000000e+0	34	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB1 [GeneID=7040] and IL6 [GeneID=3569] versus those treated with TGFB1 [GeneID=7040], IL6 [GeneID=3569] and IL23A [GeneID=51561].	6	1.396963e-2	1.000000e+0	1.000000e+0	7.158388e+1	1.396963e-2	1	1.396963e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_CTRL_VS_T_GONDII_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to T. gondii.	7	1.402189e-2	1.000000e+0	1.000000e+0	7.131708e+1	1.402189e-2	1	1.402189e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	9.064258e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN	Genes down-regulated in comparison of macrophages exposed to T. gondii versus macrophages exposed to 5 worms/well B. malayi.	8	1.407585e-2	1.000000e+0	1.000000e+0	7.104364e+1	1.407585e-2	1	1.407585e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	9.064258e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN	Genes down-regulated in comparison of CD4 [GeneID=920] T cells treated with TGFB1 [GeneID=7040] versus those treated with TGFB3 [GeneID=7043] and IL6 [GeneID=3569].	9	1.423036e-2	1.000000e+0	1.000000e+0	7.027231e+1	1.423036e-2	1	1.423036e-2	1.000000e+0	13	2.051397e-2	1.000000e+0	1.000000e+0	4.849731e+1	2.061970e-2	1	186	5.000000e-1	5.376344e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from TIV influenza vaccinee at day 3 post-vaccination versus those at day 7 post-vaccination.	10	1.440843e-2	1.000000e+0	1.000000e+0	6.940379e+1	1.440843e-2	1	1.440843e-2	1.000000e+0	1	1.623027e-2	1.000000e+0	1.000000e+0	6.136395e+1	1.629621e-2	1	147	5.000000e-1	6.802721e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN	Genes down-regulated in comparison of CD4 [GeneID=920] dendritic cells (DC) versus CD8 DCs.	11	1.448543e-2	1.000000e+0	1.000000e+0	6.903490e+1	1.448543e-2	1	1.448543e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	9.064258e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 3 days after stimulation with YF17D vaccine versus PBMC 7 days after the stimulation.	12	1.454909e-2	1.000000e+0	1.000000e+0	6.873281e+1	1.454909e-2	1	1.454909e-2	1.000000e+0	34	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN	Genes down-regulated in comparison of untreated CD8+ dendritic cells (DC) at 4 h versus those treated with IFNG [GeneID=3458] at 16 h.	13	1.458652e-2	1.000000e+0	1.000000e+0	6.855644e+1	1.458652e-2	1	1.458652e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP	Genes up-regulated in comparison of IgD+ peripheral blood B cells versus dark zone germincal center B cells.	14	1.462960e-2	1.000000e+0	1.000000e+0	6.835455e+1	1.462960e-2	1	1.462960e-2	1.000000e+0	55	2.226868e-2	1.000000e+0	7.733305e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE17721_POLYIC_VS_CPG_16H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with poly(I:C) (TLR3 agonist) at 16 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 16 h.	15	1.504266e-2	1.000000e+0	1.000000e+0	6.647761e+1	1.504266e-2	1	1.504266e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	CYP11B2
MSigDB Immunologic Signatures	GSE22886_TCELL_VS_BCELL_NAIVE_UP	Genes up-regulated in comparison of naive CD4 [GeneID=920] CD8 T cells versus naive B cells.	16	1.509606e-2	1.000000e+0	1.000000e+0	6.624244e+1	1.509606e-2	1	1.509606e-2	1.000000e+0	30	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN	Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) before vs after YF17D vaccination.	17	1.538824e-2	1.000000e+0	1.000000e+0	6.498467e+1	1.538824e-2	1	1.538824e-2	1.000000e+0	18	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to M. tuberculosis.	18	1.554272e-2	1.000000e+0	1.000000e+0	6.433879e+1	1.554272e-2	1	1.554272e-2	1.000000e+0	55	2.226868e-2	1.000000e+0	7.733305e-1	4.465594e+1	2.239344e-2	1	202	5.000000e-1	4.950495e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 7 days after stimulation with YF17D vaccine.	19	1.559108e-2	1.000000e+0	1.000000e+0	6.413926e+1	1.559108e-2	1	1.559108e-2	1.000000e+0	20	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE7764_NKCELL_VS_SPLENOCYTE_DN	Genes down-regulated in comparison of NK cells versus total splenocytes.	20	1.570732e-2	1.000000e+0	1.000000e+0	6.366460e+1	1.570732e-2	1	1.570732e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN	Genes down-regulated in comparison of naive CD4 [GeneID=920] T cells versus natural regulatory T cell (Treg).	21	1.571758e-2	1.000000e+0	1.000000e+0	6.362302e+1	1.571758e-2	1	1.571758e-2	1.000000e+0	20	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE10325_MYELOID_VS_LUPUS_MYELOID_DN	Genes down-regulated in comparison of healthy myeloid cells versus systemic lupus erythematosus myeloid cells.	22	1.581373e-2	1.000000e+0	1.000000e+0	6.323618e+1	1.581373e-2	1	1.581373e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP	Genes up-regulated in comparison of TconvLP versus DEC-Pept CD25- (see Table S1 in the paper for details).	23	1.583498e-2	1.000000e+0	1.000000e+0	6.315132e+1	1.583498e-2	1	1.583498e-2	1.000000e+0	30	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP	Genes up-regulated in comparison of untreated CD4 [GeneID=920] T cells at 0 h versus the cells treated with IL4 [GeneID=3565] and anti-IL12 at 2 h.	24	1.597026e-2	1.000000e+0	1.000000e+0	6.261638e+1	1.597026e-2	1	1.597026e-2	1.000000e+0	5	1.952626e-2	1.000000e+0	1.000000e+0	5.096328e+1	1.962197e-2	1	177	5.000000e-1	5.649718e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC 3 days after stimulation with YF17D vaccine.	25	1.597043e-2	1.000000e+0	1.000000e+0	6.261572e+1	1.597043e-2	1	1.597043e-2	1.000000e+0	11	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE6269_FLU_VS_STREP_AUREUS_INF_PBMC_UP	Genes up-regulated in comparison of peripheral blood mononuclear cells (PBMC) from patients with acute influenza infection versus PBMC from patients with acute S. aureus infection.	26	1.632161e-2	1.000000e+0	1.000000e+0	6.126845e+1	1.632161e-2	1	1.632161e-2	1.000000e+0	3	1.798882e-2	1.000000e+0	1.000000e+0	5.534049e+1	1.806995e-2	1	163	5.000000e-1	6.134969e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP	Genes up-regulated in plasma cells versus memory B cells.	27	1.638316e-2	1.000000e+0	1.000000e+0	6.103827e+1	1.638316e-2	1	1.638316e-2	1.000000e+0	6	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	CYP11B2
MSigDB Immunologic Signatures	GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN	Genes down-regulated in comparison of control microglia cells versus those 24 h after stimulation with IFNG [GeneID=3458].	28	1.663662e-2	1.000000e+0	1.000000e+0	6.010836e+1	1.663662e-2	1	1.663662e-2	1.000000e+0	50	2.193980e-2	1.000000e+0	8.381004e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from LAIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	29	1.668967e-2	1.000000e+0	1.000000e+0	5.991731e+1	1.668967e-2	1	1.668967e-2	1.000000e+0	20	2.106249e-2	1.000000e+0	1.000000e+0	4.722775e+1	2.117399e-2	1	191	5.000000e-1	5.235602e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE2826_XID_VS_BTK_KO_BCELL_DN	Genes down-regulated in comparison of primary splenic B cells from Xid mice versus those from BTK [GeneID=695] knockout mice.	30	1.674587e-2	1.000000e+0	1.000000e+0	5.971621e+1	1.674587e-2	1	1.674587e-2	1.000000e+0	54	2.215906e-2	1.000000e+0	7.837742e-1	4.487811e+1	2.228258e-2	1	201	5.000000e-1	4.975124e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE27786_BCELL_VS_CD8_TCELL_UP	Genes up-regulated in comparison of B cells versus CD8 T cells.	31	1.697980e-2	1.000000e+0	1.000000e+0	5.889350e+1	1.697980e-2	1	1.697980e-2	1.000000e+0	34	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN	Genes down-regulated in comparison of stimulated naive CD8 T cells from pmel-1 mice versus unstimulated naive CD8 T cells from pmel-1 mice.	32	1.707501e-2	1.000000e+0	1.000000e+0	5.856513e+1	1.707501e-2	1	1.707501e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) versus PBMC stimulated with YF17D vaccine.	33	1.730318e-2	1.000000e+0	1.000000e+0	5.779284e+1	1.730318e-2	1	1.730318e-2	1.000000e+0	50	2.193980e-2	1.000000e+0	8.381004e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP	Genes up-regulated in comparison of macrophages versus macrophages exposed to B. malayi (5 worms/well).	34	1.761152e-2	1.000000e+0	9.893530e-1	5.678101e+1	1.761152e-2	1	1.761152e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE14000_UNSTIM_VS_16H_LPS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) before and 16 h after LPS (TLR4 agonist) stimulation.	35	1.764712e-2	1.000000e+0	9.630285e-1	5.666647e+1	1.764712e-2	1	1.764712e-2	1.000000e+0	57	2.259752e-2	1.000000e+0	7.572151e-1	4.400244e+1	2.272601e-2	1	205	5.000000e-1	4.878049e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE19825_CD24LOW_VS_IL2RA_HIGH_DAY3_EFF_CD8_TCELL_UP	Genes up-regulated in comparison of effector CD8 IL2RA [GeneID=3559] low T cells versus effector CD8 IL2RA [GeneID=3559] high cells.	36	1.790514e-2	1.000000e+0	9.499672e-1	5.584987e+1	1.790514e-2	1	1.790514e-2	1.000000e+0	23	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to L. donovani versus DCs exposed to L. major.	37	1.793807e-2	1.000000e+0	9.259923e-1	5.574737e+1	1.793807e-2	1	1.793807e-2	1.000000e+0	17	2.084310e-2	1.000000e+0	1.000000e+0	4.772751e+1	2.095228e-2	1	189	5.000000e-1	5.291005e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN	Genes down-regulated in comparison of dendritic cells (DC) exposed to 5 worms/well B. malayi versus DC exposed to M. tuberculosis	38	1.807076e-2	1.000000e+0	9.082935e-1	5.533803e+1	1.807076e-2	1	1.807076e-2	1.000000e+0	53	2.204943e-2	1.000000e+0	7.946115e-1	4.510250e+1	2.217172e-2	1	200	5.000000e-1	5.000000e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN	Genes down-regulated in comparison of eosinophils versus effector memory CD4 [GeneID=920] T cells.	39	1.817796e-2	1.000000e+0	8.902539e-1	5.501168e+1	1.817796e-2	1	1.817796e-2	1.000000e+0	50	2.193980e-2	1.000000e+0	8.381004e-1	4.532915e+1	2.206086e-2	1	199	5.000000e-1	5.025126e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP	Genes up-regulated in comparison of regulatory T cell (Treg) from IL2RB [GeneID=3560] defficient mice versus effector T cells from IL2RB [GeneID=3560] defficient mice.	40	1.892094e-2	1.000000e+0	9.034749e-1	5.285151e+1	1.892094e-2	1	1.892094e-2	1.000000e+0	15	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from influenza vaccinee pre-vaccination versus those at day 7 post-vaccination.	41	1.895971e-2	1.000000e+0	8.832450e-1	5.274341e+1	1.895971e-2	1	1.895971e-2	1.000000e+0	30	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP	Genes up-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) 7 days after stimulation with YF17D vaccine versus PBMC 21 days after the stimulation.	42	1.903013e-2	1.000000e+0	8.654178e-1	5.254825e+1	1.903013e-2	1	1.903013e-2	1.000000e+0	11	2.029452e-2	1.000000e+0	1.000000e+0	4.902446e+1	2.039798e-2	1	184	5.000000e-1	5.434783e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE12366_GC_VS_NAIVE_BCELL_DN	Genes down-regulated in comparison of germinal center B cells versus naive B cells.	43	1.952422e-2	1.000000e+0	8.672386e-1	5.121843e+1	1.952422e-2	1	1.952422e-2	1.000000e+0	6	1.974579e-2	1.000000e+0	1.000000e+0	5.039385e+1	1.984369e-2	1	179	5.000000e-1	5.586592e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP	Genes up-regulated in comparison of monocytes from TIV influenza vaccinee pre-vaccination versus those at day 7 post-vaccination	44	1.960928e-2	1.000000e+0	8.512210e-1	5.099626e+1	1.960928e-2	1	1.960928e-2	1.000000e+0	46	2.183015e-2	1.000000e+0	9.064258e-1	4.555808e+1	2.195000e-2	1	198	5.000000e-1	5.050505e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE27786_LSK_VS_CD4_TCELL_DN	Genes down-regulated in comparison of LSK versus CD4 [GeneID=920] T cells.	45	1.962464e-2	1.000000e+0	8.329569e-1	5.095635e+1	1.962464e-2	1	1.962464e-2	1.000000e+0	15	2.073340e-2	1.000000e+0	1.000000e+0	4.798138e+1	2.084142e-2	1	188	5.000000e-1	5.319149e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE17721_LPS_VS_CPG_12H_BMDM_DN	Genes down-regulated in comparison of dendritic cells (DC) stimulated with LPS (TLR4 agonist) at 12 h versus DC cells stimulated with CpG DNA (TLR9 agonist) at 12 h.	46	1.968026e-2	1.000000e+0	8.171586e-1	5.081233e+1	1.968026e-2	1	1.968026e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP11B2
MSigDB Immunologic Signatures	GSE27786_LSK_VS_NKCELL_DN	Genes down-regulated in comparison of LSK versus NK cells.	47	1.996719e-2	1.000000e+0	8.114326e-1	5.008215e+1	1.996719e-2	1	1.996719e-2	1.000000e+0	25	2.128185e-2	1.000000e+0	1.000000e+0	4.673834e+1	2.139571e-2	1	193	5.000000e-1	5.181347e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP	Genes up-regulated in comparison of dendritic cells (DC) treated with immunosuppressive DNA versus the untreated cells.	48	2.007932e-2	1.000000e+0	7.989896e-1	4.980248e+1	2.007932e-2	1	2.007932e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE7852_LN_VS_THYMUS_TCONV_UP	Genes up-regulated in comparison of lymph node conventional T cells versus thymus conventional T cells.	49	2.010668e-2	1.000000e+0	7.837502e-1	4.973472e+1	2.010668e-2	1	2.010668e-2	1.000000e+0	23	2.117217e-2	1.000000e+0	1.000000e+0	4.698177e+1	2.128485e-2	1	192	5.000000e-1	5.208333e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE22886_TH1_VS_TH2_12H_ACT_UP	Genes up-regulated in comparison of stimulated CD4 [GeneID=920] Th1 cells at 12 h versus stimulated CD4 [GeneID=920] Th2 cells at 12 h.	50	2.030243e-2	1.000000e+0	7.755528e-1	4.925518e+1	2.030243e-2	1	2.030243e-2	1.000000e+0	18	2.095280e-2	1.000000e+0	1.000000e+0	4.747632e+1	2.106313e-2	1	190	5.000000e-1	5.263158e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 12 h versus PBMC cultured for 12 h with YF17D vaccine.	51	2.043617e-2	1.000000e+0	7.653546e-1	4.893285e+1	2.043617e-2	1	2.043617e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN	Genes down-regulated in comparison of untreated wild type macrophages at 1 h versus those from IRAK4 [GeneID=51135] deficient mice treated with LPS (TLR4 agonist) at 1 h.	52	2.053574e-2	1.000000e+0	7.542935e-1	4.869559e+1	2.053574e-2	1	2.053574e-2	1.000000e+0	14	2.062369e-2	1.000000e+0	1.000000e+0	4.823797e+1	2.073056e-2	1	187	5.000000e-1	5.347594e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE17721_12H_VS_24H_CPG_BMDM_UP	Genes up-regulated in comparison of dendritic cells (DC) stimulated with CpG DNA (TLR9 agonist) at 12 h versus those stimulated with CpG DNA (TLR9 agonist) at 24 h.	53	2.067333e-2	1.000000e+0	7.450200e-1	4.837149e+1	2.067333e-2	1	2.067333e-2	1.000000e+0	38	2.161085e-2	1.000000e+0	1.000000e+0	4.602296e+1	2.172829e-2	1	196	5.000000e-1	5.102041e-3	unnamed	CYP11B2
MSigDB Immunologic Signatures	GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN	Genes down-regulated in comparison of unstimulated peripheral blood mononuclear cells (PBMC) cultured for 3 h versus PBMC cultured for 3 h with YF17D vaccine.	54	2.092132e-2	1.000000e+0	7.399948e-1	4.779813e+1	2.092132e-2	1	2.092132e-2	1.000000e+0	34	2.150119e-2	1.000000e+0	1.000000e+0	4.625897e+1	2.161743e-2	1	195	5.000000e-1	5.128205e-3	unnamed	LY6E
MSigDB Immunologic Signatures	KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN	Genes down-regulated in comparison of naive versus memory CD8 T cells (day 40+ following LCMV-Armstrong infection).	55	2.109300e-2	1.000000e+0	7.325024e-1	4.740910e+1	2.109300e-2	1	2.109300e-2	1.000000e+0	30	2.139152e-2	1.000000e+0	1.000000e+0	4.649742e+1	2.150657e-2	1	194	5.000000e-1	5.154639e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP	Genes up-regulated in comparison of contols neutrophils versus those infected with a bacterium (F. nucleatum).	56	2.109403e-2	1.000000e+0	7.194571e-1	4.740678e+1	2.109403e-2	1	2.109403e-2	1.000000e+0	10	2.007505e-2	1.000000e+0	1.000000e+0	4.956319e+1	2.017627e-2	1	182	5.000000e-1	5.494505e-3	unnamed	LY6E
MSigDB Immunologic Signatures	GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP	Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells treated with retinoic acid (tretinoin) [PubChem=444795] versus untreated memory CD4 [GeneID=920] T cells.	57	2.116743e-2	1.000000e+0	7.092946e-1	4.724238e+1	2.116743e-2	1	2.116743e-2	1.000000e+0	44	2.172051e-2	1.000000e+0	9.428676e-1	4.578934e+1	2.183914e-2	1	197	5.000000e-1	5.076142e-3	unnamed	LY6E
#
# Ontology	TermsTested	MinAnnotCount	MaxAnnotCount
#
# GO Molecular Function	3688	1	Inf
# GO Biological Process	10440	1	Inf
# GO Cellular Component	1265	1	Inf
# Mouse Phenotype	7918	1	Inf
# Human Phenotype	6146	1	Inf
# Disease Ontology	2235	1	Inf
# MSigDB Cancer Neighborhood	427	1	Inf
# Placenta Disorders	3	1	Inf
# PANTHER Pathway	152	1	Inf
# BioCyc Pathway	332	1	Inf
# MSigDB Pathway	1320	1	Inf
# MGI Expression: Detected	9337	1	Inf
# MSigDB Perturbation	3364	1	Inf
# MSigDB Predicted Promoter Motifs	615	1	Inf
# MSigDB miRNA Motifs	221	1	Inf
# InterPro	9422	1	Inf
# TreeFam	8126	1	Inf
# HGNC Gene Families	478	1	Inf
# Ensembl Genes	18041	1	Inf
# MSigDB Oncogenic Signatures	187	1	Inf
# MSigDB Immunologic Signatures	1910	1	Inf
